Cover Page
Cover Page - USD ($) $ in Billions | 12 Months Ended | ||
Dec. 31, 2020 | Jan. 29, 2021 | Jun. 30, 2020 | |
Cover [Abstract] | |||
Document Type | 10-K | ||
Document Annual Report | true | ||
Document Period End Date | Dec. 31, 2020 | ||
Current Fiscal Year End Date | --12-31 | ||
Document Transition Report | false | ||
Entity File Number | 001-34652 | ||
Entity Registrant Name | SENSATA TECHNOLOGIES HOLDING PLC | ||
Entity Incorporation, State or Country Code | X0 | ||
Entity Tax Identification Number | 98-1386780 | ||
Entity Address, Address Line One | 529 Pleasant Street | ||
Entity Address, City or Town | Attleboro | ||
Entity Address, State or Province | MA | ||
Entity Address, Postal Zip Code | 02703 | ||
Entity Address, Country | US | ||
City Area Code | 508 | ||
Local Phone Number | 236 3800 | ||
Title of 12(b) Security | Ordinary Shares - nominal value €0.01 per share | ||
Trading Symbol | ST | ||
Security Exchange Name | NYSE | ||
Entity Well-known Seasoned Issuer | Yes | ||
Entity Voluntary Filers | No | ||
Entity Current Reporting Status | Yes | ||
Entity Interactive Data Current | Yes | ||
Entity Filer Category | Large Accelerated Filer | ||
Entity Small Business | false | ||
Entity Emerging Growth Company | false | ||
ICFR Auditor Attestation Flag | true | ||
Entity Shell Company | false | ||
Entity Public Float | $ 5.8 | ||
Entity Common Stock, Shares Outstanding | 157,645,484 | ||
Documents Incorporated by Reference | Part III of this Report incorporates information from certain portions of the registrant’s Definitive Proxy Statement to be filed with the Securities and Exchange Commission within 120 days of the registrant's fiscal year ended December 31, 2020. | ||
Entity Central Index Key | 0001477294 | ||
Document Fiscal Year Focus | 2020 | ||
Document Fiscal Period Focus | FY | ||
Amendment Flag | false |
Consolidated Balance Sheets
Consolidated Balance Sheets - USD ($) $ in Thousands | Dec. 31, 2020 | Dec. 31, 2019 |
Current assets: | ||
Cash and cash equivalents | $ 1,861,980 | $ 774,119 |
Accounts receivable, net of allowances of $19,033 and $15,129 as of December 31, 2020 and 2019, respectively | 576,647 | 557,874 |
Inventories | 451,005 | 506,678 |
Prepaid expenses and other current assets | 90,340 | 126,981 |
Total current assets | 2,979,972 | 1,965,652 |
Property, plant and equipment, net | 803,825 | 830,998 |
Goodwill | 3,111,349 | 3,093,598 |
Other intangible assets, net | 691,549 | 770,904 |
Deferred income tax assets | 84,785 | 21,150 |
Other assets | 172,722 | 152,217 |
Total assets | 7,844,202 | 6,834,519 |
Current liabilities: | ||
Current portion of long-term debt, finance lease and other financing obligations | 757,205 | 6,918 |
Accounts payable | 393,907 | 376,968 |
Income taxes payable | 19,215 | 35,234 |
Accrued expenses and other current liabilities | 324,830 | 215,626 |
Total current liabilities | 1,495,157 | 634,746 |
Deferred income tax liabilities | 259,857 | 251,033 |
Pension and other post-retirement benefit obligations | 48,002 | 36,100 |
Finance lease and other financing obligations, less current portion | 27,931 | 28,810 |
Long-term debt, net | 3,213,747 | 3,219,885 |
Other long-term liabilities | 94,022 | 90,190 |
Total liabilities | 5,138,716 | 4,260,764 |
Commitments and contingencies (Note 15) | ||
Shareholders’ equity: | ||
Ordinary shares, €0.01 nominal value per share, 177,069 shares authorized and 173,266 and 172,561 shares issued as of December 31, 2020 and 2019, respectively | 2,220 | 2,212 |
Treasury shares, at cost, 15,631 and 14,733 shares as of December 31, 2020 and 2019, respectively | (784,596) | (749,421) |
Additional paid-in capital | 1,759,668 | 1,725,091 |
Retained earnings | 1,777,729 | 1,616,357 |
Accumulated other comprehensive loss | (49,535) | (20,484) |
Total shareholders’ equity | 2,705,486 | 2,573,755 |
Total liabilities and shareholders’ equity | $ 7,844,202 | $ 6,834,519 |
Consolidated Balance Sheets (Pa
Consolidated Balance Sheets (Parentheticals) $ in Thousands | Dec. 31, 2020USD ($)shares | Dec. 31, 2020€ / shares | Dec. 31, 2019USD ($)shares | Dec. 31, 2019€ / shares |
Assets, Current [Abstract] | ||||
Allowance for doubtful accounts receivable, current | $ | $ 19,033 | $ 15,129 | ||
Stockholders' Equity Attributable to Parent [Abstract] | ||||
Ordinary shares nominal value per share (in euros per share) | € / shares | € 0.01 | € 0.01 | ||
Ordinary shares authorized (in shares) | 177,069,000 | 177,069,000 | ||
Ordinary shares issued (in shares) | 173,266,000 | 172,561,000 | ||
Treasury shares (in shares) | 15,631,000 | 14,733,000 |
Consolidated Statements of Oper
Consolidated Statements of Operations - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Income Statement [Abstract] | |||
Net revenue | $ 3,045,578 | $ 3,450,631 | $ 3,521,627 |
Operating costs and expenses: | |||
Cost of revenue | 2,119,044 | 2,267,433 | 2,266,863 |
Research and development | 131,429 | 148,425 | 147,279 |
Selling, general and administrative | 294,725 | 281,442 | 305,558 |
Amortization of intangible assets | 129,549 | 142,886 | 139,326 |
Restructuring and other charges, net | 33,094 | 53,560 | (47,818) |
Total operating costs and expenses | 2,707,841 | 2,893,746 | 2,811,208 |
Operating income | 337,737 | 556,885 | 710,419 |
Interest expense, net | (171,757) | (158,554) | (153,679) |
Other, net | (339) | (7,908) | (30,365) |
Income before taxes | 165,641 | 390,423 | 526,375 |
Provision for/(benefit from) income taxes | 1,355 | 107,709 | (72,620) |
Net income | $ 164,286 | $ 282,714 | $ 598,995 |
Basic net income per share (in dollars per share) | $ 1.04 | $ 1.76 | $ 3.55 |
Diluted net income per share (in dollars per share) | $ 1.04 | $ 1.75 | $ 3.53 |
Consolidated Statements of Comp
Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Statement of Other Comprehensive Income [Abstract] | |||
Net income | $ 164,286 | $ 282,714 | $ 598,995 |
Other comprehensive (loss)/income, net of tax: | |||
Cash flow hedges | (23,279) | 7,362 | |
Cash flow hedges | 37,363 | ||
Defined benefit and retiree healthcare plans | (5,772) | (1,668) | (377) |
Other comprehensive (loss)/income | (29,051) | 5,694 | 36,986 |
Comprehensive income | $ 135,235 | $ 288,408 | $ 635,981 |
Consolidated Statements of Cash
Consolidated Statements of Cash Flows - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Cash flows from operating activities: | |||
Net income | $ 164,286 | $ 282,714 | $ 598,995 |
Adjustments to reconcile net income to net cash provided by operating activities: | |||
Depreciation | 125,680 | 115,862 | 106,014 |
Amortization of debt issuance costs | 6,854 | 7,804 | 7,317 |
Gain on sale of business | 0 | 0 | (64,423) |
Share-based compensation | 19,125 | 18,757 | 23,825 |
Loss on debt financing | 0 | 4,364 | 2,350 |
Amortization of intangible assets | 129,549 | 142,886 | 139,326 |
Deferred income taxes | (44,900) | 27,623 | (144,068) |
Unrealized loss on derivative instruments and other | 4,709 | 30,292 | 18,176 |
Changes in operating assets and liabilities, net of the effects of acquisitions and divestitures: | |||
Accounts receivable, net | (16,668) | 26,605 | (34,877) |
Inventories | 58,390 | (10,924) | (55,445) |
Prepaid expenses and other current assets | 36,431 | 10,073 | (11,891) |
Accounts payable and accrued expenses | 90,479 | (34,563) | 48,371 |
Income taxes payable | (16,019) | 2,308 | (353) |
Other | 1,859 | (4,239) | (12,754) |
Net cash provided by operating activities | 559,775 | 619,562 | 620,563 |
Cash flows from investing activities: | |||
Acquisitions, net of cash received | (64,432) | (32,465) | (228,307) |
Additions to property, plant and equipment and capitalized software | (106,719) | (161,259) | (159,787) |
Investment in debt and equity securities | (22,963) | (9,950) | 0 |
Proceeds from sale of business, net of cash sold | 0 | 0 | 149,777 |
Other | 12,022 | (5,103) | 711 |
Net cash used in investing activities | (182,092) | (208,777) | (237,606) |
Cash flows from financing activities: | |||
Proceeds from exercise of stock options and issuance of ordinary shares | 15,457 | 15,150 | 6,093 |
Payment of employee restricted stock tax withholdings | (2,911) | (6,990) | (3,674) |
Proceeds from borrowings on debt | 1,150,000 | 450,000 | 0 |
Payments on debt | (408,914) | (464,605) | (15,653) |
Payments to repurchase ordinary shares | (35,175) | (350,004) | (399,417) |
Payments of debt and equity issuance costs | (8,279) | (10,050) | (9,931) |
Other | 0 | 0 | 16,369 |
Net cash provided by/(used in) financing activities | 710,178 | (366,499) | (406,213) |
Net change in cash and cash equivalents | 1,087,861 | 44,286 | (23,256) |
Cash and cash equivalents, beginning of year | 774,119 | 729,833 | 753,089 |
Cash and cash equivalents, end of year | 1,861,980 | 774,119 | 729,833 |
Supplemental cash flow items: | |||
Cash paid for interest | 164,494 | 169,543 | 163,478 |
Cash paid for income taxes | $ 65,823 | $ 61,031 | $ 72,924 |
Consolidated Statements of Chan
Consolidated Statements of Changes in Shareholders' Equity - USD ($) shares in Thousands, $ in Thousands | Total | Ordinary Shares | Treasury Shares | Additional Paid-In Capital | Retained Earnings | Accumulated Other Comprehensive Loss |
Balance (shares) at Dec. 31, 2017 | 178,437 | (7,076) | ||||
Stockholders equity, beginning of period at Dec. 31, 2017 | $ 2,345,626 | $ 2,289 | $ (288,478) | $ 1,663,367 | $ 1,031,612 | $ (63,164) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||
Surrender of shares for tax withholding (in shares) | (71) | |||||
Surrender of shares for tax withholding | $ (3,674) | $ (3,674) | ||||
Stock options exercised (in shares) | 172 | 114 | 58 | |||
Stock options exercised | $ 6,093 | $ 1 | $ 2,250 | 3,998 | (156) | |
Vesting of restricted securities (in shares) | 257 | |||||
Vesting of restricted securities | 0 | $ 3 | (3) | |||
Retirement of ordinary shares due to Merger (in shares) | (7,018) | (7,018) | ||||
Retirement of ordinary shares due to Merger | 0 | $ (89) | $ 286,228 | (286,139) | ||
Repurchase of ordinary shares (in shares) | (7,571) | |||||
Repurchase of ordinary shares | (399,417) | $ (399,417) | ||||
Other retirements of ordinary shares (in shares) | (71) | (71) | ||||
Other retirements of ordinary shares | 0 | $ (1) | $ 3,674 | (3,673) | ||
Share-based compensation | 23,825 | 23,825 | ||||
Net income | 598,995 | 598,995 | ||||
Other comprehensive (loss)/income | 36,986 | 36,986 | ||||
Balance (shares) at Dec. 31, 2018 | 171,719 | (7,571) | ||||
Stockholders equity, end of period at Dec. 31, 2018 | 2,608,434 | $ 2,203 | $ (399,417) | 1,691,190 | 1,340,636 | (26,178) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||
Surrender of shares for tax withholding (in shares) | (149) | |||||
Surrender of shares for tax withholding | $ (6,990) | $ (6,990) | ||||
Stock options exercised (in shares) | 537 | 537 | ||||
Stock options exercised | $ 15,150 | $ 6 | 15,144 | |||
Vesting of restricted securities (in shares) | 454 | |||||
Vesting of restricted securities | 0 | $ 5 | (5) | |||
Repurchase of ordinary shares (in shares) | (7,162) | |||||
Repurchase of ordinary shares | (350,004) | $ (350,004) | ||||
Other retirements of ordinary shares (in shares) | (149) | (149) | ||||
Other retirements of ordinary shares | 0 | $ (2) | $ 6,990 | (6,988) | ||
Share-based compensation | 18,757 | 18,757 | ||||
Net income | 282,714 | 282,714 | ||||
Other comprehensive (loss)/income | 5,694 | 5,694 | ||||
Balance (shares) at Dec. 31, 2019 | 172,561 | (14,733) | ||||
Stockholders equity, end of period at Dec. 31, 2019 | 2,573,755 | $ 2,212 | $ (749,421) | 1,725,091 | 1,616,357 | (20,484) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||
Surrender of shares for tax withholding (in shares) | (96) | |||||
Surrender of shares for tax withholding | $ (2,911) | $ (2,911) | ||||
Stock options exercised (in shares) | 452 | 452 | ||||
Stock options exercised | $ 15,457 | $ 5 | 15,452 | |||
Vesting of restricted securities (in shares) | 349 | |||||
Vesting of restricted securities | 0 | $ 4 | (4) | |||
Repurchase of ordinary shares (in shares) | (898) | |||||
Repurchase of ordinary shares | (35,175) | $ (35,175) | ||||
Other retirements of ordinary shares (in shares) | (96) | (96) | ||||
Other retirements of ordinary shares | 0 | $ (1) | $ 2,911 | (2,910) | ||
Share-based compensation | 19,125 | 19,125 | ||||
Net income | 164,286 | 164,286 | ||||
Other comprehensive (loss)/income | (29,051) | (29,051) | ||||
Balance (shares) at Dec. 31, 2020 | 173,266 | (15,631) | ||||
Stockholders equity, end of period at Dec. 31, 2020 | $ 2,705,486 | $ 2,220 | $ (784,596) | $ 1,759,668 | $ 1,777,729 | $ (49,535) |
Business Description and Basis
Business Description and Basis of Presentation | 12 Months Ended |
Dec. 31, 2020 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Business Description and Basis of Presentation | Business Description and Basis of Presentation Description of Business The accompanying audited consolidated financial statements reflect the financial position, results of operations, comprehensive income, cash flows, and changes in shareholders' equity of Sensata Technologies Holding plc ("Sensata plc"), a public limited company incorporated under the laws of England and Wales, and its wholly-owned subsidiaries, collectively referred to as the "Company," "Sensata," "we," "our," and "us." Prior to March 28, 2018, our parent company issuer was Sensata Technologies Holding N.V. ("Sensata N.V."), which was incorporated under the laws of the Netherlands. On March 28, 2018, Sensata plc completed a cross-border merger (the "Merger") with Sensata N.V., which changed the location of our incorporation from the Netherlands to England and Wales, but did not change the business being conducted by us or our subsidiaries. We are a global industrial technology company that develops, manufactures, and sells sensors, electrical protection products, and other products that are used in mission-critical systems and applications that create valuable business insights for our customers and end users. Our sensors are used by our customers to translate a physical parameter, such as pressure, temperature, position, or location of an object, into electronic signals that our customers’ products and solutions can act upon. These actionable insights lead to products that are safer, cleaner, more efficient, more electrified, and increasingly more connected. Our electrical protection product portfolio is comprised of various sensors, controllers, receivers, and software, and includes high-voltage contactors and other products embedded within systems to maximize their efficiency and protect them from excessive heat or current. Sensata plc conducts its operations through subsidiary companies that operate business and product development centers primarily in Belgium, Bulgaria, China, Denmark, France, India, Japan, the Netherlands, South Korea, the United Kingdom (the "U.K."), and the United States (the "U.S."); and manufacturing operations primarily in Bulgaria, China, Malaysia, Mexico, the U.K., and the U.S. We operate in, and report financial information for, two reportable segments: Performance Sensing and Sensing Solutions. Refer to Note 20, "Segment Reporting," for additional information related to each of our segments. Basis of Presentation The accompanying audited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles ("U.S. GAAP") and present separately our financial position, results of operations, comprehensive income, cash flows, and changes in shareholders’ equity. All intercompany balances and transactions have been eliminated. All U.S. dollar ("USD") and share amounts presented, except per share amounts, are stated in thousands, unless otherwise indicated. Certain reclassifications have been made to prior periods to conform to current period presentation. |
Significant Accounting Policies
Significant Accounting Policies | 12 Months Ended |
Dec. 31, 2020 | |
Accounting Policies [Abstract] | |
Significant Accounting Policies | Significant Accounting Policies Use of Estimates The preparation of consolidated financial statements in accordance with U.S. GAAP requires us to exercise our judgment in the process of applying our accounting policies. It also requires that we make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingencies at the date of the financial statements, and the reported amounts of net revenue and expense during the reporting periods. Estimates are used when accounting for certain items such as allowance for doubtful accounts and sales returns, inventory obsolescence, asset impairments (including goodwill and other intangible assets), contingencies, the value of certain equity awards and the measurement of share-based compensation, the determination of accrued expenses, certain asset valuations, accounting for income taxes, the useful lives of plant and equipment, measurement of our post-retirement benefit obligations, and the identification, valuation, and determination of useful lives of identifiable intangible assets acquired in business combinations. The accounting estimates used in the preparation of the consolidated financial statements may change as new events occur, as more experience is acquired, as additional information is obtained, and as the operating environment changes. Actual results could differ from those estimates. Revenue Recognition We recognize revenue to depict the transfer of promised goods to customers in an amount that reflects the consideration to which we expect to be entitled in exchange for those goods. In order to achieve this, we use the five step model outlined in Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") Topic 606, Revenue from Contracts with Customers . This five step model requires us to identify the contract with the customer, identify the performance obligation(s) in the contract, determine the transaction price, allocate the transaction price to the performance obligation(s), and recognize revenue when (or as) we satisfy the performance obligation(s). The vast majority of our contracts (as defined in FASB ASC Topic 606) are customer purchase orders that require us to transfer specified quantities of tangible products to our customers. These performance obligations are generally satisfied within a short period of time. Amounts billed to our customers for shipping and handling after control has transferred are recognized as revenue and the related costs that we incur are presented in cost of revenue. In determining the transaction price, we evaluate whether the consideration promised in the contract includes a variable amount and, if applicable, we include in the transaction price some or all of an amount of variable consideration only to the extent it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved. Variable consideration may be explicitly stated in the contract or implied based on our customary practices. Examples of variable consideration present in our contracts include rights of return, in the case of a defective or non-conforming product, and trade discounts, including early payment discounts and retrospective volume discounts. Such variable consideration has not historically been material in relation to our net revenue. Our contract terms generally require the customer to make payment shortly (that is, less than one year) after the shipment date. In such instances, we do not consider the effects of a significant financing component in determining the transaction price. Lastly, we exclude from our determination of the transaction price value-added tax and other similar taxes. Our performance obligations are satisfied, and revenue is recognized, when control of the product is transferred to the customer. The transfer of control generally occurs at the point in time the product is shipped from our warehouse or, less often, at the point in time it is received by the customer, depending on the specific terms of the arrangement. Many of our products are designed and engineered to meet customer specifications. These activities, and the testing of our products to determine compliance with those specifications, occur prior to any revenue being recognized. Products are then manufactured and sold to customers. However, in certain cases, pre-production activities are a performance obligation in a customer purchase order, and revenue is recognized when the performance obligation is satisfied. Customer arrangements do not involve post-installation or post-sale testing and acceptance. Our standard terms of sale provide our customers with a warranty against faulty workmanship and the use of defective materials, which is not considered a distinct performance obligation in accordance with FASB ASC Topic 606. Depending on the product, we generally provide such warranties for a period of twelve We also sell products to customers under negotiated agreements or where we have accepted the customer’s terms of purchase. In these instances, we may provide additional warranties for longer durations, consistent with differing end market practices, and where our liability is not limited. In addition, many sales take place in situations where commercial or civil codes, or other laws, would imply various warranties and restrict limitations on liability. Refer to Note 3, "Revenue Recognition," for additional information related to the net revenue recognized in the consolidated statements of operations. Share-Based Compensation We measure at fair value any new or modified share-based compensation arrangements with employees, such as stock options and restricted securities, and recognize as compensation expense that fair value over the requisite service period in accordance with FASB ASC Topic 718, Compensation—Stock Compensation . Share-based compensation expense is generally recognized as a component of selling, general and administrative ("SG&A") expense, which is consistent with where the related employee costs are presented, however, such costs, or a portion thereof, may be capitalized provided certain criteria are met. Share-based awards may be subject to either cliff vesting (i.e., the entire award vests on a particular date) or graded vesting (i.e., portions of the award vest at different points in time). In accordance with FASB ASC Topic 718, compensation expense associated with share-based awards subject to cliff vesting must be recognized on a straight-line basis. For awards without performance conditions that are subject to graded vesting, companies have the option to recognize compensation expense either on a straight-line or accelerated basis. We have elected to recognize compensation expense for these awards on a straight-line basis. However, awards that are subject to both graded vesting and performance conditions must be expensed on an accelerated basis. We estimate the fair value of options on the grant date using the Black-Scholes-Merton option-pricing model. Key inputs and assumptions used in this model are as follows: • The fair value of the underlying ordinary shares. This is determined as the closing price of our ordinary shares on the New York Stock Exchange (the "NYSE") on the grant date. • The expected term. This is determined based upon our own historical average term of exercised and outstanding options. • Expected volatility. We consider our own historical volatility as well as our implied volatility in estimating expected volatility for stock options. Implied volatility provides a forward-looking indication and may offer insight into expected volatility. • Risk-free interest rate. The risk-free interest rate is based on the yield for a U.S. Treasury security having a maturity similar to the expected term of the related option grant. • Expected dividend yield. The dividend yield of 0% is based on our history of having never declared or paid any dividends on our ordinary shares as well as our current intention not to declare dividends in the foreseeable future. Restricted securities are valued using the closing price of our ordinary shares on the NYSE on the grant date. Certain of our restricted securities include performance conditions that require us to estimate the probable outcome of the performance condition. Compensation expense is recognized if it is probable that the performance condition will be achieved. We elect to recognize share-based compensation expense net of estimated forfeitures as permitted by FASB ASC Topic 718. Accordingly, we only recognize compensation expense for those awards expected to vest over the requisite service period. Compensation expense recognized for each award ultimately reflects the number of units that actually vest. Refer to Note 4, "Share-Based Payment Plans," for additional information related to share-based compensation. Financial Instruments Our material financial instruments include derivative instruments, debt instruments, equity investments, and trade accounts receivable. Derivative financial instruments: We account for our derivative financial instruments in accordance with FASB ASC Topic 820, Fair Value Measurements and Disclosures and FASB ASC Topic 815, Derivatives and Hedging . In accordance with FASB ASC Topic 815, we recognize all derivatives on the balance sheet at fair value. The fair value of our derivative financial instruments is determined using widely accepted valuation techniques, including discounted cash flow analysis on the expected cash flows of each instrument. These analyses utilize observable market-based inputs, including foreign currency exchange rates and commodity forward curves, and reflect the contractual terms of these instruments, including the period to maturity. Derivative instruments that are designated and qualify as hedges of the exposure to changes in the fair value of an asset, liability, or commitment, and that are attributable to a particular risk, such as interest rate risk, are considered fair value hedges. Derivative instruments that are designated and qualify as hedges of the exposure to variability in expected future cash flows are considered cash flow hedges. Derivative instruments may also be designated as hedges of the foreign currency exposure of a net investment in a foreign operation. Currently, all of our derivative instruments that are designated as accounting hedges are cash flow hedges. We also hold derivative instruments that are not designated as accounting hedges. The accounting for changes in the fair value of our cash flow hedges depends on whether we have elected to designate the derivative as a hedging instrument for accounting purposes and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. In accordance with FASB ASC Topic 815, both the effective and ineffective portion of changes in the fair value of derivatives designated and qualifying as cash flow hedges is recognized in accumulated other comprehensive loss and is subsequently reclassified into earnings in the period in which the hedged forecasted transaction affects earnings. Changes in the fair value of derivative instruments that are not designated as accounting hedges are recognized immediately in other, net. Refer to Note 16, "Shareholders' Equity," and Note 19, "Derivative Instruments and Hedging Activities," for additional information related to the reclassification of amounts from accumulated other comprehensive loss into earnings. We present the cash flows arising from our derivative financial instruments in a manner consistent with the presentation of cash flows that relate to the underlying hedged items. We incorporate credit valuation adjustments to appropriately reflect both our own non-performance risk and the respective counterparty’s non-performance risk in the fair value measurements. In adjusting the fair value of our derivative contracts for the effect of non-performance risk, we have considered the impact of netting and any applicable credit enhancements, such as collateral postings, thresholds, mutual puts, and guarantees. We do not offset the fair value amounts recognized for derivative instruments against fair value amounts recognized for the right to reclaim cash collateral or the obligation to return cash collateral. We maintain derivative instruments with major financial institutions of investment grade credit rating and monitor the amount of credit exposure to any one issuer. We believe there are no significant concentrations of risk associated with our derivative instruments. Refer to Note 19, "Derivative Instruments and Hedging Activities," for additional information related to our derivative instruments. Debt Instruments: A premium or discount on a debt instrument is recognized on the balance sheet as an adjustment to the carrying value of the debt liability. In general, amounts paid to creditors are considered a reduction in the proceeds received from the issuance of the debt and are accounted for as a component of the premium or discount on the issuance, not as an issuance cost. Direct and incremental costs associated with the issuance of debt instruments such as legal fees, printing costs, and underwriters' fees, among others, paid to parties other than creditors, are also reported and presented as a reduction of debt on the consolidated balance sheets. Debt issuance costs and premiums or discounts are amortized over the term of the respective financing arrangement using the effective interest method. Amortization of these amounts is included as a component of interest expense, net in the consolidated statements of operations. In accounting for debt refinancing transactions, we apply the provisions of FASB ASC Subtopic 470-50, Modifications and Extinguishments . Our evaluation of the accounting under FASB ASC Subtopic 470-50 is done on a creditor by creditor basis in order to determine if the terms of the debt are substantially different and, as a result, whether to apply modification or extinguishment accounting. In the event that an individual holder of existing debt did not invest in new debt, we apply extinguishment accounting. Borrowings associated with individual holders of new debt that are not holders of existing debt are accounted for as new issuances. Refer to Note 14, "Debt," for additional information related to our debt instruments and transactions. Equity Investments: We measure equity investments (other than those accounted for under the equity method, those that result in consolidation of the investee, and certain other investments) either at fair value, with changes to fair value recognized in net income, or in certain instances, by use of a measurement alternative prescribed in FASB ASC Topic 321, Investments - Equity Securities . Under the measurement alternative, such investments are measured at cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer. Refer to Note 18, "Fair Value Measures," for additional information related to our measurement of financial instruments, including equity investments. Trade accounts receivable: Trade accounts receivable are recognized at invoiced amounts and do not bear interest. Trade accounts receivable are reduced by an allowance for losses on receivables. Concentrations of risk with respect to trade accounts receivable are generally limited due to the large number of customers in various industries and their dispersion across several geographic areas. Although we do not foresee that credit risk associated with these receivables will deviate from historical experience, repayment is dependent upon the financial stability of these individual customers. We estimate an allowance for credit losses on trade accounts receivable at an amount that represents our estimated expected credit losses over the lifetime of our receivables. Our contract terms generally require the customer to make payment shortly after (that is, less than one year) the shipment date. Our largest customer accounted for approximately 7% of our net revenue for the year ended December 31, 2020. Allowance for Losses on Receivables The allowance for losses on receivables is used to present accounts receivable, net at an amount that represents our estimate of the related transaction price recognized as revenue in accordance with FASB ASC Topic 606. The allowance represents an estimate of expected credit losses over the lifetime of our receivables, even if the loss is considered remote, and reflects expected recoveries of amounts previously written-off. We estimate the allowance on the basis of specifically identified receivables that are evaluated individually for impairment and a statistical analysis of the remaining receivables determined by reference to past default experience. We consider the need to adjust historical information to reflect the extent to which we expect current conditions and reasonable forecasts to differ from the conditions that existed for the historical period considered. Customers are generally not required to provide collateral for purchases. The allowance for losses on receivables also includes an allowance for sales returns (variable consideration). Management judgments are used to determine when to charge off uncollectible trade accounts receivable. We base these judgments on the age of the receivable, credit quality of the customer, current economic conditions, and other factors that may affect a customer’s ability and intent to pay. Losses on receivables have not historically been significant. Goodwill and Other Intangible Assets Businesses acquired are recognized at their fair value on the date of acquisition, with the excess of the purchase price over the fair value of identifiable assets acquired and liabilities assumed recognized as goodwill. Intangible assets acquired may include either definite-lived or indefinite-lived intangible assets, or both. In accordance with the guidance in FASB ASC Topic 350, Intangibles—Goodwill and Other , goodwill and intangible assets determined to have an indefinite useful life are not amortized. Instead these assets are evaluated for impairment on an annual basis and whenever events or business conditions change that could indicate that the asset is impaired. We evaluate goodwill and indefinite-lived intangible assets for impairment in the fourth quarter of each fiscal year, unless events occur which trigger the need for an earlier impairment review. Goodwill: Our reporting units have been identified based on the definitions and guidance provided in FASB ASC Topic 350. Identification of reporting units includes an analysis of the components that comprise each of our operating segments, which considers, among other things, the manner in which we operate our business and the availability of discrete financial information. Components of an operating segment are aggregated to form one reporting unit if the components have similar economic characteristics. We periodically review these reporting units to ensure that they continue to reflect the manner in which the business is operated. Some assets and liabilities relate to the operations of multiple reporting units. We allocate these assets and liabilities to the related reporting units based on methods that we believe are reasonable and supportable. We apply that allocation method on a consistent basis from year to year. Other assets and liabilities, such as debt, cash and cash equivalents, and property, plant and equipment, net ("PP&E") associated with our corporate offices, are viewed as being corporate in nature. Accordingly, we do not assign these assets and liabilities to our reporting units. In the event we reorganize our business, we reassign the assets (including goodwill) and liabilities among the affected reporting units using a reasonable and supportable methodology. As businesses are acquired, we assign assets acquired (including goodwill) and liabilities assumed to a new or existing reporting unit as of the date of the acquisition. In the event a disposal group meets the definition of a business, goodwill is allocated to the disposal group based on the relative fair value of the disposal group to the retained portion of the related reporting unit. We have the option to first assess qualitative factors to determine whether a quantitative analysis must be performed. The objective of a qualitative analysis is to assess whether it is more likely than not that the fair value of a reporting unit is less than its carrying value. We make this assessment based on macroeconomic conditions, industry and market considerations, cost factors, overall financial performance, and other relevant factors as applicable. If we elect not to use this option, or if we determine that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then we prepare a discounted cash flow analysis to determine whether the carrying value of reporting unit exceeds its estimated fair value. If the carrying value of a reporting unit exceeds its estimated fair value, we recognize an impairment of goodwill for the amount of this excess, in accordance with the guidance in FASB Accounting Standards Update ("ASU") No. 2017-04, Intangibles - Goodwill and Other (Topic 350), Simplifying the Test for Goodwill Impairment , which we adopted as of January 1, 2020. Indefinite-lived intangible assets: Similar to goodwill, we perform an annual impairment review of our indefinite-lived intangible assets in the fourth quarter of each fiscal year, unless events occur that trigger the need for an earlier impairment review. We have the option to first assess qualitative factors in determining whether it is more likely than not that an indefinite-lived intangible asset is impaired. If we elect not to use this option, or we determine that it is more likely than not that the asset is impaired, we perform a quantitative impairment analysis in which we estimate the fair value of the indefinite-lived intangible asset and compare that amount to its carrying value. In this analysis, we estimate the fair value by using the relief-from-royalty method, in which we make assumptions about future conditions impacting the fair value of our indefinite-lived intangible assets, including projected growth rates, cost of capital, effective tax rates, and royalty rates. Impairment, if any, is based on the excess of the carrying value over the fair value of these assets. Definite-lived intangible assets: Acquisition-related definite-lived intangible assets are amortized on an economic-benefit basis according to the useful lives of the assets, or on a straight-line basis if a pattern of economic benefits cannot be reliably determined. Capitalized software and capitalized software licenses are presented on the consolidated balance sheets as intangible assets. Capitalized software licenses are amortized on a straight-line basis over the lesser of the term of the license or the estimated useful life of the software. Capitalized software is amortized on a straight-line basis over its estimated useful life. Reviews are regularly performed to determine whether facts or circumstances exist that indicate that the carrying values of our definite-lived intangible assets are impaired. If we determine that such facts or circumstances exist, we estimate the recoverability of these assets by comparing the projected undiscounted net cash flows associated with these assets to their respective carrying values. If the sum of the projected undiscounted net cash flows is less than the carrying value of an asset, the impairment charge is measured as the excess of the carrying value over the fair value of that asset. We determine fair value by using the appropriate income approach valuation methodology, depending on the nature of the definite-lived intangible asset. Refer to Note 11, "Goodwill and Other Intangible Assets, Net," for additional information related to our goodwill and other intangible assets. Income Taxes We estimate our provision for (or benefit from) income taxes in each of the jurisdictions in which we operate. The provision for (or benefit from) income taxes includes both our current and deferred tax exposure. Our deferred tax exposure is measured using the asset and liability method, under which deferred income taxes are recognized to reflect the future tax consequences of differences between the tax bases of assets and liabilities and their financial reporting amounts at each balance sheet date, based on enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to reverse or settle. The effect on deferred tax assets and liabilities of a change in statutory tax rates is recognized in the consolidated statements of operations as an adjustment to income tax expense in the period that includes the enactment date. In measuring our deferred tax assets, we consider all available evidence, both positive and negative, to determine whether, based on the weight of that evidence, a valuation allowance is needed for all or some portion of the deferred tax assets. If it is determined that it is more likely than not that future tax benefits associated with a deferred tax asset will not be realized, a valuation allowance is provided. As a result, we maintain valuation allowances against the deferred tax assets in jurisdictions that have incurred losses in recent periods and in which it is more likely than not that such deferred tax assets will not be utilized in the foreseeable future. In accordance with FASB ASC Topic 740, Income Taxes , we record uncertain tax positions on the basis of a two-step process. First, we determine whether it is more likely than not that the tax positions will be sustained based on the technical merits of the position. Second, for those tax positions that meet the more-likely-than-not recognition threshold, we recognize the largest amount of tax benefit that is greater than 50 percent likely to be realized upon ultimate settlement with the relevant tax authority. Significant judgment is required in evaluating whether our tax positions meet this two-step process. The more-likely-than-not recognition threshold must be met in each reporting period to support continued recognition of any tax benefits claimed, both in the current year, as well as any year which remains open for review by the relevant tax authority at the balance sheet date. Penalties and interest related to uncertain tax positions may be classified as either income taxes or another expense line item in the consolidated statements of operations. We classify interest and penalties related to uncertain tax positions within the provision for/(benefit from) income taxes line of the consolidated statements of operations. Refer to Note 7, "Income Taxes," for additional information related to our income taxes. Pension and Other Post-Retirement Benefits We sponsor various pension and other post-retirement benefit plans covering our current and former employees in several countries. The funded status of pension and other post-retirement benefit plans, recognized on our consolidated balance sheets as an asset, current liability, or long-term liability, is measured as the difference between the fair value of plan assets and the benefit obligation at the measurement date. In general, the measurement date coincides with our fiscal year end, however, certain significant events, such as (1) plan amendments, (2) business combinations, (3) settlements or curtailments, or (4) plan mergers, may trigger the need for an interim measurement of both the plan assets and benefit obligations. Benefit obligations represent the actuarial present value of all benefits attributed by the pension formula as of the measurement date to employee service rendered before that date. The value of benefit obligations takes into consideration various financial assumptions, including assumed discount rate and the rate of increase in healthcare costs, and demographic assumptions, including compensation rate increases, retirement patterns, employee turnover rates, and mortality rates. We review these assumptions annually. Our review of demographic assumptions includes analyzing historical patterns and/or referencing industry standard tables, combined with our expectations around future compensation and staffing strategies. The difference between these assumptions and our actual experience results in the recognition of an actuarial gain or loss. Actuarial gains and losses are recorded directly to other comprehensive income or loss. If the total net actuarial gain or loss included in accumulated other comprehensive loss exceeds a threshold of 10% of the greater of the projected benefit obligation or the market related value of plan assets, it is subject to amortization and recorded as a component of net periodic benefit cost over the average remaining service lives of the employees participating in the pension or post-retirement benefit plan. The discount rate reflects the current rate at which the pension and other post-retirement liabilities could be effectively settled, considering the timing of expected payments for plan participants. It is used to discount the estimated future obligations of the plans to the present value of the liability reflected in the financial statements. In estimating this rate in countries that have a market of high-quality, fixed-income investments, we consider rates of return on these investments included in various bond indices, adjusted to eliminate the effects of call provisions and differences in the timing and amounts of cash outflows related to the bonds. In other countries where a market of high-quality, fixed-income investments does not exist, we estimate the discount rate using government bond yields or long-term inflation rates. The expected return on plan assets reflects the average rate of earnings expected on the funds invested to provide for the benefits included in the projected benefit obligation. To determine the expected return on plan assets, we use the fair value of plan assets and consider the historical returns earned by similarly invested assets, the rates of return expected on plan assets in the future, and our investment strategy and asset mix with respect to the plans’ funds. Changes to benefit obligations may also be initiated by a settlement or curtailment. A settlement of a defined benefit obligation is an irrevocable transaction that relieves us (or the plan) of primary responsibility for the defined benefit obligation and eliminates significant risks related to the obligation and the assets used to effect the settlement. The settlement of all or more than a minor portion of the pension obligation constitutes an event that requires recognition of all or part of the net actuarial gains or losses deferred in accumulated other comprehensive loss. Our policy is to apply settlement accounting to the extent our year-to date settlements for a given plan exceed the sum of our forecasted full year service cost and interest cost for that particular plan. A curtailment is an event that significantly reduces the expected years of service of active employees or eliminates for a significant number of employees the accrual of defined benefits for some or all of their future service. The curtailment accounting provisions are applied on a plan-by-plan basis. The total gain or loss resulting from a curtailment is the sum of two distinct elements: (1) prior service cost write-off and (2) curtailment gain or loss. Our policy is that a curtailment event represents one for which we expect a 10% (or greater) reduction in future years of service or an elimination of the accrual of defined benefits for some or all of the future services of 10% (or greater) of the plan's participants. Contributions made to pension and other post-retirement benefit plans are presented as cash used in operations within the consolidated statements of cash flows. We present the service cost component of net periodic benefit cost in the cost of revenue, research and development ("R&D"), and SG&A expense line items, and we present the non–service components of net periodic benefit cost in other, net. Refer to Note 13, "Pension and Other Post-Retirement Benefits," for additional information related to our pension and other post-retirement benefit plans. Inventories Inventories are stated at the lower of cost or estimated net |
Revenue Recognition
Revenue Recognition | 12 Months Ended |
Dec. 31, 2020 | |
Revenue from Contract with Customer [Abstract] | |
Revenue Recognition | Revenue Recognition We recognize revenue to depict the transfer of promised goods to customers in an amount that reflects the consideration to which we expect to be entitled in exchange for those goods. The vast majority of our revenue is derived from the sale of tangible products whereby control of the product transfers to the customer at a point in time, we recognize revenue at a point in time, and the underlying contract is a purchase order that establishes a firm purchase commitment for a short period of time. Our standard terms of sale provide our customers with a warranty against faulty workmanship and the use of defective materials. We do not offer separately priced extended warranty or product maintenance contracts. Refer to Note 2, "Significant Accounting Policies," for additional information. We have elected to apply certain practical expedients that allow for more limited disclosures than those that would otherwise be required by FASB ASC Topic 606, including (1) the disclosure of transaction price allocated to the remaining unsatisfied performance obligations at the end of the period and (2) an explanation of when we expect to recognize the related revenue. We believe that our end markets are the categories that best depict how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors. The following table presents net revenue disaggregated by segment and end market for the years ended December 31, 2020, 2019, and 2018: Performance Sensing Sensing Solutions Total For the year ended December 31, For the year ended December 31, For the year ended December 31, 2020 2019 2018 2020 2019 2018 2020 2019 2018 Net revenue: Automotive $ 1,715,749 $ 1,986,537 $ 2,076,834 $ 35,621 $ 42,446 $ 49,961 $ 1,751,370 $ 2,028,983 $ 2,126,795 HVOR (1) 508,061 559,479 550,817 — — — 508,061 559,479 550,817 Industrial — — — 336,506 351,942 336,617 336,506 351,942 336,617 Appliance and HVAC (2) — — — 189,782 201,745 208,482 189,782 201,745 208,482 Aerospace — — — 136,167 176,505 164,294 136,167 176,505 164,294 Other — — — 123,692 131,977 134,622 123,692 131,977 134,622 Net revenue $ 2,223,810 $ 2,546,016 $ 2,627,651 $ 821,768 $ 904,615 $ 893,976 $ 3,045,578 $ 3,450,631 $ 3,521,627 __________________________________________ (1) Heavy vehicle and off-road (2) Heating, ventilation and air conditioning In addition, refer to Note 20, "Segment Reporting," for a presentation of net revenue disaggregated by product category and geographic region. Contract Assets and Liabilities |
Share-Based Payment Plans
Share-Based Payment Plans | 12 Months Ended |
Dec. 31, 2020 | |
Share-based Payment Arrangement [Abstract] | |
Share-Based Payment Plans | Share-Based Payment Plans We issue share-based compensation awards under the Sensata Technologies Holding plc First Amended and Restated 2010 Equity Incentive Plan (the "2010 Equity Incentive Plan"). The purpose of the 2010 Equity Incentive Plan is to promote long-term growth and profitability by providing our present and future eligible directors, officers, and employees with incentives to contribute to, and participate in, our success. There are 10.0 million ordinary shares authorized for grants of awards under the 2010 Equity Incentive Plan, of which 1.8 million were available as of December 31, 2020. Refer to Note 2, "Significant Accounting Policies," for additional information related to our to share-based compensation accounting policies. Share-Based Compensation Awards We grant option, restricted stock unit ("RSU"), and performance-based restricted stock unit ("PRSU") awards under the 2010 Equity Incentive Plan. For option and RSU awards, vesting is typically subject only to service conditions. For PRSU awards, vesting is also subject to service conditions, however the number of awarded units that ultimately vest also depends on the attainment of certain predefined performance criteria. Our awards include continued vesting provisions for retirement eligible employees. Throughout this Annual Report on Form 10-K, RSU and PRSU awards are often referred to collectively as "restricted securities." Options A summary of stock option activity for the years ended December 31, 2020, 2019, and 2018 is presented in the table below (amounts have been calculated based on unrounded shares): Number of Options (thousands) Weighted-Average Weighted-Average Aggregate Balance as of December 31, 2017 3,606 $ 37.69 6.0 $ 50,130 Granted 307 $ 51.83 Forfeited or expired (39) $ 45.59 Exercised (172) $ 35.31 $ 3,143 Balance as of December 31, 2018 3,702 $ 38.89 5.3 $ 27,846 Granted 382 $ 46.92 Forfeited or expired (83) $ 48.92 Exercised (537) $ 28.21 $ 11,690 Balance as of December 31, 2019 3,464 $ 41.19 5.0 $ 44,696 Forfeited or expired (155) $ 48.30 Exercised (452) $ 34.22 $ 5,117 Balance as of December 31, 2020 2,857 $ 41.90 4.4 $ 31,955 Options vested and exercisable as of December 31, 2020 2,445 $ 40.92 3.8 $ 29,896 Vested and expected to vest as of December 31, 2020 2,831 $ 41.85 4.3 $ 31,829 A summary of the status of our unvested options as of December 31, 2020, and of the changes during the year then ended, is presented in the table below (amounts have been calculated based on unrounded shares): Number of Options (thousands) Weighted-Average Grant-Date Fair Value Balance as of December 31, 2019 818 $ 14.33 Vested during the year (333) $ 13.17 Forfeited during the year (73) $ 14.58 Balance as of December 31, 2020 412 $ 15.22 The fair value of stock options that vested during the years ended December 31, 2020, 2019, and 2018 was $4.4 million , $7.8 million, and $5.5 million, respectively. Option awards granted to employees under the 2010 Equity Incentive Plan generally vest 25% per year over four years from the grant date. We recognize compensation expense for options on a straight-line basis over the requisite service period, which is generally the same as the vesting period. The options generally expire ten years from the date of grant. For options granted prior to April 2019, except as otherwise provided in specific option award agreements, if a participant ceases to be employed by us, options not yet vested generally expire and are forfeited at the termination date, and options that are fully vested generally expire 60 days after termination of the participant’s employment. Exclusions to the general policy for terminated employees include termination for cause (in which case the options expire on the participant’s termination date) and termination due to death or disability (in which case any unvested options shall immediately vest and expire six months after the participant’s termination date). For options granted in or after April 2019, the same terms apply, except that fully vested options expire 90 days after termination of the participant's employment for any reason other than termination for cause (in which case the options expire on the participant's termination date), termination due to due to death or disability (in which case the options expire one year after the participant's termination date), and termination for a qualified retirement (in which case options will continue to vest and expire ten years from the grant date). We did not grant any options in the year ended December 31, 2020. The weighted-average grant-date fair value per option granted during the years ended December 31, 2019 and 2018 was $13.90 and $15.70, respectively. The fair value of options was estimated on the date of grant using the Black-Scholes-Merton option-pricing model. The weighted-average key assumptions used in estimating the grant-date fair value of options for the years ended December 31, 2019 and 2018 were as follows: For the year ended December 31, 2019 2018 Expected dividend yield 0.00 % 0.00 % Expected volatility 25.00 % 25.00 % Risk-free interest rate 2.35 % 2.62 % Expected term (years) 6.0 6.0 Fair value per share of underlying ordinary shares $ 46.92 $ 51.83 Restricted Securities We grant RSU awards that cliff vest between one year and three years from the grant date, and we grant PRSU awards that cliff vest three years after the grant date. For PRSU awards, the number of units that ultimately vest depends on the extent to which certain performance criteria are met, as described in the table below. For restricted securities granted in or after April 2019, terms include provisions allowing continued or accelerated vesting for a qualified retirement. Beginning in April 2020, we began granting RSUs that vest ratably over three years, one-third per year beginning on the first anniversary of the grant date. These RSUs will fully vest on various dates between April 2023 and December 2023. A summary of restricted securities granted in the years ended December 31, 2020, 2019, and 2018 is presented below: Percentage Range of Units That May Vest (1) 0.0% to 150.0% 0.0% to 172.5% (Awards in thousands) RSU Awards Granted Weighted-Average PRSU Awards Granted Weighted-Average PRSU Awards Granted Weighted-Average 2020 806 $ 29.06 — $ — 401 $ 28.22 2019 298 $ 47.73 76 $ 46.92 138 $ 46.92 2018 218 $ 51.05 63 $ 51.83 118 $ 51.83 __________________________________________ (1) Represents the percentage range of PRSU award units granted that may vest according to the terms of the awards. The amounts presented within this table do not reflect our current assessment of the probable outcome of vesting based on the achievement or expected achievement of performance conditions. Compensation expense for the year ended December 31, 2020 reflects our estimate of the probable outcome of the performance conditions associated with the PRSU awards granted in the years ended December 31, 2020, 2019, and 2018. A summary of activity related to outstanding restricted securities for the years ended December 31, 2020, 2019, and 2018 is presented in the table below (amounts have been calculated based on unrounded shares): Restricted Securities (thousands) Weighted-Average Balance as of December 31, 2017 1,081 $ 44.43 Granted 399 $ 51.40 Forfeited (121) $ 48.28 Vested (240) $ 53.01 Balance as of December 31, 2018 1,119 $ 44.66 Granted (1) 555 $ 46.73 Forfeited (115) $ 47.07 Vested (454) $ 39.62 Balance as of December 31, 2019 1,105 $ 47.51 Granted 1,207 $ 28.78 Forfeited (284) $ 37.89 Vested (349) $ 43.54 Balance as of December 31, 2020 1,679 $ 36.49 __________________________________________ (1) Includes 43 thousand PRSU awards granted due to greater than 100% vesting. Aggregate intrinsic value information for restricted securities as of December 31, 2020, 2019, and 2018 is presented below: As of December 31, 2020 2019 2018 Outstanding $ 88,534 $ 59,526 $ 50,161 Expected to vest $ 58,675 $ 34,717 $ 44,203 The weighted-average remaining periods over which the restrictions will lapse as of December 31, 2020, 2019, and 2018 are as follows: As of December 31, 2020 2019 2018 Outstanding 1.1 1.1 1.2 Expected to vest 1.1 1.0 1.2 The expected to vest restricted securities are calculated based on the application of a forfeiture rate assumption to all outstanding restricted securities as well as our assessment of the probability of meeting the required performance conditions that pertain to the PRSU awards. Share-Based Compensation Expense The table below presents non-cash compensation expense related to our equity awards, which is recognized within SG&A expense in the consolidated statements of operations, during the identified periods: For the year ended December 31, 2020 2019 2018 Stock options $ 2,868 $ 6,552 $ 5,739 Restricted securities 16,257 12,205 18,086 Share-based compensation expense $ 19,125 $ 18,757 $ 23,825 In the years ended December 31, 2020, 2019, and 2018, we recognized $2.5 million, $3.2 million, and $3.0 million, respectively, of income tax benefit associated with share-based compensation expense. The table below presents unrecognized compensation expense at December 31, 2020 for each class of award, and the remaining expected term for this expense to be recognized: Unrecognized Expected Options $ 5,280 1.0 Restricted securities 21,943 1.7 Total unrecognized compensation expense $ 27,223 |
Restructuring and Other Charges
Restructuring and Other Charges, Net | 12 Months Ended |
Dec. 31, 2020 | |
Restructuring and Related Activities [Abstract] | |
Restructuring and Other Charges, Net | Restructuring and Other Charges, Net On June 30, 2020, in response to the potential long-term impact of the global financial and health crisis caused by the coronavirus ("COVID-19") pandemic on our business, we committed to a plan to reorganize our business (the “Q2 2020 Global Restructure Program”). The Q2 2020 Global Restructure Program, consisting of voluntary and involuntary reductions-in-force and certain site closures, was commenced in order to align our cost structure to the demand levels that we anticipated in the coming quarters. We have taken a large portion of the actions contemplated under the Q2 2020 Global Restructure Program, with the majority expected to be completed on or before June 30, 2021. The reductions-in-force, which are subject to the laws and regulations of the countries in which the actions are planned, are expected to impact approximately 880 positions. Over the life of the Q2 2020 Global Restructure Program, we expect to incur restructuring charges of betwe en $31.0 million and $33.7 million related to reductions-in-force and between $8.0 million and $10.0 million related to site closures. We expect to settle these charges with cash on hand. We expect these restructuring charges to impact our business segments and corporate functions as follows: Reductions-in-Force Site Closures (Dollars in millions) Positions Minimum Maximum Minimum Maximum Performance Sensing 180 $ 10.7 $ 11.6 $ 3.0 $ 4.0 Sensing Solutions 286 8.9 9.6 5.0 6.0 Corporate and other 414 11.4 12.5 — — Total 880 $ 31.0 $ 33.7 $ 8.0 $ 10.0 Charges recognized in the year ended December 31, 2020 resulting from the Q2 2020 Global Restructure Program are presented by segment below. Approximately $0.6 million of these charges relate to site closures in Sensing Solutions. For the year ended Performance Sensing $ 9,073 Sensing Solutions 6,445 Corporate and other 8,940 Q2 2020 Global Restructure Program, net $ 24,458 Restructuring and other charges, net for the years ended December 31, 2020, 2019, and 2018 were as follows: For the year ended December 31, 2020 2019 2018 Q2 2020 Global Restructure Program, net $ 24,458 $ — $ — Other restructuring charges Severance costs, net (1) 3,042 29,240 7,566 Facility and other exit costs 1,323 808 877 Gain on sale of Valves Business (2) — — (64,423) Other (3) 4,271 23,512 8,162 Restructuring and other charges, net $ 33,094 $ 53,560 $ (47,818) __________________________________________ (1) For each of the years ended December 31, 2020, 2019, and 2018, these charges include termination benefits provided in connection with workforce reductions of manufacturing, engineering, and administrative positions, including the elimination of certain positions related to site consolidations, net of reversals. For the year ended December 31, 2020, these charges related to termination benefits arising from the shutdown and relocation of operating sites in Northern Ireland and Belgium. For the year ended December 31, 2019, these charges included approximately $12.7 million of benefits provided under a voluntary retirement incentive program offered to a limited number of eligible employees in the U.S., and $6.5 million of termination benefits provided under a one-time benefit arrangement related to the shutdown and relocation of an operating site in Germany. (2) In the year ended December 31, 2018, we completed the sale of the capital stock of Schrader Bridgeport International, Inc. and August France Holding Company SAS (collectively, the "Valves Business"). The gain on this sale was recorded in restructuring and other charges, net. (3) Represents charges that are not included in one of the other classifications. In the year ended December 31, 2020, we settled intellectual property litigation brought against Schrader by Wasica Finance GmbH ("Wasica") and released $11.7 million of the related liability. This release largely offset a charge of $12.1 million resulting from a prejudgment interest-related award granted by the court on behalf of Wasica in the three months ended June 30, 2020. Refer to Note 15, "Commitments and Contingencies," for additional information related to this matter. In the year ended December 31, 2019, we recognized a $17.8 million loss related to the termination of a supply agreement in connection with the Metal Seal Precision, Ltd. ("Metal Seal") litigation. In the year ended December 31, 2018, we incurred $5.9 million of incremental direct costs in order to transact the sale of the Valves Business. For each of the years ended December 31, 2020, 2019, and 2018, we recorded expense related to the deferred compensation arrangement that we entered into in connection with the acquisition of GIGAVAC, LLC ("GIGAVAC") in the year ended December 31, 2018. The following table presents a rollforward of the severance portion of our restructuring obligations for the years ended December 31, 2020 and 2019. Q2 Plan Other Total Balance as of December 31, 2018 $ — $ 6,591 $ 6,591 Charges, net of reversals — 29,240 29,240 Payments — (21,095) (21,095) Foreign currency remeasurement — 43 43 Balance as of December 31, 2019 — 14,779 14,779 Charges, net of reversals 23,824 3,042 26,866 Payments (13,853) (13,969) (27,822) Foreign currency remeasurement 871 185 1,056 Balance as of December 31, 2020 $ 10,842 $ 4,037 $ 14,879 |
Other, Net
Other, Net | 12 Months Ended |
Dec. 31, 2020 | |
Other Income and Expenses [Abstract] | |
Other, Net | Other, Net Other, net consisted of the following for the years ended December 31, 2020, 2019, and 2018: For the year ended December 31, 2020 2019 2018 Currency remeasurement gain/(loss) on net monetary assets (1) $ 10,833 $ (6,802) $ (18,905) (Loss)/gain on foreign currency forward contracts (2) (6,762) 2,225 2,070 Gain/(loss) on commodity forward contracts (2) 10,027 4,888 (8,481) Loss on debt financing (3) — (4,364) (2,350) Net periodic benefit cost, excluding service cost (4) (9,980) (3,186) (3,585) Other (4,457) (669) 886 Other, net $ (339) $ (7,908) $ (30,365) __________________________________________ (1) Relates to the remeasurement of non-USD denominated net monetary assets and liabilities into USD. Refer to the Foreign Currency section of Note 2, "Significant Accounting Policies," for additional information. (2) Relates to changes in the fair value of derivative financial instruments not designated as cash flow hedges. Refer to Note 19, "Derivative Instruments and Hedging Activities," for additional information related to gains and losses on our commodity and foreign currency exchange forward contracts. (3) Refer to Note 14, "Debt," for additional information related to our debt financing transactions. (4) Refer to Note 13, "Pension and Other Post-Retirement Benefits," for additional information on net periodic benefit cost included in other, net. |
Income Taxes
Income Taxes | 12 Months Ended |
Dec. 31, 2020 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes Effective April 27, 2006 (inception), and concurrent with the completion of the acquisition of the Sensors & Controls business ("S&C") of Texas Instruments Incorporated ("TI") (the "2006 Acquisition"), we commenced filing tax returns in the Netherlands as a stand-alone entity. On March 28, 2018, the Company reincorporated its headquarters in the U.K. We file income tax returns in the countries in which our subsidiaries are incorporated and/or operate, including Belgium, Bulgaria, China, France, Germany, Japan, Malaysia, Mexico, the Netherlands, South Korea, the U.S., and the U.K. The 2006 Acquisition purchase accounting and the related debt and equity capitalization of the various subsidiaries of the consolidated company, and the realignment of the functions performed and risks assumed by the various subsidiaries, are of significant consequence to the determination of future book and taxable income of the respective subsidiaries and Sensata as a whole. Refer to Note 2, "Significant Accounting Policies," for detailed discussion of the accounting policies related to income taxes. Income before taxes Income before taxes for the years ended December 31, 2020, 2019, and 2018 was categorized by jurisdiction as follows: U.S. Non-U.S. Total 2020 $ (80,856) $ 246,497 $ 165,641 2019 $ 13,183 $ 377,240 $ 390,423 2018 $ 68,027 $ 458,348 $ 526,375 Provision for/(benefit from) income taxes Provision for/(benefit from) income taxes for the years ended December 31, 2020, 2019, and 2018 was categorized by jurisdiction as follows: U.S. Federal Non-U.S. U.S. State Total 2020 Current $ (2,624) $ 48,572 $ 307 $ 46,255 Deferred (14,776) (34,252) 4,128 (44,900) Total $ (17,400) $ 14,320 $ 4,435 $ 1,355 2019 Current $ 5,643 $ 73,947 $ 496 $ 80,086 Deferred 9,687 17,339 597 27,623 Total $ 15,330 $ 91,286 $ 1,093 $ 107,709 2018 Current $ 5,700 $ 64,666 $ 1,082 $ 71,448 Deferred (109,663) (18,770) (15,635) (144,068) Total $ (103,963) $ 45,896 $ (14,553) $ (72,620) Effective tax rate reconciliation The principal reconciling items from income tax computed at the U.S. statutory tax rate for the years ended December 31, 2020, 2019, and 2018 were as follows: For the year ended December 31, 2020 2019 2018 Tax computed at statutory rate of 21% $ 34,785 $ 81,989 $ 110,539 Intangible property transfers (54,188) — — Foreign tax rate differential (21,994) (19,107) (41,200) Valuation allowances 8,869 19,640 (123,426) Withholding taxes not creditable 12,198 9,509 8,734 Change in tax laws or rates 11,229 5,121 (22,264) Research and development incentives (7,408) (8,410) (19,475) U.S. state taxes, net of federal benefit 3,504 863 (11,499) Unrealized foreign currency exchange losses/(gains), net 2,650 (43) 11,346 Reserve for tax exposure (171) 20,079 10,775 Nontaxable items and other 11,881 (1,932) 3,850 Provision for/(benefit from) income taxes $ 1,355 $ 107,709 $ (72,620) Intangible property transfers The decrease in our effective tax rate for the year ended December 31, 2020, was primarily due to a $54.2 million net income tax benefit in the fourth quarter of 2020 related to intangible property transfers. Foreign tax rate differential We operate in locations outside the U.S., including Belgium, Bermuda, Bulgaria, China, Malaysia, the Netherlands, South Korea, and the U.K., that historically have had statutory tax rates different than the U.S. statutory tax rate. This can result in a foreign tax rate differential that may reflect a tax benefit or detriment. This foreign tax rate differential can change from year to year based upon the jurisdictional mix of earnings and changes in current and future enacted tax rates. Our subsidiary in Changzhou, China is currently eligible for a reduced tax rate of 15%, which is effective through 2021. The impact on current tax expense of the tax holidays and exemptions is included in the foreign tax rate differential line in the reconciliation of the statutory tax rate to effective rate. The remeasurement of the deferred tax assets and liabilities is included in the change in tax laws or rates line. Valuation allowance impact on tax expense During the year ended December 31, 2018, we released a substantial portion of our valuation allowance against our deferred tax assets in the U.S. We continue to maintain a valuation allowance against certain of our interest, goodwill tax basis, foreign tax, and state tax credit carryforwards. Withholding taxes not creditable Withholding taxes may apply to intercompany interest, royalty, management fees, and certain payments to third parties. Such taxes are deducted if they cannot be credited against the recipient’s tax liability in its country of residence. Additional consideration has been given to the withholding taxes associated with unremitted earnings and the recipient's ability to obtain a tax credit for such taxes. Earnings are not considered to be indefinitely reinvested in the jurisdictions in which they were earned. In certain jurisdictions we recognize a deferred tax liability on withholding and other taxes on intercompany payments including dividends. Research and development incentives Certain income of our U.K. subsidiaries is eligible for lower tax rates under the "patent box" regime, resulting in certain of our intellectual property income being taxed at a rate lower than the U.K. statutory tax rate. Certain R&D expenses are eligible for a bonus deduction under China’s R&D super deduction regime. In fiscal year 2018, we substantially completed an assessment of our ability to claim an R&D credit in the U.S. As a result of this assessment, we recognized a tax benefit of $10.0 million. Deferred income tax assets and liabilities The primary components of deferred income tax assets and liabilities as of December 31, 2020 and 2019 were as follows: As of December 31, 2020 2019 Deferred tax assets: Net operating loss, interest expense, and other carryforwards $ 342,689 $ 283,094 Prepaid and accrued expenses 67,221 67,143 Intangible assets and goodwill 110,382 20,457 Pension liability and other 14,241 7,158 Property, plant and equipment 13,789 14,749 Share-based compensation 9,609 10,288 Inventories and related reserves 9,329 16,712 Unrealized exchange loss 3,182 1,959 Total deferred tax assets 570,442 421,560 Valuation allowance (202,101) (146,775) Net deferred tax asset 368,341 274,785 Deferred tax liabilities: Intangible assets and goodwill (480,082) (440,009) Tax on undistributed earnings of subsidiaries (35,254) (31,636) Operating lease right of use assets (11,324) (12,522) Property, plant and equipment (16,110) (13,762) Unrealized exchange gain (643) (6,739) Total deferred tax liabilities (543,413) (504,668) Net deferred tax liability $ (175,072) $ (229,883) Valuation allowance and net operating loss carryforwards We recognize deferred tax assets to the extent that we believe these assets are more likely than not to be realized. In measuring our deferred tax assets, we consider all available evidence, both positive and negative, to determine whether, based on the weight of that evidence, a valuation allowance is needed for all or some portion of the deferred tax assets. Significant judgment is required in considering the relative impact of the negative and positive evidence, and weight given to each category of evidence is commensurate with the extent to which it can be objectively verified. The more negative evidence that exists, the more positive evidence is necessary, and the more difficult it is to support a conclusion that a valuation allowance is not needed. Additionally, we utilize the "more likely than not" criteria established in FASB ASC Topic 740 to determine whether the future tax benefit from the deferred tax assets should be recognized. As a result, we have established valuation allowances on the deferred tax assets in jurisdictions that have incurred net operating losses and in which it is more likely than not that such losses will not be utilized in the foreseeable future. As of each reporting date, we consider new evidence, both positive and negative, that could impact our view with regard to future realization of deferred tax assets. Our interest expense carryforwards in certain jurisdictions are subject to limitations. We consider these limitations in our assessment of positive and negative evidence. Our assessment of these limitations has resulted in the conclusion that a portion of our interest carryforwards are subject to a valuation allowance. For tax purposes, certain goodwill and indefinite-lived intangible assets are generally amortizable over 6 to 20 years. For book purposes, goodwill and indefinite-lived intangible assets are not amortized, but are tested for impairment annually. The tax amortization of goodwill and indefinite-lived intangible assets will result in a taxable temporary difference, which will not reverse unless the related book goodwill or indefinite-lived intangible asset is impaired or written off. This liability may not be used to support deductible temporary differences, such as net operating loss carryforwards, which may expire within a definite period. The total valuation allowance increased $55.3 million in the year ended December 31, 2020 and decreased $10.3 million in the year ended December 31, 2019. In connection with our 2020 intangible property transfer, we recorded a valuation allowance of $43.2 million. Subsequently reported tax benefits relating to the valuation allowance for deferred tax assets as of December 31, 2020 will be allocated to income tax benefit recognized in the consolidated statements of operations. As of December 31, 2020, we have U.S. federal net operating loss carryforwards of $801.1 million, of which $446.6 million will expire from 2028 to 2037, and $354.5 million do not expire. We have state net operating loss carryforwards with limited and unlimited lives. Our limited life state net operating losses will expire beginning in 2021. As of December 31, 2020, we have suspended interest expense carryforwards of $339.1 million, which have an unlimited life. We also have net operating loss carryforwards in foreign jurisdictions of $239.7 million, which will begin to expire in 2021. Unrecognized tax benefits A reconciliation of the amount of unrecognized tax benefits is as follows: For the year ended December 31, 2020 2019 2018 Balance at beginning of year $ 117,591 $ 89,609 $ 59,884 Increases related to current year tax positions 46,329 17,378 15,676 Increases related to prior year tax positions 43,082 15,356 14,609 Increases related to business combinations — 450 1,000 Decreases related to settlements with tax authorities (5,183) (3,515) — Decreases related to prior year tax positions (1,294) (1,773) (1,144) Decreases related to lapse of applicable statute of limitations (452) (87) — Changes related to foreign currency exchange rate 1,337 173 (416) Balance at end of year $ 201,410 $ 117,591 $ 89,609 We recognize interest and penalties related to unrecognized tax benefits in the consolidated statements of operations and the consolidated balance sheets. The table that follows presents the expense/(income) related to such interest and penalties recognized in the consolidated statements of operations during the years ended December 31, 2020, 2019, and 2018, and the amount of interest and penalties recorded on the consolidated balance sheets as of December 31, 2020 and 2019: Statements of Operations Balance Sheets For the year ended December 31, As of December 31, (In millions) 2020 2019 2018 2020 2019 Interest $ 0.4 $ 0.9 $ (0.2) $ 1.7 $ 1.3 Penalties $ 0.2 $ (0.1) $ (0.2) $ 0.4 $ 0.3 At December 31, 2020, we anticipate that the liability for unrecognized tax benefits could decrease by up to $56.8 million within the next twelve months due to the expiration of certain statutes of limitation or the settlement of examinations or issues with tax authorities. The amount of unrecognized tax benefits as of December 31, 2020 that if recognized would impact our effective tax rate is $109.2 million. Our major tax jurisdictions include Belgium, Bulgaria, China, France, Germany, Japan, Malaysia, Mexico, the Netherlands, South Korea, the U.K., and the U.S. These jurisdictions generally remain open to examination by the relevant tax authority for the tax years 2006 through 2020. Indemnifications |
Net Income Per Share
Net Income Per Share | 12 Months Ended |
Dec. 31, 2020 | |
Earnings Per Share [Abstract] | |
Net Income Per Share | Net Income per Share Basic and diluted net income per share are calculated by dividing net income by the number of basic and diluted weighted-average ordinary shares outstanding during the period. For the years ended December 31, 2020, 2019, and 2018, the weighted-average ordinary shares outstanding used to calculate basic and diluted net income per share were as follows: For the year ended December 31, (In thousands) 2020 2019 2018 Basic weighted-average ordinary shares outstanding 157,373 160,946 168,570 Dilutive effect of stock options 275 600 822 Dilutive effect of unvested restricted securities 486 422 467 Diluted weighted-average ordinary shares outstanding 158,134 161,968 169,859 Net income and net income per share are presented in the consolidated statements of operations. Certain potential ordinary shares were excluded from our calculation of diluted weighted-average ordinary shares outstanding because either they would have had an anti-dilutive effect on net income per share or they related to equity awards that were contingently issuable for which the contingency had not been satisfied. Refer to Note 4, "Share-Based Payment Plans," for additional information related to our equity awards. These potential ordinary shares are as follows: For the year ended December 31, (In thousands) 2020 2019 2018 Anti-dilutive shares excluded 1,575 1,170 930 Contingently issuable shares excluded 995 641 687 |
Inventories
Inventories | 12 Months Ended |
Dec. 31, 2020 | |
Inventory Disclosure [Abstract] | |
Inventories | Inventories The components of inventories as of December 31, 2020 and 2019 were as follows: As of December 31, 2020 2019 Finished goods $ 170,488 $ 197,531 Work-in-process 87,006 104,007 Raw materials 193,511 205,140 Inventories $ 451,005 $ 506,678 Refer to Note 2, "Significant Accounting Policies," for a discussion of our accounting policies related to inventories. |
Property, Plant and Equipment,
Property, Plant and Equipment, Net | 12 Months Ended |
Dec. 31, 2020 | |
Property, Plant and Equipment [Abstract] | |
Property, Plant and Equipment, Net | Property, Plant and Equipment, Net PP&E, net as of December 31, 2020 and 2019 consisted of the following: As of December 31, 2020 2019 Land $ 17,880 $ 17,880 Buildings and improvements 273,899 266,864 Machinery and equipment 1,428,793 1,367,293 Total property, plant and equipment 1,720,572 1,652,037 Accumulated depreciation (916,747) (821,039) Property, plant and equipment, net $ 803,825 $ 830,998 Depreciation expense for PP&E, including amortization of leasehold improvements and depreciation of assets under finance leases, totaled $125.7 million, $115.9 million, and $106.0 million for the years ended December 31, 2020, 2019, and 2018, respectively. PP&E, net as of December 31, 2020 and 2019 included the following assets under finance leases: As of December 31, 2020 2019 Assets under finance leases in property, plant and equipment $ 49,714 $ 49,714 Accumulated depreciation (26,107) (24,316) Assets under finance leases in property, plant and equipment, net $ 23,607 $ 25,398 Refer to Note 2, "Significant Accounting Policies," for a discussion of our accounting policies related to PP&E, net. |
Goodwill and Other Intangible A
Goodwill and Other Intangible Assets, Net | 12 Months Ended |
Dec. 31, 2020 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Goodwill and Other Intangible Assets, Net | Goodwill and Other Intangible Assets, Net The following table outlines the changes in net goodwill by segment for the years ended December 31, 2020 and 2019. Performance Sensing Sensing Solutions Total Balance as of December 31, 2018 $ 2,155,633 $ 925,669 $ 3,081,302 GIGAVAC acquisition 16,387 (16,564) (177) Other acquisition — 12,473 12,473 Balance as of December 31, 2019 2,172,020 921,578 3,093,598 Other acquisition 17,751 — 17,751 Balance as of December 31, 2020 $ 2,189,771 $ 921,578 $ 3,111,349 At each of December 31, 2020, 2019, and 2018, accumulated goodwill impairment was $0.0 million related to Performance Sensing and $18.5 million related to Sensing Solutions. Goodwill attributed to acquisitions reflects our allocation of purchase price to the estimated fair value of certain assets acquired and liabilities assumed, and has been included in our segments based on a methodology using anticipated future earnings of the components of business. We own the Klixon ® and Airpax ® tradenames, which are indefinite-lived intangible assets as they have each been in continuous use for over 65 years and we have no plans to discontinue using either of them. We have recorded $59.1 million and $9.4 million, respectively, on the consolidated balance sheets related to these tradenames. In addition, in the year ended December 31, 2020, we recognized indefinite-lived intangible assets of $6.9 million related to in-process research & development acquired in a fiscal year 2020 business combination transaction. We evaluated our goodwill and other indefinite-lived intangible assets for impairment as of October 1, 2020 using a combination of the quantitative and qualitative methods. Under the qualitative method, we assess whether it is more likely than not that the fair value of a reporting unit is less than its carrying value based on various factors, including macroeconomic conditions, industry and market considerations, cost factors, and overall financial performance, and other relevant factors as applicable. If the results of the qualitative analysis indicate that it is not more likely than not that the fair value of a reporting unit is less than its carrying value, no further analysis is prepared. Otherwise, we perform a quantitative analysis under which a discounted cash flow analysis is prepared to determine whether the fair value of the reporting unit is less than its carrying value. Based on these analyses, we have determined that as of October 1, 2020 the fair value of each of our reporting units and indefinite-lived intangible assets exceeded their carrying values. We consider a combination of quantitative and qualitative factors to determine whether a reporting unit is at risk of failing Step 1 of the goodwill impairment test, including: the timing of our most recent quantitative impairment tests and the relative amount by which a reporting unit’s fair value exceeded its then carrying value, the inputs and assumptions underlying our valuation models and the sensitivity of our fair value measurements to those inputs and assumptions, the impact that adverse economic or market conditions may have on the degree of uncertainty inherent in our long-term operating forecasts, and changes in the carrying value of a reporting unit’s net assets from the time of our most recent goodwill impairment test. Based on the results of this analysis, we do not consider any of our reporting units to be at risk of failing Step 1 of the goodwill impairment test. The following tables outline the components of definite-lived intangible assets as of December 31, 2020 and 2019: As of December 31, 2020 Weighted- Gross Accumulated Accumulated Net Completed technologies 14 $ 781,508 $ (578,178) $ (2,430) $ 200,900 Customer relationships 11 1,858,998 (1,501,960) (12,144) 344,894 Tradenames 21 66,654 (19,816) — 46,838 Capitalized software and other (1) 7 69,227 (45,680) — 23,547 Total 12 $ 2,776,387 $ (2,145,634) $ (14,574) $ 616,179 As of December 31, 2019 Weighted- Gross Accumulated Accumulated Net Completed technologies 14 $ 770,608 $ (529,926) $ (2,430) $ 238,252 Customer relationships 11 1,827,998 (1,430,515) (12,144) 385,339 Non-compete agreements 8 23,400 (23,400) — — Tradenames 21 66,654 (16,598) — 50,056 Capitalized software and other (1) 7 67,784 (38,997) — 28,787 Total 12 $ 2,756,444 $ (2,039,436) $ (14,574) $ 702,434 __________________________________________ (1) During the years ended December 31, 2020 and 2019, we wrote-off approximately $0.1 million and $0.3 million, respectively, of fully-amortized capitalized software that was not in use. The following table outlines amortization of definite-lived intangible assets for the years ended December 31, 2020, 2019, and 2018: For the year ended December 31, 2020 2019 2018 Acquisition-related definite-lived intangible assets $ 122,915 $ 136,087 $ 132,235 Capitalized software 6,634 6,799 7,091 Amortization of intangible assets $ 129,549 $ 142,886 $ 139,326 The table below presents estimated amortization of definite-lived intangible assets for each of the next five years: For the year ended December 31, 2021 $ 117,489 2022 $ 104,101 2023 $ 90,208 2024 $ 73,544 2025 $ 45,629 |
Accrued Expenses and Other Curr
Accrued Expenses and Other Current Liabilities | 12 Months Ended |
Dec. 31, 2020 | |
Accrued expenses and other current liabilities [Abstract] | |
Accrued Expenses and Other Current Liabilities | Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities as of December 31, 2020 and 2019 consisted of the following: As of December 31, 2020 2019 Accrued compensation and benefits $ 85,140 $ 52,394 Accrued interest 53,630 42,803 Foreign currency and commodity forward contracts 19,627 1,925 Accrued severance 14,879 14,779 Current portion of operating lease liabilities 11,389 11,543 Current portion of pension and post-retirement benefit obligations 3,498 3,220 Other accrued expenses and current liabilities 136,667 88,962 Accrued expenses and other current liabilities $ 324,830 $ 215,626 |
Pension and Other Post-Retireme
Pension and Other Post-Retirement Benefits | 12 Months Ended |
Dec. 31, 2020 | |
Retirement Benefits [Abstract] | |
Pension and Other Post-Retirement Benefits | Pension and Other Post-Retirement Benefits We provide various pension and other post-retirement plans for current and former employees, including defined benefit, defined contribution, and retiree healthcare benefit plans. Refer to Note 2, "Significant Accounting Policies," for a detailed discussion of the accounting policies related to our pension and other post-retirement benefit plans. U.S. Benefit Plans The principal retirement plans in the U.S. include a qualified defined benefit pension plan and a defined contribution plan. In addition, we provide post-retirement medical coverage and non-qualified benefits to certain employees. Defined Benefit Pension Plans The benefits under the qualified defined benefit pension plan are determined using a formula based upon years of service and the highest five TI closed the qualified defined benefit pension plan to participants hired after November 1997. In addition, participants eligible to retire under the TI plan as of April 26, 2006 were given the option of continuing to participate in the qualified defined benefit pension plan or retiring under the qualified defined benefit pension plan and thereafter participating in an enhanced defined contribution plan. We intend to contribute amounts to the qualified defined benefit pension plan in order to meet the minimum funding requirements of federal laws and regulations, plus such additional amounts as we deem appropriate. During the year ended December 31, 2020, we did not contribute to the qualified defined benefit plan. We expect to contribute to the qualified defined benefit pension plan in fiscal year 2021. We also sponsor a non-qualified defined benefit pension plan, which is closed to new participants and is unfunded. Effective January 31, 2012, we froze the defined benefit pension plans and eliminated future benefit accruals. Defined Contribution Plans We have one defined contribution plan for U.S. employees, which provides for an employer matching contribution of up to 4% of the employee's annual eligible earnings. The aggregate expense related to the defined contribution plan was $4.3 million, $5.5 million, and $5.7 million for the years ended December 31, 2020, 2019, and 2018, respectively. Retiree Healthcare Benefit Plan We offer access to group medical coverage during retirement to some of our U.S. employees. We make contributions toward the cost of those retiree medical benefits for certain retirees. The contribution rates are based upon varying factors, the most important of which are an employee’s date of hire, date of retirement, years of service, and eligibility for Medicare benefits. The balance of the cost is borne by the participants in the plan. For the year ended December 31, 2020, we did not and do not expect to, receive any amount of Medicare Part D Federal subsidy. Our projected benefit obligation as of December 31, 2020 and 2019 did not include an assumption for a Federal subsidy. Non-U.S. Benefit Plans Retirement coverage for non-U.S. employees is provided through separate defined benefit and defined contribution plans. Retirement benefits are generally based on an employee’s years of service and compensation. Funding requirements are determined on an individual country and plan basis and are subject to local country practices and market circumstances. We do not expect to contribute to the non-U.S. defined benefit plans during 2021. Impact on Financial Statements The components of net periodic benefit cost/(credit) associated with our defined benefit and retiree healthcare plans for the years ended December 31, 2020, 2019, and 2018 were as follows: For the year ended December 31, 2020 2019 2018 U.S. Plans Non-U.S. Plans U.S. Plans Non-U.S. Plans U.S. Plans Non-U.S. Plans Defined Benefit Retiree Healthcare Defined Benefit Defined Benefit Retiree Healthcare Defined Benefit Defined Benefit Retiree Healthcare Defined Benefit Service cost $ — $ 10 $ 3,522 $ — $ 7 $ 2,836 $ — $ 50 $ 3,122 Interest cost 762 155 1,466 1,483 203 1,344 1,473 272 1,310 Expected return on plan assets (1,339) — (712) (1,694) — (702) (1,710) — (929) Amortization of net loss 1,184 16 1,204 946 — 766 1,080 5 407 Amortization of net prior service (credit)/cost — (1,029) 5 — (1,306) 9 — (1,728) 6 Loss on settlement 5,026 — 2,712 565 — 1,572 1,047 — 1,461 Loss on curtailment — 530 — — — — — — 891 Net periodic benefit cost/(credit) $ 5,633 $ (318) $ 8,197 $ 1,300 $ (1,096) $ 5,825 $ 1,890 $ (1,401) $ 6,268 The following table outlines the rollforward of the benefit obligation and plan assets for the defined benefit and retiree healthcare benefit plans for the years ended December 31, 2020 and 2019: For the year ended December 31, 2020 2019 U.S. Plans Non-U.S. Plans U.S. Plans Non-U.S. Plans Defined Benefit Retiree Healthcare Defined Benefit Defined Benefit Retiree Healthcare Defined Benefit Change in benefit obligation: Beginning balance $ 45,548 $ 5,588 $ 74,172 $ 45,169 $ 6,017 $ 65,691 Service cost — 10 3,522 — 7 2,836 Interest cost 762 155 1,466 1,483 203 1,344 Plan participants’ contributions — 696 35 — 474 31 Actuarial loss/(gain) 7,526 (1,213) 13,006 1,711 (92) 9,344 Curtailment loss — 530 — — — — Benefits paid (17,568) (719) (8,507) (2,815) (1,021) (5,235) Foreign currency remeasurement — — 4,618 — — 161 Ending balance $ 36,268 $ 5,047 $ 88,312 $ 45,548 $ 5,588 $ 74,172 Change in plan assets: Beginning balance $ 44,870 $ — $ 43,906 $ 39,875 $ — $ 39,868 Actual return on plan assets 2,333 — 2,071 4,484 — 4,125 Employer contributions 19 23 7,714 3,326 547 4,889 Plan participants’ contributions — 696 35 — 474 31 Benefits paid (17,568) (719) (8,507) (2,815) (1,021) (5,235) Foreign currency remeasurement — — 3,254 — — 228 Ending balance $ 29,654 $ — $ 48,473 $ 44,870 $ — $ 43,906 Funded status at end of year $ (6,614) $ (5,047) $ (39,839) $ (678) $ (5,588) $ (30,266) Accumulated benefit obligation at end of year $ 36,268 NA $ 77,886 $ 45,548 NA $ 65,633 The following table outlines the funded status amounts recognized in the consolidated balance sheets as of December 31, 2020 and 2019: As of December 31, 2020 2019 U.S. Plans Non-U.S. Plans U.S. Plans Non-U.S. Plans Defined Benefit Retiree Healthcare Defined Benefit Defined Benefit Retiree Healthcare Defined Benefit Noncurrent assets $ — $ — $ — $ 2,788 $ — $ — Current liabilities (1,091) (586) (1,821) (952) (717) (1,551) Noncurrent liabilities (5,523) (4,461) (38,018) (2,514) (4,871) (28,715) Funded status $ (6,614) $ (5,047) $ (39,839) $ (678) $ (5,588) $ (30,266) Balances recognized within accumulated other comprehensive loss that have not been recognized as components of net periodic benefit cost, net of tax, as of December 31, 2020, 2019, and 2018 are as follows: As of December 31, 2020 2019 2018 U.S. Plans Non-U.S. Plans U.S. Plans Non-U.S. Plans U.S. Plans Non-U.S. Plans Defined Benefit Retiree Healthcare Defined Benefit Defined Benefit Retiree Healthcare Defined Benefit Defined Benefit Retiree Healthcare Defined Benefit Net prior service cost/(credit) $ — $ 1,094 $ (20) $ — $ 306 $ (16) $ — $ (692) $ (10) Net loss $ 19,026 $ (131) $ 22,833 $ 18,780 $ 809 $ 17,151 $ 20,759 $ 880 $ 14,425 Information for plans with an accumulated benefit obligation in excess of plan assets as of December 31, 2020 and 2019 is as follows: As of December 31, 2020 2019 U.S. Plans Non-U.S. Plans U.S. Plans Non-U.S. Plans Projected benefit obligation $ 36,268 $ 88,312 $ 3,465 $ 74,020 Accumulated benefit obligation $ 36,268 $ 77,886 $ 3,465 $ 65,633 Plan assets $ 29,654 $ 48,473 $ — $ 43,754 Information for plans with a projected benefit obligation in excess of plan assets as of December 31, 2020 and 2019 is as follows: As of December 31, 2020 2019 U.S. Plans Non-U.S. Plans U.S. Plans Non-U.S. Plans Projected benefit obligation $ 41,315 $ 88,312 $ 9,053 $ 74,020 Plan assets $ 29,654 $ 48,473 $ — $ 43,754 Other changes in plan assets and benefit obligations, net of tax, recognized in other comprehensive income/(loss) for the years ended December 31, 2020, 2019, and 2018 are as follows: For the year ended December 31, 2020 2019 2018 U.S. Plans Non-U.S. Plans U.S. Plans Non-U.S. Plans U.S. Plans Non-U.S. Plans Defined Benefit Retiree Healthcare Defined Benefit Defined Benefit Retiree Healthcare Defined Benefit Defined Benefit Retiree Healthcare Defined Benefit Net (gain)/loss $ 4,997 $ (928) $ 8,425 $ (824) $ (71) $ 4,365 $ 2,002 $ (124) $ 3,669 Amortization of net loss (906) (12) (839) (723) — (539) (1,080) (5) (298) Amortization of net prior service credit/(cost) — 562 (4) — 998 (6) — 1,728 (4) Divestiture — — — — — — — — (228) Plan amendment — — — — — — — (3,243) — Settlement effect (3,845) — (1,904) (432) — (1,100) (1,047) — (1,023) Curtailment effect — 226 — — — — — — 30 Total in other comprehensive (income)/loss $ 246 $ (152) $ 5,678 $ (1,979) $ 927 $ 2,720 $ (125) $ (1,644) $ 2,146 Assumptions and Investment Policies Weighted-average assumptions used to calculate the projected benefit obligations of our defined benefit and retiree healthcare benefit plans as of December 31, 2020 and 2019 are as follows: As of December 31, 2020 2019 Defined Benefit Retiree Healthcare Defined Benefit Retiree Healthcare U.S. assumed discount rate 1.65 % 1.80 % 2.60 % 2.80 % Non-U.S. assumed discount rate 1.97 % NA 1.90 % NA Non-U.S. average long-term pay progression 2.93 % NA 2.87 % NA Weighted-average assumptions used to calculate the net periodic benefit cost of our defined benefit and retiree healthcare benefit plans for the years ended December 31, 2020, 2019, and 2018 are as follows: For the year ended December 31, 2020 2019 2018 Defined Benefit Retiree Healthcare Defined Benefit Retiree Healthcare Defined Benefit Retiree Healthcare U.S. assumed discount rate 2.60 % 2.80 % 3.79 % 3.90 % 3.45 % 3.10 % Non-U.S. assumed discount rate 5.53 % NA 5.76 % NA 5.87 % NA U.S. average long-term rate of return on plan assets 4.29 % NA 4.53 % NA 4.57 % NA Non-U.S. average long-term rate of return on plan assets 1.61 % NA 1.77 % NA 2.26 % NA Non-U.S. average long-term pay progression 4.83 % NA 4.43 % NA 4.82 % NA Assumed healthcare cost trend rates for the U.S. retiree healthcare benefit plan as of December 31, 2020, 2019, and 2018 are as follows: As of December 31, 2020 2019 2018 Assumed healthcare trend rate for next year: Attributed to less than age 65 6.00 % 6.30 % 6.60 % Attributed to age 65 or greater 6.30 % 6.70 % 7.10 % Ultimate trend rate 4.50 % 4.50 % 4.50 % Year in which ultimate trend rate is reached: Attributed to less than age 65 2038 2038 2038 Attributed to age 65 or greater 2038 2038 2038 The table below outlines the benefits expected to be paid to participants in each of the following years, taking into consideration expected future service, as appropriate. The majority of the payments will be paid from plan assets and not company assets. Expected Benefit Payments For the year ended December 31, U.S. Defined Benefit U.S. Retiree Healthcare Non-U.S. Defined Benefit 2021 $ 12,177 $ 586 $ 3,546 2022 $ 3,378 $ 561 $ 3,809 2023 $ 4,221 $ 487 $ 3,777 2024 $ 2,548 $ 460 $ 3,766 2025 $ 2,506 $ 415 $ 4,639 2026 - 2030 $ 7,928 $ 1,463 $ 24,768 Plan Assets We hold assets for our defined benefit plans in the U.S., Japan, the Netherlands, and Belgium. Information about the assets for each of these plans is detailed below. Refer to Note 18, "Fair Value Measures," for additional information related to the level s of the fair value hierarchy in accordance with FASB ASC Topic 820. U.S. Plan Assets Our target asset allocation for the U.S. defined benefit plan is 83% fixed income and 17% equity securities. To arrive at the targeted asset allocation, we and our investment adviser reviewed market opportunities using historical data, as well as the actuarial valuation for the plan, to ensure that the levels of acceptable return and risk are well-defined and monitored. The following table presents information about the plan’s target and actual asset allocation, as of December 31, 2020: Target Allocation Actual Allocation as of December 31, 2020 U.S. large cap equity 7% 9% U.S. small / mid cap equity 2% 2% Globally managed volatility fund 3% 3% International (non-U.S.) equity 4% 5% Fixed income (U.S. investment grade) 68% 70% High-yield fixed income 2% 2% International (non-U.S.) fixed income 1% 1% Money market funds 13% 9% __________________________________________ The portfolio is monitored for automatic rebalancing on a monthly basis. The following table presents information about the plan assets measured at fair value as of December 31, 2020 and 2019: As of December 31, 2020 2019 U.S. large cap equity $ 2,548 $ 2,221 U.S. small / mid cap equity 706 637 Global managed volatility fund 826 849 International (non-U.S.) equity 1,362 1,195 Total equity mutual funds 5,442 4,902 Fixed income (U.S. investment grade) 20,801 18,830 High-yield fixed income 594 561 International (non-U.S.) fixed income 277 264 Total fixed income mutual funds 21,672 19,655 Money market funds 2,540 20,313 Total plan assets $ 29,654 $ 44,870 All fair value measures presented above are categorized in Level 1 of the fair value hierarchy. Investments in mutual funds are based on the publicly-quoted final net asset values on the last business day of the year. Permitted asset classes include U.S. and non-U.S. equity, U.S. and non-U.S. fixed income, cash, and cash equivalents. Fixed income includes both investment grade and non-investment grade. Permitted investment vehicles include mutual funds, individual securities, derivatives, and long-duration fixed income securities. While investments in individual securities, derivatives, long-duration fixed income securities, cash, and cash equivalents are permitted, the plan did not hold these types of investments as of December 31, 2020 and 2019. Prohibited investments include direct investments in real estate, commodities, unregistered securities, uncovered options, currency exchange contracts, and natural resources (such as timber, oil, and gas). Japan Plan Assets The target asset allocation of the Japan defined benefit plan is 50% fixed income securities and 50% equity securities, cash, and cash equivalents, with allowance for a 40% deviation in either direction. We, along with the trustee of the plan's assets, minimize investment risk by thoroughly assessing potential investments based on indicators of historical returns and current credit ratings. Additionally, investments are diversified by type and geography. The following table presents information about the plan’s target asset allocation, as well as the actual allocation, as of December 31, 2020: Target Allocation Actual Allocation as of December 31, 2020 Fixed income securities, cash, and cash equivalents 10%-90% 72% Equity securities 10%-90% 28% The following table presents information about the plan assets measured at fair value as of December 31, 2020 and 2019: As of December 31, 2020 2019 U.S. equity $ 2,736 $ 2,413 International (non-U.S.) equity 6,724 6,343 Total equity securities 9,460 8,756 U.S. fixed income 3,091 3,835 International (non-U.S.) fixed income 11,142 9,716 Total fixed income securities 14,233 13,551 Cash and cash equivalents 9,793 9,726 Total plan assets $ 33,486 $ 32,033 All fair value measures presented above are categorized in Level 1 of the fair value hierarchy, with the exception of U.S. fixed income securities of $0.3 million of December 31, 2020 and 2019, which are categorized as Level 2. The fair values of equity and fixed income securities are based on publicly-quoted closing stock and bond values on the last business day of the year. Permitted asset classes include equity securities that are traded on the official stock exchange(s) of the respective countries, fixed income securities with certain credit ratings, cash, and cash equivalents. The Netherlands Plan Assets The assets of the Netherlands defined benefit plan are insurance policies. The contributions we make to the plan are used to purchase insurance policies that provide for specific benefit payments to plan participants. The benefit formula is determined independently by us. Upon retirement of an individual plan participant, the insurance contracts purchased are converted to provide specific benefits for the participant. The contributions paid by us are commingled with contributions paid to the insurance provider by other employers for investment purposes and to reduce plan administration costs. However, this defined benefit plan is not considered a multi-employer plan. The following table presents information about the plan assets measured at fair value as of December 31, 2020 and 2019: As of December 31, 2020 2019 Insurance policies $ 12,905 $ 10,472 All fair value measures presented above are categorized in Level 3 of the fair value hierarchy. The following table presents a rollforward of these assets for the years ended December 31, 2020 and 2019: Insurance Policies Balance as of December 31, 2018 $ 8,897 Actual return on plan assets still held at reporting date 1,821 Purchases, sales, settlements, and exchange rate changes (246) Balance as of December 31, 2019 10,472 Actual return on plan assets still held at reporting date 1,373 Purchases, sales, settlements, and exchange rate changes 1,060 Balance as of December 31, 2020 $ 12,905 The fair values of the insurance contracts are measured based on the future benefit payments that would be made by the insurance company to vested plan participants if we were to switch to another insurance company without actually surrendering our policy. In this case, the insurance company would guarantee to pay the vested benefits at retirement accrued under the plan based on current salaries and service to date (i.e., with no allowance for future salary increases or pension increases). The cash flows of the future benefit payments are discounted using the same discount rate that is applied to value the related defined benefit plan liability. Belgium Plan Assets |
Debt
Debt | 12 Months Ended |
Dec. 31, 2020 | |
Debt Disclosure [Abstract] | |
Debt | Debt Our long-term debt and finance lease and other financing obligations as of December 31, 2020 and 2019 consisted of the following: As of December 31, Maturity Date 2020 2019 Term Loan September 20, 2026 $ 456,096 $ 460,725 4.875% Senior Notes October 15, 2023 500,000 500,000 5.625% Senior Notes November 1, 2024 400,000 400,000 5.0% Senior Notes October 1, 2025 700,000 700,000 6.25% Senior Notes (1) February 15, 2026 750,000 750,000 4.375% Senior Notes February 15, 2030 450,000 450,000 3.75% Senior Notes February 15, 2031 750,000 — Less: debt discount (9,605) (11,758) Less: deferred financing costs (28,114) (24,452) Less: current portion (754,630) (4,630) Long-term debt, net $ 3,213,747 $ 3,219,885 Finance lease and other financing obligations $ 30,506 $ 31,098 Less: current portion (2,575) (2,288) Finance lease and other financing obligations, less current portion $ 27,931 $ 28,810 ___________________________ (1) On February 3, 2021, we announced that we intended to redeem in full the $750.0 million aggregate principal amount outstanding on our 6.25% Senior Notes due 2026 in March 2021. As a result, these notes have been classified as current on our consolidated balance sheet as of December 31, 2020. There were no outstanding borrowings on our $420.0 million revolving credit facility (the "Revolving Credit Facility") as of December 31, 2020 and 2019. Secured Credit Facility The credit agreement governing our secured credit facility (as amended, the "Credit Agreement") provides for senior secured credit facilities (the "Senior Secured Credit Facilities") consisting of a term loan facility (the "Term Loan"), the Revolving Credit Facility, and incremental availability under which additional secured credit facilities could be issued under certain circumstances. Term Loan The principal amount of the Term Loan amortizes in equal quarterly installments in an aggregate annual amount equal to 1.0% of the aggregate principal amount of the Term Loan upon completion of the tenth amendment of the Credit Agreement entered into on September 20, 2019 (the "Tenth Amendment,") with the balance due at maturity. In accordance with the terms of the Credit Agreement, the Term Loan may, at our option, be maintained from time to time as a Base Rate loan or a Eurodollar Rate loan (each as defined in the Credit Agreement), with each representing a different determination of interest rates. The interest rate margins for the Term Loan are fixed at, and as of December 31, 2020 were, 0.75% and 1.75% for Base Rate loans and Eurodollar Rate loans, respectively, subject to floors of 1.00% and 0.00% for Base Rate loans and Eurodollar Rate loans, respectively. As of December 31, 2020, we maintained the Term Loan as a Eurodollar Rate loan, which accrued interest at 1.90%. Revolving Credit Facility In accordance with the terms of the Credit Agreement, borrowings under the Revolving Credit Facility may, at our option, be maintained from time to time as Base Rate loans, Eurodollar Rate loans, or EURIBOR loans (each as defined in the Credit Agreement), with each representing a different determination of interest rates. The interest rate margins and letter of credit fees under the Revolving Credit Facility are as follows (each depending on our senior secured net leverage ratio): (i) the interest rate margin for Base Rate loans range from 0.00% to 0.50%; (ii) the interest rate margin for Eurodollar Rate and EURIBOR loans range from 1.00% to 1.50%; and (iii) the letter of credit fees range from 0.875% to 1.375%. We are required to pay to our revolving credit lenders, on a quarterly basis, a commitment fee on the unused portion of the Revolving Credit Facility. The commitment fee ranges from 0.125% to 0.250%, depending on our senior secured net leverage ratios. As of December 31, 2020, there was $416.1 million available under the Revolving Credit Facility, net of $3.9 million of obligations in respect of outstanding letters of credit issued thereunder. Outstanding letters of credit are issued primarily for the benefit of certain operating activities. As of December 31, 2020, no amounts had been drawn against these outstanding letters of credit. Availability under the Revolving Credit Facility may be borrowed, repaid, and re-borrowed to fund our working capital needs and for other general corporate purposes. Early redemption of the 6.25% Senior Notes On February 3, 2021, we announced that we intended to redeem in full the $750.0 million aggregate principal amount outstanding on our 6.25% Senior Notes due 2026 in March 2021. On February 15, 2021, the “make-whole” premium with respect to the 6.25% Senior Notes will expire, and we will redeem the 6.25% Senior Notes in accordance with the terms of the 6.25% Senior Notes Indenture and the terms of the notice of redemption. We expect to redeem the 6.25% Senior Notes on March 5, 2021 at a redemption price equal to 103.125% of the aggregate principal amount of the outstanding 6.25% Senior Notes, plus accrued and unpaid interest to (but not including) the redemption date. Fiscal year 2020 transactions On April 1, 2020, in order to enhance our financial flexibility given the general uncertainty associated with the COVID-19 pandemic, we withdrew $400.0 million from the Revolving Credit Facility. On August 17, 2020, we repaid these borrowings using a portion of the proceeds from issuance of $750.0 million aggregate principal amount of 3.75% senior notes due 2031 (the "3.75% Senior Notes"), issued by our indirect, wholly-owned subsidiary, Sensata Technologies Inc. ("STI"). Fiscal year 2019 transactions On March 27, 2019 certain indirect, wholly-owned subsidiaries of Sensata plc, including Sensata Technologies B.V. ("STBV"), entered into the ninth amendment (the "Ninth Amendment") of the Credit Agreement. Among other changes to the Credit Agreement, the Ninth Amendment (i) extended the maturity date of the Revolving Credit Facility to March 27, 2024; (ii) added pounds sterling as an available currency for revolving credit loans and letters of credit under the Revolving Credit Facility; (iii) lowered the interest rate margins related to the Revolving Credit Facility (depending on our senior secured net leverage ratio); (iv) lowered our letter of credit fees (depending on our senior secured net leverage ratio); (v) reduced our revolving credit commitment fees (depending on our senior secured net leverage ratio); and (vi) modified the senior secured net leverage ratio financial covenant to increase the Revolving Credit Facility utilization threshold above which such financial covenant is tested from 10% to 20% and eliminated the requirement that such ratio be tested (regardless of utilization) for purposes of satisfying the conditions to any borrowing or other utilization under the Revolving Credit Facility. On June 13, 2019, our subsidiaries that were at the time borrowers under the Credit Agreement entered into an amendment to the Credit Agreement with the administrative agent to correct certain technical and immaterial errors in the Credit Agreement. On September 20, 2019 certain of our subsidiaries, including STBV and STI, entered into the Tenth Amendment. Under the terms of the Tenth Amendment, among other changes to the Credit Agreement, (i) the final maturity date of the Term Loan was extended to September 20, 2026; (ii) STI became the sole borrower under the Credit Agreement and assumed substantially all of the obligations of STBV and Sensata Technologies Finance Company, LLC ("STFC") thereunder; (iii) STBV became a guarantor of STI’s obligations under the Credit Agreement, and STFC ceased to be a guarantor with respect to the Credit Agreement; (iv) certain subsidiaries of STBV that previously guaranteed STBV’s and/or STFC’s obligations under the Credit Agreement (the “Released Guarantors”) were released from their guarantees under the Credit Agreement, subject to the satisfaction of certain tests (the “Guarantees Release”); (v) the permission to incur incremental additional indebtedness under the Credit Agreement was increased; and (vi) certain of the operational and restrictive covenants and other terms and conditions of the Senior Secured Credit Facilities to which STBV and its restricted subsidiaries are subject were modified to provide us with increased flexibility and permissions thereunder (including permission, subject to no default or event of default, to make restricted payments (including dividends) in an amount equal to $50.0 million annually, which can be increased to an unlimited amount subject to compliance with a specified senior secured net leverage ratio). All obligations under the Senior Secured Credit Facilities are unconditionally guaranteed by certain of our subsidiaries and secured by substantially all present and future property and assets of STBV and its guarantor subsidiaries. The Credit Agreement provides that, if our senior secured net leverage ratio exceeds a specified level, we are required to use a portion of our excess cash flow, as defined in the Credit Agreement, generated by operating, investing, or financing activities to prepay the outstanding borrowings under the Senior Secured Credit Facilities. The Credit Agreement also requires mandatory prepayments of the outstanding borrowings under the Senior Secured Credit Facilities upon certain asset dispositions and casualty events, in each case subject to certain reinvestment rights, and the incurrence of certain indebtedness (excluding any permitted indebtedness). These provisions were not triggered during the year ended December 31, 2020. Senior Notes We have various tranches of senior notes outstanding. Information regarding these senior notes (together, the "Senior Notes") is included in the following table. The Senior Notes were issued under indentures (the "Senior Notes Indentures") among the issuers listed in the table below, The Bank of New York Mellon, as trustee, and our guarantor subsidiaries named in the respective Senior Notes Indentures. Each of the Senior Notes were issued at par, with interest payable semi-annually on the dates shown in the table below. 4.875% Senior Notes 5.625% Senior Notes 5.000% Senior Notes 6.250% Senior Notes (1) 4.375% Senior Notes (2) 3.750% Senior Notes Aggregate principal amount $ 500,000 $ 400,000 $ 700,000 $ 750,000 $ 450,000 $ 750,000 Interest rate 4.875 % 5.625 % 5.000 % 6.250 % 4.375 % 3.750 % Issuer STBV STBV STBV STUK STI STI Issue date April 2013 October 2014 March 2015 November 2015 September 2019 August 2020 Interest due April 15 May 1 April 1 February 15 February 15 February 15 Interest due October 15 November 1 October 1 August 15 August 15 August 15 Maturity Date October 2023 November 2024 October 2025 February 2026 February 2030 February 2031 __________________________________________ (1) The 6.25% Senior Notes were issued by our indirect, wholly-owned subsidiary, Sensata Technologies UK Financing Co. plc ("STUK") under an indenture dated as of November 27, 2015 (the "6.25% Senior Notes Indenture"). On February 3, 2021, we announced that we intended to redeem in full the $750.0 million aggregate principal amount outstanding on our 6.25% Senior Notes due 2026 in March 2021. (2) The proceeds of the issuance of the 4.375% Senior Notes were used to repay a portion of the Term Loan concurrent with the entry into the Tenth Amendment. Redemption Except as described below with respect to the 3.75% Senior Notes and the 4.375% Senior Notes, at any time, and from time to time, we may optionally redeem the Senior Notes, in whole or in part, at a price equal to 100% of the principal amount of the notes redeemed, plus accrued and unpaid interest, if any, up to, but excluding, the date of redemption, plus a "make-whole" premium set forth in the relevant Senior Notes Indenture. The "make-whole" premium will not be payable with respect to any such redemption of the 4.375% Senior Notes on or after November 15, 2029. The "make-whole" premium will not be payable with respect to any such redemption of the 3.75% Senior Notes on or after February 15, 2026; on or after such date, we may optionally redeem the 3.75% Senior Notes, in whole or in part, at the following prices (expressed as a percentage of principal amount), plus accrued and unpaid interest, if any, up to but excluding the redemption date: Period beginning February 15, Price 2026 101.875 % 2027 100.938 % 2028 and thereafter 100.000 % Upon the occurrence of certain specific change in control events, we will be required to offer to repurchase the notes at 101% of their principal amount, plus accrued and unpaid interest, if any, to, but excluding, the date of repurchase. If changes in certain tax laws or treaties, or any change in the official application, administration, or interpretation thereof, of any relevant taxing jurisdiction become effective that would impose withholding taxes or other deductions on the payments of any of the Senior Notes or the guarantees thereof, we may, at our option, redeem the relevant Senior Notes in whole but not in part, at a redemption price equal to 100% of the principal amount thereof, plus accrued and unpaid interest, if any, to, but excluding, the redemption date, premium, if any, and all additional amounts (as described in the relevant Senior Notes Indenture), if any, then due and which will become due on the date of redemption. Guarantees The obligations of the issuers of the Senior Notes are guaranteed by STBV and all of its subsidiaries (excluding the company that is the issuer of the relevant Senior Notes) that guarantee the obligations of STI under the Credit Agreement (after giving effect to the Guarantees Release pursuant to the Tenth Amendment). The Released Guarantors are not guarantors of the 3.75% Senior Notes or the 4.375% Senior Notes, and upon consummation of the Tenth Amendment, the guarantees of the Released Guarantors with respect to the other Senior Notes were released. Events of Default The Senior Notes Indentures provide for events of default that include, among others, nonpayment of principal or interest when due, breach of covenants or other provisions in the relevant Senior Notes Indenture, defaults in payment of certain other indebtedness, certain events of bankruptcy or insolvency, failure to pay certain judgments, and the cessation of the full force and effect of the guarantees of significant subsidiaries. Generally, if an event of default occurs, the trustee or the holders of at least 25% in principal amount of the then outstanding Senior Notes issued under the relevant Senior Notes Indenture may declare the principal of, and accrued but unpaid interest on, all of the relevant Senior Notes to be due and payable immediately. All provisions regarding remedies in an event of default are subject to the relevant Senior Notes Indenture. Restrictions and Covenants As of December 31, 2020, STBV and all of its subsidiaries were subject to certain restrictive covenants under the Credit Agreement and the Senior Notes Indentures. Under certain circumstances, STBV is permitted to designate a subsidiary as "unrestricted" for purposes of the Credit Agreement, in which case the restrictive covenants thereunder will not apply to that subsidiary; the Senior Notes Indentures do not contain such a permission. STBV has not designated any subsidiaries as unrestricted. The net assets of STBV subject to these restrictions totaled $2,726.2 million at December 31, 2020. Credit Agreement The Credit Agreement contains non-financial restrictive covenants (subject to important exceptions and qualifications set forth in the Credit Agreement) that limit our ability to, among other things: • incur indebtedness or liens, prepay subordinated debt, or amend the terms of our subordinated debt; • make loans and investments (including acquisitions) or sell assets; • change our business or accounting policies, merge, consolidate, dissolve or liquidate, or amend the terms of our organizational documents; • enter into affiliate transactions; • pay dividends and make other restricted payments; or • enter into certain burdensome contractual obligations. In addition, under the Credit Agreement, STBV and its subsidiaries are required to maintain a senior secured net leverage ratio not to exceed 5.0:1.0 at the conclusion of certain periods when outstanding loans and letters of credit that are not cash collateralized for the full face amount thereof exceed 20% of the commitments under the Revolving Credit Facility. Senior Notes Indentures The Senior Notes Indentures contain restrictive covenants (subject to important exceptions and qualifications set forth in the Senior Notes Indentures) that limit the ability of STBV and its subsidiaries to, among other things: • incur liens; • incur or guarantee indebtedness without guaranteeing the Senior Notes; • engage in sale and leaseback transactions; or • effect mergers or consolidations, or sell, assign, convey, transfer, lease or otherwise dispose of all or substantially all of the assets of STBV and its subsidiaries. Certain of these covenants will be suspended if the Senior Notes are assigned an investment grade rating by Standard & Poor's Rating Services or Moody's Investors Service, Inc. and provided no default has occurred and is continuing at such time. The suspended covenants will be reinstated if the Senior Notes are no longer assigned an investment grade rating by either rating agency or an event of default has occurred and is continuing at such time. As of December 31, 2020, none of the Senior Notes were assigned an investment grade rating by either rating agency. Restrictions on Payment of Dividends STBV's subsidiaries are generally not restricted in their ability to pay dividends or otherwise distribute funds to STBV, except for restrictions imposed under applicable corporate law. STBV, however, is limited in its ability to pay dividends or otherwise make distributions to its immediate parent company and, ultimately, to Sensata plc, under the Credit Agreement. Specifically, the Credit Agreement prohibits STBV from paying dividends or making distributions to its parent companies except for purposes that include, but are not limited to, the following: • customary and reasonable operating expenses, legal and accounting fees and expenses, and overhead of such parent companies incurred in the ordinary course of business, provided that such amounts, in the aggregate, do not exceed $20.0 million in any fiscal year; • dividends and other distributions in an aggregate amount not to exceed $200.0 million plus certain amounts, including the retained portion of excess cash flow, but only insofar as no default or event of default exists and the senior secured net leverage ratio is less than 2.0:1.0 calculated on a pro forma basis; • so long as no default or an event of default exists, dividends and other distributions in an aggregate amount not to exceed $50.0 million in any calendar year (with the unused portion in any year being carried over to succeeding years) plus unlimited additional amounts but only insofar as the senior secured net leverage ratio is less than 2.5:1.0 calculated on a pro forma basis; and • other dividends and other distributions in an aggregate amount not to exceed $150.0 million, so long as no default or event of default exists. The Senior Notes Indentures generally allow STBV to pay dividends and make other distributions to its parent companies. Compliance with Financial and Non-Financial Covenants We were in compliance with all of the financial and non–financial covenants and default provisions associated with our indebtedness as of December 31, 2020 and for the fiscal year then ended. Accounting for Debt Financing Transactions During the year ended December 31, 2020, in connection with the entry into the 3.75% Senior Notes, we incurred $8.4 million of related third-party costs, which are presented as a reduction of long-term debt on our consolidated balance sheets. During the year ended December 31, 2019, in connection with the entry into the Ninth Amendment, we incurred $2.4 million of creditor fees and related third-party costs, which are presented as a reduction of long-term debt on our consolidated balance sheets. During the year ended December 31, 2019, in connection with of the issuance of the 4.375% Senior Notes, the entry into the Tenth Amendment, and the subsequent partial repayment of the Term Loan, we recognized a loss of $4.4 million, presented in the other, net line of our consolidated statement of operations, as well as $5.0 million of deferred financing costs, which are presented as a reduction of long-term debt on our consolidated balance sheets. During the year ended December 31, 2018, in connection with the Merger, we paid $5.8 million of creditor fees and related third-party costs in order to obtain consents to the transaction from our existing lenders. As a result, and based on application of the provisions in FASB ASC Subtopic 470-50, we recognized a $3.5 million adjustment to the carrying value of long-term debt, net and a $2.4 million loss in other, net. Refer to Note 2, "Significant Accounting Policies," for additional information related to our accounting policies regarding debt financing transactions. Finance Lease and Other Financing Obligations Refer to Note 17, "Leases," for additional information related to our finance leases. Debt Maturities The aggregate principal amount of each tranche of our Senior Notes is due in full at its maturity date. The Term Loan must be repaid in full on or prior to its final maturity date. Loans made pursuant to the Revolving Credit Facility must be repaid in full at its maturity date and can be repaid prior to then at par. All letters of credit issued thereunder will terminate at the final maturity of the Revolving Credit Facility unless cash collateralized prior to such time. The following table presents the remaining mandatory principal repayments of long-term debt, excluding finance lease payments, other financing obligations, and discretionary repurchases of debt, in each of the years ended December 31, 2021 through 2025 and thereafter. On February 3, 2021, we announced that we intended to redeem in full the $750.0 million aggregate principal amount outstanding on our 6.25% Senior Notes due 2026 in March 2021. This redemption is reflected in fiscal year 2021 in the following table. In accordance with the terms of the 6.25% Senior Notes, redemption will be at 103.125% of aggregate principal amount outstanding, and will represent an additional cash outflow of approximately $23.4 million in fiscal year 2021, which is not presented below. For the year ended December 31, Aggregate Maturities 2021 $ 754,630 2022 4,630 2023 504,630 2024 404,630 2025 704,630 Thereafter 1,632,946 Total long-term debt principal payments $ 4,006,096 |
Commitments and Contingencies
Commitments and Contingencies | 12 Months Ended |
Dec. 31, 2020 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies Non-cancelable purchase agreements exist with various suppliers, primarily for services such as information technology support. The terms of these agreements are fixed and determinable. As of December 31, 2020, we had the following purchase commitments: For the year ending December 31, 2021 $ 41,355 2022 14,517 2023 6,889 2024 149 2025 132 Thereafter 196 Total purchase commitments $ 63,238 Off-Balance Sheet Arrangements From time to time, we execute contracts that require us to indemnify the other parties to the contracts. These indemnification obligations generally arise in two contexts. First, in connection with certain transactions, such as the divestiture of a business or the issuance of debt or equity securities, the agreement typically contains standard provisions requiring us to indemnify the purchaser against breaches by us of representations and warranties contained in the agreement. These indemnities are generally subject to time and liability limitations. Second, we enter into agreements in the ordinary course of business, such as customer contracts, that might contain indemnification provisions relating to product quality, intellectual property infringement, governmental regulations and employment related matters, and other typical indemnities. In certain cases, indemnification obligations arise by law. We believe that our indemnification obligations are consistent with other companies in the markets in which we compete. Performance under any of these indemnification obligations would generally be triggered by a breach of the terms of the contract or by a third-party claim. Historically, we have experienced only immaterial and irregular losses associated with these indemnifications. Consequently, any future liabilities brought about by these indemnifications cannot reasonably be estimated or accrued. Indemnifications Provided As Part of Contracts and Agreements We are party to the following types of agreements pursuant to which we may be obligated to indemnify a third party with respect to certain matters. Officers and Directors: Our articles of association provide for indemnification of directors and officers by us to the fullest extent permitted by applicable law, as it now exists or may hereinafter be amended (but, in the case of an amendment, only to the extent such amendment permits broader indemnification rights than permitted prior thereto), against any and all liabilities, including all expenses (including attorneys’ fees), judgments, fines, and amounts paid in settlement actually and reasonably incurred by him or her in connection with such action, suit, or proceeding, provided he or she acted in good faith and in a manner he or she reasonably believed to be in, or not opposed to, our best interests, and, with respect to any criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful or outside of his or her mandate. The articles do not provide a limit to the maximum future payments, if any, under the indemnification. No indemnification is provided for in respect of any claim, issue, or matter as to which such person has been adjudged to be liable for gross negligence or willful misconduct in the performance of his or her duty on our behalf. In addition, we have a liability insurance policy that insures directors and officers against the cost of defense, settlement, or payment of claims and judgments under some circumstances. Certain indemnification payments may not be covered under our directors’ and officers’ insurance coverage. Initial Purchasers of Senior Notes : Pursuant to the terms of the purchase agreements entered into in connection with our private placement senior note offerings, we are obligated to indemnify the initial purchasers of the Senior Notes against certain liabilities caused by any untrue statement or alleged untrue statement of a material fact in various documents relied upon by such initial purchasers, or to contribute to payments the initial purchasers may be required to make in respect thereof. The purchase agreements do not provide a limit to the maximum future payments, if any, under these indemnifications. Intellectual Property and Product Liability Indemnification: We routinely sell products with a limited intellectual property and product liability indemnification included in the terms of sale. Historically, we have had only immaterial and irregular losses associated with these indemnifications. Consequently, any future liabilities resulting from these indemnifications cannot reasonably be estimated or accrued. Product Warranty Liabilities Refer to Revenue Recognition in Note 2, "Significant Accounting Policies," for additional information related to the warranties we provide to customers. In the event a warranty claim based on defective materials exists, we may be able to recover some of the cost of the claim from the vendor from whom the materials were purchased. Our ability to recover some of the costs will depend on the terms and conditions to which we agreed when the materials were purchased. When a warranty claim is made, the only collateral available to us is the return of the inventory from the customer making the warranty claim. Historically, when customers make a warranty claim, we either replace the product or provide the customer with a credit. We generally do not rework the returned product. Our policy is to accrue for warranty claims when a loss is both probable and estimable. This is accomplished by accruing for estimated returns and estimated costs to replace the product at the time the related revenue is recognized. Liabilities for warranty claims have historically not been material. In some instances, customers may make claims for costs they incurred or other damages related to a claim. Environmental Remediation Liabilities Our operations and facilities are subject to U.S. and non-U.S. laws and regulations governing the protection of the environment and our employees, including those governing air emissions, chemical usage, water discharges, the management and disposal of hazardous substances and wastes, and the cleanup of contaminated sites. We could incur substantial costs, including cleanup costs, fines, civil or criminal sanctions, or third-party property damage or personal injury claims, in the event of violations or liabilities under these laws and regulations, or non-compliance with the environmental permits required at our facilities. Potentially significant expenditures could be required in order to comply with environmental laws that may be adopted or imposed in the future. We are, however, not aware of any threatened or pending material environmental investigations, lawsuits, or claims involving us or our operations. Legal Proceedings and Claims We are regularly involved in a number of claims and litigation matters that arise in the ordinary course of business. Although it is not feasible to predict the outcome of these matters, based upon our experience and current information known to us, we do not expect the outcome of these matters, either individually or in the aggregate, to have a material adverse effect on our results of operations, financial position, and/or cash flows. We account for litigation and claims losses in accordance with FASB ASC Topic 450, Contingencies . Under FASB ASC Topic 450, loss contingency provisions are recognized for probable and estimable losses at our best estimate of a loss or, when a best estimate cannot be made, at our estimate of the minimum loss. These estimates are often developed prior to knowing the amount of the ultimate loss, require the application of considerable judgment, and are refined each accounting period as additional information becomes known. Accordingly, we are often initially unable to develop a best estimate of loss and therefore the minimum amount, which could be an immaterial amount, is recognized. As information becomes known, either the minimum loss amount is increased, or a best estimate can be made, generally resulting in additional loss provisions. A best estimate amount may be changed to a lower amount when events result in an expectation of a more favorable outcome than previously expected. Pending Litigation and Claims: There are no material pending litigation and claims outstanding as of December 31, 2020. Litigation and Claims resolved in the current year: We were a defendant in a lawsuit, Wasica Finance Gmbh et al v. Schrader International Inc. et al, Case No. 13-1353-CPS, U.S.D.C., Delaware , in which the claimant alleged infringement of their patent (US 5,602,524) in connection with certain of our tire pressure monitoring system products. The patent in question has expired, and as a result, the claimant sought damages for past alleged infringement with interest and costs. The asserted patent was the U.S. counterpart of a German patent that had been previously asserted against Schrader. Schrader succeeded in proving that German patent to be invalid. On February 14, 2020, a jury found us liable for damages in the amount of $31.2 million. As a result, we recorded a loss of $29.2 million in the three months ended March 31, 2020 through cost of revenue. On July 6, 2020, the court awarded an additional $12.1 million for plaintiffs and against us for prejudgment interest-related damages, and as a result, in the three months ended June 30, 2020, we recorded a loss of $12.1 million through restructuring and other charges, net, to reflect the court's order. The parties executed and closed a Litigation Settlement & License Agreement on September 18, 2020 to settle the matter for $31.6 million. As a result of this settlement, in the three months ended September 30, 2020, we recognized a gain of $11.7 million, presented in restructuring and other charges, net. The lawsuit was formally dismissed by the District Court (D. Del) on September 22, 2020, and the U.S. Court of Appeals for the Federal Circuit on September 24, 2020. |
Shareholders' Equity
Shareholders' Equity | 12 Months Ended |
Dec. 31, 2020 | |
Stockholders' Equity Note [Abstract] | |
Shareholders' Equity | Shareholders’ Equity Treasury Shares Ordinary shares repurchased by us are recognized, measured at cost, and presented as treasury shares on our consolidated balance sheets, resulting in a reduction of shareholders' equity. In connection with the Merger, all then outstanding treasury shares were canceled in accordance with U.K. law. Accordingly, we (1) derecognized the total purchase price of these treasury shares, (2) recognized a reduction to ordinary shares at an amount equal to the total par value of such shares, and (3) recognized a reduction to retained earnings at an amount equal to the excess of the total repurchase price over the total par value of the then outstanding treasury shares, or $286.1 million. From time to time, our Board of Directors has authorized various share repurchase programs, which may be modified or terminated by our Board of Directors at any time. Under these programs, we may repurchase ordinary shares at such times and in amounts to be determined by our management, based on market conditions, legal requirements, and other corporate considerations, on the open market or in privately negotiated transactions, provided that such transactions were completed pursuant to an agreement and with a third party approved by our shareholders at the annual general meeting. The authorized amount of our various share repurchase programs may be modified or terminated by our Board of Directors at any time. We currently have a $500.0 million share repurchase program authorized by our Board of Directors in July 2019 (the "July 2019 Program"). On April 2, 2020, we announced a temporary suspension of July 2019 Program, which will continue to remain on hold until market conditions show greater improvement and stability. As of December 31, 2020, approximately $302.3 million remained available under the July 2019 Program. As a result of certain aspects of U.K. law, we discontinued the practice of reissuing treasury shares as part of our share-based compensation programs upon completion of the Merger. The number of treasury shares reissued prior to completion of the Merger was not material. Accumulated Other Comprehensive Loss The components of accumulated other comprehensive loss were as follows: Cash Flow Hedges Defined Benefit and Retiree Healthcare Plans Accumulated Other Comprehensive Loss Balance as of December 31, 2017 $ (28,179) $ (34,985) $ (63,164) Pre-tax current period change 49,817 (1,183) 48,634 Tax effect (12,454) 806 (11,648) Balance as of December 31, 2018 9,184 (35,362) (26,178) Pre-tax current period change 9,816 (2,198) 7,618 Tax effect (2,454) 530 (1,924) Balance as of December 31, 2019 16,546 (37,030) (20,484) Pre-tax current period change (31,114) (7,848) (38,962) Tax effect 7,835 2,076 9,911 Balance as of December 31, 2020 $ (6,733) $ (42,802) $ (49,535) The details of the components of other comprehensive (loss)/income, net of tax, for the years ended December 31, 2020, 2019, and 2018 are as follows: For the year ended December 31, 2020 2019 2018 Cash Flow Hedges Defined Benefit and Retiree Healthcare Plans Total Cash Flow Hedges Defined Benefit and Retiree Healthcare Plans Total Cash Flow Hedges Defined Benefit and Retiree Healthcare Plans Total Other comprehensive (loss)/income before reclassifications $ (17,738) $ (12,494) $ (30,232) $ 28,795 $ (3,470) $ 25,325 $ 26,859 $ (2,120) $ 24,739 Amounts reclassified from accumulated other comprehensive loss (5,541) 6,722 1,181 (21,433) 1,802 (19,631) 10,504 1,743 12,247 Other comprehensive (loss)/income $ (23,279) $ (5,772) $ (29,051) $ 7,362 $ (1,668) $ 5,694 $ 37,363 $ (377) $ 36,986 The details of the (gain)/loss reclassified from accumulated other comprehensive loss for the years ended December 31, 2020, 2019, and 2018 are as follows: Amount of (Gain)/Loss Reclassified from Accumulated Other Comprehensive Loss For the year ended December 31, Affected Line in Consolidated Statements of Operations 2020 2019 2018 Derivative instruments designated and qualifying as cash flow hedges: Foreign currency forward contracts $ (10,785) $ (26,180) $ 18,072 Net revenue (1) Foreign currency forward contracts 3,397 (2,397) (5,442) Cost of revenue (1) Foreign currency forward contracts — — 1,376 Other, net (1) Total, before taxes (7,388) (28,577) 14,006 Income before taxes Income tax effect 1,847 7,144 (3,502) Provision for/(benefit from) income taxes Total, net of taxes $ (5,541) $ (21,433) $ 10,504 Net income Defined benefit and retiree healthcare plans $ 9,118 $ 2,552 $ 1,993 Other, net (2) Defined benefit and retiree healthcare plans — — 228 Restructuring and other charges, net (3) Total, before taxes 9,118 2,552 2,221 Income before taxes Income tax effect (2,396) (750) (478) Provision for/(benefit from) income taxes Total, net of taxes $ 6,722 $ 1,802 $ 1,743 Net income __________________________________________ (1) Refer to Note 19, "Derivative Instruments and Hedging Activities," for additional information related to amounts to be reclassified from accumulated other comprehensive loss in future periods. (2) Refer to Note 13, "Pension and Other Post-Retirement Benefits," for additional information related to net periodic benefit cost. |
Leases
Leases | 12 Months Ended |
Dec. 31, 2020 | |
Leases [Abstract] | |
Leases | Leases The table below shows right-of-use asset and lease liability amounts and the financial statement line item in which those amounts are presented: December 31, 2020 December 31, 2019 Operating lease right-of-use assets: Other assets $ 49,980 $ 55,333 Total operating lease right-of-use assets $ 49,980 $ 55,333 Operating lease liabilities: Accrued expenses and other current liabilities $ 11,389 $ 11,543 Other long-term liabilities 43,307 45,457 Total operating lease liabilities $ 54,696 $ 57,000 Finance lease right-of-use assets: Property, plant and equipment, at cost $ 49,714 $ 49,714 Accumulated depreciation (26,107) (24,316) Property, plant and equipment, net $ 23,607 $ 25,398 Finance lease liabilities: Current portion of long-term debt, finance lease and other financing obligations $ 2,403 $ 1,974 Finance lease and other financing obligations, less current portion 27,931 28,669 Total finance lease liabilities $ 30,334 $ 30,643 The vast majority of our finance lease obligations are for facilities in Baoying, China and Attleboro, Massachusetts. As of December 31, 2020 and 2019, the combined finance lease obligation outstanding for these facilities was $29.4 million and $29.4 million, respectively. The table below presents the lease liabilities arising from obtaining right-of-use assets in the years ended December 31, 2020 and 2019: For the year ended December 31, 2020 2019 Operating leases $ 3,232 $ 5,423 Finance leases $ — $ — The table below presents our total lease cost for the years ended December 31, 2020 and 2019 (short-term lease cost was not material for the years ended December 31, 2020 and 2019): For the year ended December 31, 2020 2019 Operating lease cost $ 16,658 $ 16,124 Finance lease cost: Amortization of right-of-use assets $ 1,794 $ 1,808 Interest on lease liabilities 2,565 2,695 Total finance lease cost $ 4,359 $ 4,503 Rent expense for the year ended December 31, 2018 (prior to the adoption of FASB ASC Topic 842) was $21.0 million. The table below presents the cash paid related to our operating and finance leases for the years ended December 31, 2020 and 2019: For the year ended December 31, 2020 2019 Operating cash flows from operating leases $ 16,489 $ 15,911 Operating cash flows from finance leases $ 2,262 $ 2,731 Financing cash flows from finance leases $ 944 $ 1,933 The table below presents the weighted-average remaining lease term of our operating and finance leases (in years): 2020 Operating leases 7.6 Finance leases 11.8 The table below presents our weighted-average discount rate as of December 31, 2020: 2020 Operating leases 5.7 % Finance leases 8.5 % The table below presents a maturity analysis of the obligations related to our operating lease liabilities and finance lease liabilities in effect as of December 31, 2020: Operating Leases Finance Leases Year ending December 31, 2021 $ 14,608 $ 4,572 2022 12,176 3,848 2023 8,829 3,813 2024 7,561 3,873 2025 5,048 3,934 Thereafter 21,808 29,486 Total undiscounted cash flows related to lease liabilities 70,030 49,526 Less imputed interest (15,334) (19,192) Total lease liabilities $ 54,696 $ 30,334 |
Leases | Leases The table below shows right-of-use asset and lease liability amounts and the financial statement line item in which those amounts are presented: December 31, 2020 December 31, 2019 Operating lease right-of-use assets: Other assets $ 49,980 $ 55,333 Total operating lease right-of-use assets $ 49,980 $ 55,333 Operating lease liabilities: Accrued expenses and other current liabilities $ 11,389 $ 11,543 Other long-term liabilities 43,307 45,457 Total operating lease liabilities $ 54,696 $ 57,000 Finance lease right-of-use assets: Property, plant and equipment, at cost $ 49,714 $ 49,714 Accumulated depreciation (26,107) (24,316) Property, plant and equipment, net $ 23,607 $ 25,398 Finance lease liabilities: Current portion of long-term debt, finance lease and other financing obligations $ 2,403 $ 1,974 Finance lease and other financing obligations, less current portion 27,931 28,669 Total finance lease liabilities $ 30,334 $ 30,643 The vast majority of our finance lease obligations are for facilities in Baoying, China and Attleboro, Massachusetts. As of December 31, 2020 and 2019, the combined finance lease obligation outstanding for these facilities was $29.4 million and $29.4 million, respectively. The table below presents the lease liabilities arising from obtaining right-of-use assets in the years ended December 31, 2020 and 2019: For the year ended December 31, 2020 2019 Operating leases $ 3,232 $ 5,423 Finance leases $ — $ — The table below presents our total lease cost for the years ended December 31, 2020 and 2019 (short-term lease cost was not material for the years ended December 31, 2020 and 2019): For the year ended December 31, 2020 2019 Operating lease cost $ 16,658 $ 16,124 Finance lease cost: Amortization of right-of-use assets $ 1,794 $ 1,808 Interest on lease liabilities 2,565 2,695 Total finance lease cost $ 4,359 $ 4,503 Rent expense for the year ended December 31, 2018 (prior to the adoption of FASB ASC Topic 842) was $21.0 million. The table below presents the cash paid related to our operating and finance leases for the years ended December 31, 2020 and 2019: For the year ended December 31, 2020 2019 Operating cash flows from operating leases $ 16,489 $ 15,911 Operating cash flows from finance leases $ 2,262 $ 2,731 Financing cash flows from finance leases $ 944 $ 1,933 The table below presents the weighted-average remaining lease term of our operating and finance leases (in years): 2020 Operating leases 7.6 Finance leases 11.8 The table below presents our weighted-average discount rate as of December 31, 2020: 2020 Operating leases 5.7 % Finance leases 8.5 % The table below presents a maturity analysis of the obligations related to our operating lease liabilities and finance lease liabilities in effect as of December 31, 2020: Operating Leases Finance Leases Year ending December 31, 2021 $ 14,608 $ 4,572 2022 12,176 3,848 2023 8,829 3,813 2024 7,561 3,873 2025 5,048 3,934 Thereafter 21,808 29,486 Total undiscounted cash flows related to lease liabilities 70,030 49,526 Less imputed interest (15,334) (19,192) Total lease liabilities $ 54,696 $ 30,334 |
Fair Value Measures
Fair Value Measures | 12 Months Ended |
Dec. 31, 2020 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measures | Fair Value Measures Our assets and liabilities recorded at fair value have been categorized based upon a fair value hierarchy in accordance with FASB ASC Topic 820. The levels of the fair value hierarchy are described below: • Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets and liabilities that we have the ability to access at the measurement date. • Level 2 inputs utilize inputs, other than quoted prices included in Level 1, that are observable for the asset or liability, either directly or indirectly. Level 2 inputs include quoted prices for similar assets and liabilities in active markets, quoted prices in markets that are not active, and inputs other than quoted prices that are observable for the asset or liability, such as interest rates and yield curves that are observable at commonly quoted intervals. • Level 3 inputs are unobservable inputs for the asset or liability, allowing for situations where there is little, if any, market activity for the asset or liability. Measured on a Recurring Basis The fair values of our assets and liabilities measured at fair value on a recurring basis as of as of December 31, 2020 and 2019 are as shown in the below table. All fair value measures presented are categorized in Level 2 of the fair value hierarchy. As of December 31, 2020 2019 Assets measured at fair value: Foreign currency forward contracts 16,163 23,561 Commodity forward contracts 8,902 3,623 Total assets measured at fair value 25,065 27,184 Liabilities measured at fair value: Foreign currency forward contracts 24,660 1,959 Commodity forward contracts 310 462 Total liabilities measured at fair value 24,970 2,421 Refer to Note 2, "Significant Accounting Policies," for additional information related to the methods used to estimate the fair value of our financial instruments, and refer Note 19, "Derivative Instruments and Hedging Activities," for additional information related to the inputs used to determine these fair value measurements and the nature of the risks that these derivative instruments are intended to mitigate. Although we have determined that the majority of the inputs used to value our derivative instruments fall within Level 2 of the fair value hierarchy, the credit valuation adjustments associated with our derivatives utilize Level 3 inputs, such as estimates of current credit spreads, to appropriately reflect both our own non-performance risk and the respective counterparties' non-performance risk in the fair value measurement. As of December 31, 2020 and 2019, we have assessed the significance of the impact of the credit valuation adjustments on the overall valuation of our derivative positions and have determined that the credit valuation adjustments are not significant to the overall valuation of our derivatives. As a result, we have determined that our derivatives in their entirety are classified in Level 2 in the fair value hierarchy. Measured on a Nonrecurring Basis We evaluated our goodwill and other indefinite-lived intangible assets for impairment as of October 1, 2020. Refer to Note 11, "Goodwill and Other Intangible Assets, Net," for additional information. Based on these analyses, we determined that no impairments were required. As of December 31, 2020, no events or changes in circumstances occurred that would have triggered the need for an additional impairment review of goodwill or other indefinite-lived intangible assets. Financial Instruments Not Recorded at Fair Value The following table presents the carrying values and fair values of financial instruments not recorded at fair value in the consolidated balance sheets as of December 31, 2020 and 2019. All fair value measures presented are categorized within Level 2 of the fair value hierarchy. As of December 31, 2020 2019 Carrying Value (1) Fair Value Carrying Value (1) Fair Value Term Loan $ 456,096 $ 454,955 $ 460,725 $ 464,181 4.875% Senior Notes $ 500,000 $ 538,750 $ 500,000 $ 532,500 5.625% Senior Notes $ 400,000 $ 448,000 $ 400,000 $ 444,000 5.0% Senior Notes $ 700,000 $ 777,000 $ 700,000 $ 759,500 6.25% Senior Notes $ 750,000 $ 778,125 $ 750,000 $ 808,125 4.375% Senior Notes $ 450,000 $ 487,125 $ 450,000 $ 457,875 3.75% Senior Notes $ 750,000 $ 776,250 $ — $ — __________________________________________ (1) Excluding any related debt discounts and deferred financing costs. In addition to the above, we hold certain equity investments that do not have readily determinable fair values for which we use the measurement alternative prescribed in FASB ASC Topic 321 . Such investments are measured at cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer. There were no impairments or changes resulting from observable transactions for any of these investments, and no adjustments have been made to their carrying values. Refer to the table below for the carrying values of equity investments using the measurement alternative, which are presented as a component of other assets in the consolidated balance sheets. As of December 31, 2020 2019 Quanergy Systems, Inc $ 50,000 $ 50,000 Other 15,000 3,700 Total $ 65,000 $ 53,700 |
Derivative Instruments and Hedg
Derivative Instruments and Hedging Activities | 12 Months Ended |
Dec. 31, 2020 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Derivative Instruments and Hedging Activities | Derivative Instruments and Hedging Activities We utilize derivative instruments that are designated and qualify as hedges of our exposure to variability in expected future cash flows. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on these hedging instruments with the earnings effect of the hedged forecasted transactions. We may enter into other derivative contracts that are intended to economically hedge certain risks, even though we elect not to apply hedge accounting under FASB ASC Topic 815. Derivative financial instruments not designated as hedges are used to manage our exposure to certain risks, not for trading or speculative purposes. Refer to Note 2, "Significant Accounting Policies," for additional information related to the valuation techniques and accounting policies regarding derivative instruments and hedging activities. Foreign Currency Risk We are exposed to fluctuations in the values of certain foreign currencies relative to our functional currency, the USD. We enter into forward contracts to manage this exposure. We currently have outstanding foreign currency forward contracts that qualify as cash flow hedges intended to offset the effect of exchange rate fluctuations on forecasted sales and certain manufacturing costs. We also have outstanding foreign currency forward contracts that are intended to preserve the economic value of foreign currency denominated monetary assets and liabilities, which are not designated for hedge accounting treatment in accordance with FASB ASC Topic 815. For each of the years ended December 31, 2020, 2019, and 2018, amounts excluded from the assessment of effectiveness of our foreign currency forward contracts were not material. As of December 31, 2020, we estimate that $9.7 million of net losses will be reclassified from accumulated other comprehensive loss to earnings during the twelve month period ending December 31, 2021. As of December 31, 2020, we had the following outstanding foreign currency forward contracts: Notional Effective Date(s) Maturity Date(s) Index (Exchange Rates) Weighted- Average Strike Rate Hedge Designation (1) 22.0 EUR December 29, 2020 January 29, 2021 Euro ("EUR") to USD 1.23 USD Not designated 317.3 EUR Various from February 2019 to December 2020 Various from January 2021 to December 2022 EUR to USD 1.17 USD Cash flow hedge 584.0 CNY December 28, 2020 January 29, 2021 USD to Chinese Renminbi ("CNY") 6.57 CNY Not designated 500.0 CNY November 5, 2020 Various from January to December 2021 USD to CNY 6.74 CNY Cash flow hedge 897.0 JPY December 28, 2020 January 29, 2021 USD to Japanese Yen ("JPY") 103.53 JPY Not designated 17,321.7 KRW Various from March 2019 to December 2020 Various from January 2021 to December 2022 USD to Korean Won ("KRW") 1,167.03 KRW Cash flow hedge 22.0 MYR December 30, 2020 January 29, 2021 USD to Malaysian Ringgit ("MYR") 4.06 MYR Not designated 284.0 MXN December 29, 2020 January 29, 2021 USD to Mexican Peso ("MXN") 19.95 MXN Not designated 2,963.5 MXN Various from February 2019 to December 2020 Various from January 2021 to December 2022 USD to MXN 22.56 MXN Cash flow hedge 6.0 GBP December 29, 2020 January 29, 2021 British Pound Sterling ("GBP") to USD 1.35 USD Not designated 48.9 GBP Various from February 2019 to December 2020 Various from January 2021 to December 2022 GBP to USD 1.29 USD Cash flow hedge ______________________________________ (1) Derivative financial instruments not designated as hedges are used to manage our exposure to currency exchange rate risk. They are intended to preserve the economic value, and they are not used for trading or speculative purposes. Commodity Risk We enter into commodity forward contracts in order to limit our exposure to variability in raw material costs that is caused by movements in the price of underlying metals. The terms of these forward contracts fix the price at a future date for various notional amounts associated with these commodities. These instruments are not designated for hedge accounting treatment in accordance with FASB ASC Topic 815. As of December 31, 2020, we had the following outstanding commodity forward contracts: Commodity Notional Remaining Contracted Periods Weighted-Average Silver 742,939 troy oz. January 2021- December 2022 $ 20.54 Gold 7,326 troy oz. January 2021-December 2022 $ 1,733.35 Nickel 165,037 pounds January 2021-December 2022 $ 6.62 Aluminum 2,224,837 pounds January 2021-December 2022 $ 0.86 Copper 1,803,323 pounds January 2021-December 2022 $ 2.83 Platinum 7,440 troy oz. January 2021-December 2022 $ 911.09 Palladium 831 troy oz. January 2021-December 2022 $ 1,988.33 Financial Instrument Presentation The following table presents the fair values of our derivative financial instruments and their classification in the consolidated balance sheets as of December 31, 2020 and 2019: Asset Derivatives Liability Derivatives Balance Sheet As of December 31, Balance Sheet As of December 31, 2020 2019 2020 2019 Derivatives designated as hedging instruments: Foreign currency forward contracts Prepaid expenses and other current assets $ 11,281 $ 20,957 Accrued expenses and other current liabilities $ 18,834 $ 1,055 Foreign currency forward contracts Other assets 4,728 2,530 Other long-term liabilities 5,182 428 Total $ 16,009 $ 23,487 $ 24,016 $ 1,483 Derivatives not designated as hedging instruments: Commodity forward contracts Prepaid expenses and other current assets $ 7,598 $ 3,069 Accrued expenses and other current liabilities $ 149 $ 394 Commodity forward contracts Other assets 1,304 554 Other long-term liabilities 161 68 Foreign currency forward contracts Prepaid expenses and other current assets 154 74 Accrued expenses and other current liabilities 644 476 Total $ 9,056 $ 3,697 $ 954 $ 938 These fair value measurements are all categorized within Level 2 of the fair value hierarchy. Refer to Note 18, "Fair Value Measures," for additional information related to the categorization of these fair value measurements within the fair value hierarchy. The following tables present the effect of our derivative financial instruments on the consolidated statements of operations and the consolidated statements of comprehensive income for the years ended December 31, 2020 and 2019: Derivatives designated as hedging instruments Amount of Deferred (Loss)/Gain Recognized in Other Comprehensive (Loss)/Income Location of Net Gain/(Loss) Reclassified from Accumulated Other Comprehensive Loss into Net Income Amount of Net Gain/(Loss) Reclassified from Accumulated Other Comprehensive Loss into Net Income For the year ended December 31, For the year ended December 31, 2020 2019 2020 2019 Foreign currency forward contracts $ (25,866) $ 23,881 Net revenue $ 10,785 $ 26,180 Foreign currency forward contracts $ 2,140 $ 14,512 Cost of revenue $ (3,397) $ 2,397 Derivatives not designated as hedging instruments Amount of Gain/(Loss) Recognized in Net Income Location of Gain/(Loss) Recognized in Net Income For the year ended December 31, 2020 2019 Commodity forward contracts $ 10,027 $ 4,888 Other, net Foreign currency forward contracts $ (6,762) $ 2,225 Other, net Credit risk related contingent features We have agreements with our derivative counterparties that contain a provision whereby if we default on our indebtedness and repayment of the indebtedness has been accelerated by the lender, then we could also be declared in default on our derivative obligations. |
Segment Reporting
Segment Reporting | 12 Months Ended |
Dec. 31, 2020 | |
Segment Reporting [Abstract] | |
Segment Reporting | Segment ReportingIn the three months ended June 30, 2020, we altered the way we measure segment operating income in order to align with a change to the performance measures provided to and used by our chief operating decision maker for purposes of assessing performance and deciding how to allocate resources to each segment. Whereas R&D and SG&A expenses related to our megatrend initiatives were historically allocated to our operating segments, beginning in fiscal year 2020 these amounts are presented within corporate and other. Prior period information has been recast to reflect this revised presentation. We have historically operated in, and reported financial information for, the following two reportable segments: Performance Sensing and Sensing Solutions, each of which was also an operating segment. In the fourth quarter of 2020, a change in focus of the evaluation of our business by our chief operating decision maker in order to make decisions about resource allocation, among other factors such as solidification of a reporting structure to accommodate this focus, necessitated a reevaluation of our conclusion that Performance Sensing was an operating segment. Based on our assessment of these factors, we determined that the Performance Sensing operating segment should be divided into two operating segments, Automotive and HVOR. We also determined that each of these operating segments meet the criteria for aggregation in FASB ASC Topic 280, Reportable Segments . No change was made to Sensing Solutions, and it remains an operating segment. None of the preceding changes resulted in any impact on the overall composition of our reportable segments and prior periods were not required to be recast for this change. An operating segment’s performance is primarily evaluated based on segment operating income, which excludes amortization of intangible assets, restructuring and other charges, net, and certain corporate costs/credits not associated with the operations of the segment, including share-based compensation expense and a portion of depreciation expense associated with assets recorded in connection with acquisitions. Corporate and other costs excluded from an operating (and reportable) segment’s performance are separately stated below and also include costs that are related to functional areas such as finance, information technology, legal, and human resources. We believe that segment operating income, as defined above, is an appropriate measure for evaluating the operating performance of our segments. However, this measure should be considered in addition to, and not as a substitute for, or superior to, operating income or other measures of financial performance prepared in accordance with U.S. GAAP. The accounting policies of each of our operating and reportable segments are materially consistent with those described in Note 2, "Significant Accounting Policies." As discussed above, the Performance Sensing reportable segment represents the aggregation of the Automotive and HVOR operating segments, which primarily serve the automotive and HVOR industries, respectively, through development and manufacture of sensors, high-voltage contactors, and other solutions used in mission-critical systems and applications such as those in subsystems of automobiles, on-road trucks, and off-road equipment (e.g., tire pressure monitoring, thermal management, electrical protection, regenerative braking, powertrain (engine/transmission), and exhaust management). Our products are used in subsystems that, among other things, improve operating performance and efficiency, as well as contribute to environmentally sustainable and safe solutions as the world continues to pivot in those directions Sensing Solutions primarily serves the industrial and aerospace industries through development and manufacture of a broad portfolio of application-specific sensor and electrical protection products used in a diverse range of industrial markets, including the appliance, HVAC, semiconductor, material handling, factory automation, and water management markets, as well as the aerospace market. The following table presents net revenue and segment operating income for the reported segments and other operating results not allocated to the reported segments for the years ended December 31, 2020, 2019, and 2018 (prior periods have been recast as discussed above): For the year ended December 31, 2020 2019 2018 Net revenue: Performance Sensing $ 2,223,810 $ 2,546,016 $ 2,627,651 Sensing Solutions 821,768 904,615 893,976 Total net revenue $ 3,045,578 $ 3,450,631 $ 3,521,627 Segment operating income (as defined above): Performance Sensing $ 532,529 $ 670,470 $ 728,251 Sensing Solutions 241,218 293,967 294,996 Total segment operating income 773,747 964,437 1,023,247 Corporate and other (273,367) (211,106) (221,320) Amortization of intangible assets (129,549) (142,886) (139,326) Restructuring and other charges, net (33,094) (53,560) 47,818 Operating income 337,737 556,885 710,419 Interest expense, net (171,757) (158,554) (153,679) Other, net (339) (7,908) (30,365) Income before taxes $ 165,641 $ 390,423 $ 526,375 No customer exceeded 10% of our net revenue in any of the periods presented. The following table presents net revenue by product category for the years ended December 31, 2020, 2019, and 2018: Performance Sensing Sensing Solutions For the year ended December 31, 2020 2019 2018 Net revenue: Sensors X X $ 2,380,608 $ 2,712,926 $ 2,755,280 Electrical Protection (1) X X 504,001 573,631 522,172 Other (1) X X 160,969 164,074 244,175 Net revenue $ 3,045,578 $ 3,450,631 $ 3,521,627 (1) Beginning in the year ended December 31, 2020, we adjusted our product categories to better reflect how we view our products. The product category we previously referred to as "controls" was renamed to "electrical protection," and our GIGAVAC products, which were previously grouped in "other," have been recast into "electrical protection." The amount of revenue recast from "other" to "electrical protection" in the years ended December 31, 2019 and 2018 was $91.9 million and $13.4 million, respectively. The "sensors" product category was unchanged. The following table presents depreciation and amortization expense for our reportable segments for the years ended December 31, 2020, 2019, and 2018: For the year ended December 31, 2020 2019 2018 Depreciation and amortization: Performance Sensing $ 91,522 $ 85,511 $ 72,067 Sensing Solutions 16,564 16,678 16,798 Corporate and other (1) 147,143 156,559 156,475 Total depreciation and amortization $ 255,229 $ 258,748 $ 245,340 __________________________________________ (1) Included within corporate and other is depreciation and amortization expense associated with the fair value step-up recognized in prior acquisitions and accelerated depreciation recognized in connection with restructuring actions. We do not allocate the additional depreciation and amortization expense associated with the step-up in the fair value of the PP&E and intangible assets associated with these acquisitions or accelerated depreciation related to restructuring actions to our segments. This treatment is consistent with the financial information reviewed by our chief operating decision maker. The following table presents total assets for our reportable segments as of December 31, 2020 and 2019: As of December 31, 2020 2019 Assets: Performance Sensing $ 1,447,885 $ 1,515,396 Sensing Solutions 459,544 479,455 Corporate and other (1) 5,936,773 4,839,668 Total assets $ 7,844,202 $ 6,834,519 __________________________________________ (1) The following is included within corporate and other as of December 31, 2020 and 2019: goodwill of $3,111.3 million and $3,093.6 million, respectively; other intangible assets, net of $691.5 million and $770.9 million, respectively; cash and cash equivalents of $1,862.0 million and $774.1 million, respectively; and PP&E, net of $41.7 million and $41.2 million, respectively. This treatment is consistent with the financial information reviewed by our chief operating decision maker. The following table presents additions to PP&E and capitalized software for our reportable segments for the years ended December 31, 2020, 2019, and 2018: For the year ended December 31, 2020 2019 2018 Additions to property, plant and equipment and capitalized software: Performance Sensing $ 79,252 $ 125,412 $ 130,234 Sensing Solutions 16,885 19,520 12,492 Corporate and other 10,582 16,327 17,061 Total additions to property, plant and equipment and capitalized software $ 106,719 $ 161,259 $ 159,787 Geographic Area Information The following tables present net revenue by geographic area and by significant country for the years ended December 31, 2020, 2019, and 2018. In these tables, net revenue is aggregated according to the location of our subsidiaries. For the year ended December 31, 2020 2019 2018 Net revenue: Americas $ 1,197,846 $ 1,460,101 $ 1,480,567 Europe 816,287 969,470 1,028,534 Asia and rest of world 1,031,445 1,021,060 1,012,526 Net revenue $ 3,045,578 $ 3,450,631 $ 3,521,627 For the year ended December 31, 2020 2019 2018 Net revenue: United States $ 1,082,671 $ 1,333,532 $ 1,360,590 Netherlands 482,020 576,804 585,036 China 641,516 575,211 560,938 Korea 172,229 188,226 188,114 United Kingdom 122,403 151,674 163,963 All other 544,739 625,184 662,986 Net revenue $ 3,045,578 $ 3,450,631 $ 3,521,627 The following tables present PP&E, net, by geographic area and by significant country as of December 31, 2020 and 2019. In these tables, PP&E, net is aggregated based on the location of our subsidiaries. As of December 31, 2020 2019 Property, plant and equipment, net: Americas $ 266,378 $ 289,300 Europe 196,132 192,772 Asia and rest of world 341,315 348,926 Property, plant and equipment, net $ 803,825 $ 830,998 As of December 31, 2020 2019 Property, plant and equipment, net: United States $ 108,615 $ 97,226 China 257,935 266,161 Mexico 157,576 191,861 Bulgaria 147,103 138,644 United Kingdom 34,453 40,003 Malaysia 78,752 78,310 All other 19,391 18,793 Property, plant and equipment, net $ 803,825 $ 830,998 |
Unaudited Quarterly Data
Unaudited Quarterly Data | 12 Months Ended |
Dec. 31, 2020 | |
Quarterly Financial Information Disclosure [Abstract] | |
Unaudited Quarterly Data | Unaudited Quarterly Data A summary of the unaudited quarterly results of operations for the years ended December 31, 2020 and 2019 is as follows: For the three months ended December 31, 2020 September 30, 2020 June 30, 2020 March 31, 2020 Net revenue $ 906,491 $ 788,313 $ 576,505 $ 774,269 Gross profit $ 296,551 $ 258,058 $ 164,062 $ 207,863 Net income $ 121,667 $ 76,729 $ (42,541) $ 8,431 Basic net income per share $ 0.77 $ 0.49 $ (0.27) $ 0.05 Diluted net income per share $ 0.77 $ 0.49 $ (0.27) $ 0.05 For the three months ended December 31, 2019 September 30, 2019 June 30, 2019 March 31, 2019 Net revenue $ 846,691 $ 849,715 $ 883,726 $ 870,499 Gross profit $ 290,209 $ 294,805 $ 308,491 $ 289,693 Net income $ 53,538 $ 70,675 $ 73,436 $ 85,065 Basic net income per share (1) $ 0.34 $ 0.44 $ 0.45 $ 0.52 Diluted net income per share $ 0.34 $ 0.44 $ 0.45 $ 0.52 __________________________________________ (1) The sum of net income per share for the four quarters does not equal the full year net income per share due to rounding. COVID-19 The decline in revenue in the first, second, and third quarters of 2020 compared to the corresponding quarters of 2019 relates in large part to the impact of the COVID-19 pandemic on our business. The second quarter of 2020 was most significantly impacted, and we experienced partial recovery in the third quarter of 2020. Restructuring and other charges, net The below table presents amounts recognized in restructuring and other charges, net in the periods presented: For the three months ended December 31, September 30, June 30, March 31, 2020 $ 897 $ (10,519) $ 38,218 $ 4,498 2019 $ 25,520 $ 6,421 $ 16,310 $ 5,309 On June 30, 2020, we initiated the Q2 2020 Global Restructure Program and recognized approximately $24.1 million of severance charges related to that program in the second quarter of 2020. In the third quarter of 2020, we settled intellectual property litigation brought against Schrader by Wasica, which resulted in the derecognition of nearly the entire $12.1 million liability that we recorded in the second quarter of 2020 resulting from a prejudgment interest-related award granted by the court on behalf of Wasica. In fiscal year 2019, restructuring and other charges net includes a $17.8 million loss related to the termination of a supply agreement in connection with the Metal Seal litigation in the fourth quarter, $6.5 million of termination benefits provided under a one-time benefit arrangement related to the shutdown and relocation of an operating site in Germany in the third quarter, and $12.7 million of benefits provided under a voluntary retirement incentive program offered to a limited number of eligible employees in the U.S., in the second quarter. Refer to Note 5, "Restructuring and Other Charges, Net," for additional information related to restructuring and other charges. Income taxes In response to the global financial and health crisis caused by the COVID-19 pandemic, the U.S. federal government enacted the Coronavirus Aid, Relief, and Economic Security Act on March 27, 2020. Federal limitations on interest deductions were reduced in connection with this legislation, and we recorded a deferred tax benefit of $7.5 million in the three months ended March 31, 2020, as we were able to utilize additional interest expense that was previously subject to a valuation allowance. In the fourth quarter of 2020 we recognized a net income tax benefit of $54.2 million related to intangible property transfers. Litigation |
Subsequent Event
Subsequent Event | 12 Months Ended |
Dec. 31, 2020 | |
Subsequent Events [Abstract] | |
Subsequent Event | Subsequent EventsOn February 3, 2021, we announced that we intended to redeem in full the $750.0 million aggregate principal amount outstanding on our 6.25% Senior Notes due 2026 in March 2021. This resulted in classification of the Senior Notes as current on our December 31, 2020 consolidated balance sheet. Refer to Note 14, “Debt,” for additional information on the terms of this redemption.On February 11, 2021, we entered into a securities purchase agreement (the "SPA") to acquire all of the outstanding equity interests of Xirgo Technologies, LLC ("Xirgo") for an aggregate purchase price of $400 million, subject to adjustment for certain closing and post-closing items. Xirgo is a leading provider of telematics and data insight, headquartered in Camarillo, California. The product offerings and technology of Xirgo will augment our existing portfolio in advancing our Smart & Connected megatrend initiative. We expect to integrate Xirgo into our Performance Sensing reportable segment. The transaction contemplated by the SPA is expected to close in the first quarter of 2021, subject to clearance under the Hart-Scott-Rodino Act and the satisfaction of certain customary closing conditions. |
Schedule I - Condensed Financia
Schedule I - Condensed Financial Information of the Registrant | 12 Months Ended |
Dec. 31, 2020 | |
Condensed Financial Information Disclosure [Abstract] | |
Schedule I - Condensed Financial Information of the Registrant | SCHEDULE I—CONDENSED FINANCIAL INFORMATION OF THE REGISTRANT SENSATA TECHNOLOGIES HOLDING PLC (Parent Company Only) Balance Sheets (In thousands) As of December 31, 2020 2019 Assets Current assets: Cash and cash equivalents $ 664 $ 238 Intercompany receivables 837 — Intercompany notes receivable from subsidiaries 65,972 43,673 Prepaid expenses and other current assets 1,821 1,246 Total current assets 69,294 45,157 Deferred income tax assets 506 570 Other non-current assets 51 — Investment in subsidiaries 2,726,216 2,554,954 Total assets $ 2,796,067 $ 2,600,681 Liabilities and shareholders’ equity Current liabilities: Accounts payable $ 414 $ 572 Intercompany accounts payable to subsidiaries 12,937 1,909 Intercompany notes payable to subsidiaries 76,482 23,216 Accrued expenses and other current liabilities 748 1,229 Total current liabilities 90,581 26,926 Total liabilities 90,581 26,926 Total shareholders’ equity 2,705,486 2,573,755 Total liabilities and shareholders’ equity $ 2,796,067 $ 2,600,681 The accompanying notes are an integral part of these condensed financial statements. SENSATA TECHNOLOGIES HOLDING PLC (Parent Company Only) Statements of Operations (In thousands) For the year ended December 31, 2020 2019 2018 Net revenue $ — $ — $ — Operating costs and expenses: Selling, general and administrative 12,477 8,860 10,153 Total operating costs and expenses 12,477 8,860 10,153 Loss from operations (12,477) (8,860) (10,153) Intercompany dividend income — 700,000 — Intercompany interest expense, net (479) (23,294) (4,709) Other, net 115 (21) 474 (Loss)/income before income taxes and equity in net income of subsidiaries (12,841) 667,825 (14,388) Equity in net income/(loss) of subsidiaries 182,733 (401,715) 613,383 (Provision for)/benefit from income taxes (5,606) 16,604 — Net income $ 164,286 $ 282,714 $ 598,995 The accompanying notes are an integral part of these condensed financial statements. SENSATA TECHNOLOGIES HOLDING PLC (Parent Company Only) Statements of Comprehensive Income (In thousands) For the year ended December 31, 2020 2019 2018 Net income $ 164,286 $ 282,714 $ 598,995 Other comprehensive (loss)/income, net of tax: Defined benefit plan — — 535 Subsidiaries' other comprehensive (loss)/income (29,051) 5,694 36,451 Other comprehensive (loss)/income (29,051) 5,694 36,986 Comprehensive income $ 135,235 $ 288,408 $ 635,981 The accompanying notes are an integral part of these condensed financial statements. SENSATA TECHNOLOGIES HOLDING PLC (Parent Company Only) Statements of Cash Flows (In thousands) For the year ended December 31, 2020 2019 2018 Net cash used in operating activities $ (7,911) $ (14,989) $ (14,253) Cash flows from investing activities: Dividends received from subsidiary — 700,000 — Net cash provided by investing activities — 700,000 — Cash flows from financing activities: Proceeds from exercise of stock options and issuance of ordinary shares 15,457 15,150 6,093 Proceeds from/(payments on) intercompany borrowings 30,966 (344,018) 410,190 Payments to repurchase ordinary shares (35,175) (350,004) (399,417) Payments of employee restricted stock tax withholdings (2,911) (6,990) (3,674) Net cash provided by/(used in) financing activities 8,337 (685,862) 13,192 Net change in cash and cash equivalents 426 (851) (1,061) Cash and cash equivalents, beginning of year 238 1,089 2,150 Cash and cash equivalents, end of year $ 664 $ 238 $ 1,089 The accompanying notes are an integral part of these condensed financial statements. Sensata Technologies Holding plc (Parent Company)—Schedule I—Condensed Financial Information of Sensata Technologies Holding plc ("Sensata plc"), included in this Annual Report on Form 10-K (this "Report"), provides all parent company information that is required to be presented in accordance with the United States (the "U.S.") Securities and Exchange Commission ("SEC") rules and regulations for financial statement schedules. The accompanying condensed financial statements have been prepared in accordance with the reduced disclosure requirements permitted by the SEC. Sensata plc and subsidiaries' audited consolidated financial statements are included elsewhere in this Report. On September 28, 2017, the Board of Directors of Sensata Technologies Holding N.V. ("Sensata N.V.") unanimously approved a plan to change our location of incorporation from the Netherlands to the United Kingdom (the "U.K."). To effect this change, on February 16, 2018 the shareholders of Sensata N.V. approved a cross-border merger between Sensata N.V. and Sensata plc, a newly formed, public limited company incorporated under the laws of England and Wales, with Sensata plc being the surviving entity (the "Merger"). We received approval of the Merger by the U.K. High Court of Justice, and the Merger was completed, on March 28, 2018. As a result thereof, Sensata plc became the publicly-traded parent of the subsidiary companies that were previously controlled by Sensata N.V., with no changes made to the business being conducted by us prior to the Merger. Due to the fact that the Merger was a business combination between entities under common control, the assets and liabilities exchanged were accounted for at their carrying values. Sensata plc conducts limited separate operations and acts primarily as a holding company. Sensata plc has no direct outstanding debt obligations. However, Sensata Technologies B.V., an indirect, wholly-owned subsidiary of Sensata plc, is limited in its ability to pay dividends or otherwise make distributions to its immediate parent company and, ultimately, to Sensata plc, under its senior secured credit facilities and the indentures governing its senior notes. For a discussion of the debt obligations of the subsidiaries of Sensata plc, refer to Note 14, "Debt," of Sensata plc and subsidiaries' audited consolidated financial statements included elsewhere in this Report (the "Consolidated Financial Statements"). All U.S. dollar amounts presented except per share amounts are stated in thousands, unless otherwise indicated. |
Schedule II - Valuation and Qua
Schedule II - Valuation and Qualifying Accounts | 12 Months Ended |
Dec. 31, 2020 | |
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract] | |
Schedule II - Valuation and Qualifying Accounts | SCHEDULE II—VALUATION AND QUALIFYING ACCOUNTS (In thousands) Balance at the Additions Deductions Balance at the End of Charged, Net of Reversals, For the year ended December 31, 2020 Accounts receivable allowances $ 15,129 $ 5,654 $ (1,750) $ 19,033 For the year ended December 31, 2019 Accounts receivable allowances $ 13,762 $ 3,005 $ (1,638) $ 15,129 For the year ended December 31, 2018 Accounts receivable allowances $ 12,947 $ 2,194 $ (1,379) $ 13,762 |
Significant Accounting Polici_2
Significant Accounting Policies (Policies) | 12 Months Ended |
Dec. 31, 2020 | |
Accounting Policies [Abstract] | |
Basis of Presention | Basis of Presentation The accompanying audited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles ("U.S. GAAP") and present separately our financial position, results of operations, comprehensive income, cash flows, and changes in shareholders’ equity. |
Reclassification | Certain reclassifications have been made to prior periods to conform to current period presentation. |
Use of Estimates | Use of Estimates The preparation of consolidated financial statements in accordance with U.S. GAAP requires us to exercise our judgment in the process of applying our accounting policies. It also requires that we make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingencies at the date of the financial statements, and the reported amounts of net revenue and expense during the reporting periods. Estimates are used when accounting for certain items such as allowance for doubtful accounts and sales returns, inventory obsolescence, asset impairments (including goodwill and other intangible assets), contingencies, the value of certain equity awards and the measurement of share-based compensation, the determination of accrued expenses, certain asset valuations, accounting for income taxes, the useful lives of plant and equipment, measurement of our post-retirement benefit obligations, and the identification, valuation, and determination of useful lives of identifiable intangible assets acquired in business combinations. The accounting estimates used in the preparation of the consolidated financial statements may change as new |
Revenue Recognition | Revenue Recognition We recognize revenue to depict the transfer of promised goods to customers in an amount that reflects the consideration to which we expect to be entitled in exchange for those goods. In order to achieve this, we use the five step model outlined in Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") Topic 606, Revenue from Contracts with Customers . This five step model requires us to identify the contract with the customer, identify the performance obligation(s) in the contract, determine the transaction price, allocate the transaction price to the performance obligation(s), and recognize revenue when (or as) we satisfy the performance obligation(s). The vast majority of our contracts (as defined in FASB ASC Topic 606) are customer purchase orders that require us to transfer specified quantities of tangible products to our customers. These performance obligations are generally satisfied within a short period of time. Amounts billed to our customers for shipping and handling after control has transferred are recognized as revenue and the related costs that we incur are presented in cost of revenue. In determining the transaction price, we evaluate whether the consideration promised in the contract includes a variable amount and, if applicable, we include in the transaction price some or all of an amount of variable consideration only to the extent it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved. Variable consideration may be explicitly stated in the contract or implied based on our customary practices. Examples of variable consideration present in our contracts include rights of return, in the case of a defective or non-conforming product, and trade discounts, including early payment discounts and retrospective volume discounts. Such variable consideration has not historically been material in relation to our net revenue. Our contract terms generally require the customer to make payment shortly (that is, less than one year) after the shipment date. In such instances, we do not consider the effects of a significant financing component in determining the transaction price. Lastly, we exclude from our determination of the transaction price value-added tax and other similar taxes. Our performance obligations are satisfied, and revenue is recognized, when control of the product is transferred to the customer. The transfer of control generally occurs at the point in time the product is shipped from our warehouse or, less often, at the point in time it is received by the customer, depending on the specific terms of the arrangement. Many of our products are designed and engineered to meet customer specifications. These activities, and the testing of our products to determine compliance with those specifications, occur prior to any revenue being recognized. Products are then manufactured and sold to customers. However, in certain cases, pre-production activities are a performance obligation in a customer purchase order, and revenue is recognized when the performance obligation is satisfied. Customer arrangements do not involve post-installation or post-sale testing and acceptance. Our standard terms of sale provide our customers with a warranty against faulty workmanship and the use of defective materials, which is not considered a distinct performance obligation in accordance with FASB ASC Topic 606. Depending on the product, we generally provide such warranties for a period of twelve We also sell products to customers under negotiated agreements or where we have accepted the customer’s terms of purchase. In these instances, we may provide additional warranties for longer durations, consistent with differing end market practices, and where our liability is not limited. In addition, many sales take place in situations where commercial or civil codes, or other laws, would imply various warranties and restrict limitations on liability. |
Share-Based Compensation | Share-Based Compensation We measure at fair value any new or modified share-based compensation arrangements with employees, such as stock options and restricted securities, and recognize as compensation expense that fair value over the requisite service period in accordance with FASB ASC Topic 718, Compensation—Stock Compensation . Share-based compensation expense is generally recognized as a component of selling, general and administrative ("SG&A") expense, which is consistent with where the related employee costs are presented, however, such costs, or a portion thereof, may be capitalized provided certain criteria are met. Share-based awards may be subject to either cliff vesting (i.e., the entire award vests on a particular date) or graded vesting (i.e., portions of the award vest at different points in time). In accordance with FASB ASC Topic 718, compensation expense associated with share-based awards subject to cliff vesting must be recognized on a straight-line basis. For awards without performance conditions that are subject to graded vesting, companies have the option to recognize compensation expense either on a straight-line or accelerated basis. We have elected to recognize compensation expense for these awards on a straight-line basis. However, awards that are subject to both graded vesting and performance conditions must be expensed on an accelerated basis. We estimate the fair value of options on the grant date using the Black-Scholes-Merton option-pricing model. Key inputs and assumptions used in this model are as follows: • The fair value of the underlying ordinary shares. This is determined as the closing price of our ordinary shares on the New York Stock Exchange (the "NYSE") on the grant date. • The expected term. This is determined based upon our own historical average term of exercised and outstanding options. • Expected volatility. We consider our own historical volatility as well as our implied volatility in estimating expected volatility for stock options. Implied volatility provides a forward-looking indication and may offer insight into expected volatility. • Risk-free interest rate. The risk-free interest rate is based on the yield for a U.S. Treasury security having a maturity similar to the expected term of the related option grant. • Expected dividend yield. The dividend yield of 0% is based on our history of having never declared or paid any dividends on our ordinary shares as well as our current intention not to declare dividends in the foreseeable future. Restricted securities are valued using the closing price of our ordinary shares on the NYSE on the grant date. Certain of our restricted securities include performance conditions that require us to estimate the probable outcome of the performance condition. Compensation expense is recognized if it is probable that the performance condition will be achieved. |
Financial Instruments | Financial Instruments Our material financial instruments include derivative instruments, debt instruments, equity investments, and trade accounts receivable. Derivative financial instruments: We account for our derivative financial instruments in accordance with FASB ASC Topic 820, Fair Value Measurements and Disclosures and FASB ASC Topic 815, Derivatives and Hedging . In accordance with FASB ASC Topic 815, we recognize all derivatives on the balance sheet at fair value. The fair value of our derivative financial instruments is determined using widely accepted valuation techniques, including discounted cash flow analysis on the expected cash flows of each instrument. These analyses utilize observable market-based inputs, including foreign currency exchange rates and commodity forward curves, and reflect the contractual terms of these instruments, including the period to maturity. Derivative instruments that are designated and qualify as hedges of the exposure to changes in the fair value of an asset, liability, or commitment, and that are attributable to a particular risk, such as interest rate risk, are considered fair value hedges. Derivative instruments that are designated and qualify as hedges of the exposure to variability in expected future cash flows are considered cash flow hedges. Derivative instruments may also be designated as hedges of the foreign currency exposure of a net investment in a foreign operation. Currently, all of our derivative instruments that are designated as accounting hedges are cash flow hedges. We also hold derivative instruments that are not designated as accounting hedges. The accounting for changes in the fair value of our cash flow hedges depends on whether we have elected to designate the derivative as a hedging instrument for accounting purposes and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. In accordance with FASB ASC Topic 815, both the effective and ineffective portion of changes in the fair value of derivatives designated and qualifying as cash flow hedges is recognized in accumulated other comprehensive loss and is subsequently reclassified into earnings in the period in which the hedged forecasted transaction affects earnings. Changes in the fair value of derivative instruments that are not designated as accounting hedges are recognized immediately in other, net. Refer to Note 16, "Shareholders' Equity," and Note 19, "Derivative Instruments and Hedging Activities," for additional information related to the reclassification of amounts from accumulated other comprehensive loss into earnings. We present the cash flows arising from our derivative financial instruments in a manner consistent with the presentation of cash flows that relate to the underlying hedged items. We incorporate credit valuation adjustments to appropriately reflect both our own non-performance risk and the respective counterparty’s non-performance risk in the fair value measurements. In adjusting the fair value of our derivative contracts for the effect of non-performance risk, we have considered the impact of netting and any applicable credit enhancements, such as collateral postings, thresholds, mutual puts, and guarantees. We do not offset the fair value amounts recognized for derivative instruments against fair value amounts recognized for the right to reclaim cash collateral or the obligation to return cash collateral. We maintain derivative instruments with major financial institutions of investment grade credit rating and monitor the amount of credit exposure to any one issuer. We believe there are no significant concentrations of risk associated with our derivative instruments. Refer to Note 19, "Derivative Instruments and Hedging Activities," for additional information related to our derivative instruments. Debt Instruments: A premium or discount on a debt instrument is recognized on the balance sheet as an adjustment to the carrying value of the debt liability. In general, amounts paid to creditors are considered a reduction in the proceeds received from the issuance of the debt and are accounted for as a component of the premium or discount on the issuance, not as an issuance cost. Direct and incremental costs associated with the issuance of debt instruments such as legal fees, printing costs, and underwriters' fees, among others, paid to parties other than creditors, are also reported and presented as a reduction of debt on the consolidated balance sheets. Debt issuance costs and premiums or discounts are amortized over the term of the respective financing arrangement using the effective interest method. Amortization of these amounts is included as a component of interest expense, net in the consolidated statements of operations. In accounting for debt refinancing transactions, we apply the provisions of FASB ASC Subtopic 470-50, Modifications and Extinguishments . Our evaluation of the accounting under FASB ASC Subtopic 470-50 is done on a creditor by creditor basis in order to determine if the terms of the debt are substantially different and, as a result, whether to apply modification or extinguishment accounting. In the event that an individual holder of existing debt did not invest in new debt, we apply extinguishment accounting. Borrowings associated with individual holders of new debt that are not holders of existing debt are accounted for as new issuances. Refer to Note 14, "Debt," for additional information related to our debt instruments and transactions. Equity Investments: We measure equity investments (other than those accounted for under the equity method, those that result in consolidation of the investee, and certain other investments) either at fair value, with changes to fair value recognized in net income, or in certain instances, by use of a measurement alternative prescribed in FASB ASC Topic 321, Investments - Equity Securities . Under the measurement alternative, such investments are measured at cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer. Refer to Note 18, "Fair Value Measures," for additional information related to our measurement of financial instruments, including equity investments. |
Allowance for Losses on Receivables | Allowance for Losses on Receivables The allowance for losses on receivables is used to present accounts receivable, net at an amount that represents our estimate of the related transaction price recognized as revenue in accordance with FASB ASC Topic 606. The allowance represents an estimate of expected credit losses over the lifetime of our receivables, even if the loss is considered remote, and reflects expected recoveries of amounts previously written-off. We estimate the allowance on the basis of specifically identified receivables that are evaluated individually for impairment and a statistical analysis of the remaining receivables determined by reference to past default experience. We consider the need to adjust historical information to reflect the extent to which we expect current conditions and reasonable forecasts to differ from the conditions that existed for the historical period considered. Customers are generally not required to provide collateral for purchases. The allowance for losses on receivables also includes an allowance for sales returns (variable consideration). Management judgments are used to determine when to charge off uncollectible trade accounts receivable. We base these judgments on the age of the receivable, credit quality of the customer, current economic conditions, and other factors that may affect a customer’s ability and intent to pay. Losses on receivables have not historically been significant. |
Goodwill and Other Intangible Assets | Goodwill and Other Intangible Assets Businesses acquired are recognized at their fair value on the date of acquisition, with the excess of the purchase price over the fair value of identifiable assets acquired and liabilities assumed recognized as goodwill. Intangible assets acquired may include either definite-lived or indefinite-lived intangible assets, or both. In accordance with the guidance in FASB ASC Topic 350, Intangibles—Goodwill and Other |
Goodwill | Goodwill: Our reporting units have been identified based on the definitions and guidance provided in FASB ASC Topic 350. Identification of reporting units includes an analysis of the components that comprise each of our operating segments, which considers, among other things, the manner in which we operate our business and the availability of discrete financial information. Components of an operating segment are aggregated to form one reporting unit if the components have similar economic characteristics. We periodically review these reporting units to ensure that they continue to reflect the manner in which the business is operated. Some assets and liabilities relate to the operations of multiple reporting units. We allocate these assets and liabilities to the related reporting units based on methods that we believe are reasonable and supportable. We apply that allocation method on a consistent basis from year to year. Other assets and liabilities, such as debt, cash and cash equivalents, and property, plant and equipment, net ("PP&E") associated with our corporate offices, are viewed as being corporate in nature. Accordingly, we do not assign these assets and liabilities to our reporting units. In the event we reorganize our business, we reassign the assets (including goodwill) and liabilities among the affected reporting units using a reasonable and supportable methodology. As businesses are acquired, we assign assets acquired (including goodwill) and liabilities assumed to a new or existing reporting unit as of the date of the acquisition. In the event a disposal group meets the definition of a business, goodwill is allocated to the disposal group based on the relative fair value of the disposal group to the retained portion of the related reporting unit. We have the option to first assess qualitative factors to determine whether a quantitative analysis must be performed. The objective of a qualitative analysis is to assess whether it is more likely than not that the fair value of a reporting unit is less than its carrying value. We make this assessment based on macroeconomic conditions, industry and market considerations, cost factors, overall financial performance, and other relevant factors as applicable. If we elect not to use this option, or if we determine that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then we prepare a discounted cash flow analysis to determine whether the carrying value of reporting unit exceeds its estimated fair value. If the carrying value of a reporting unit exceeds its estimated fair value, we recognize an impairment of goodwill for the amount of this excess, in accordance with the guidance in FASB Accounting Standards Update ("ASU") No. 2017-04, Intangibles - Goodwill and Other (Topic 350), Simplifying the Test for Goodwill Impairment |
Intangible Assets | Indefinite-lived intangible assets: Similar to goodwill, we perform an annual impairment review of our indefinite-lived intangible assets in the fourth quarter of each fiscal year, unless events occur that trigger the need for an earlier impairment review. We have the option to first assess qualitative factors in determining whether it is more likely than not that an indefinite-lived intangible asset is impaired. If we elect not to use this option, or we determine that it is more likely than not that the asset is impaired, we perform a quantitative impairment analysis in which we estimate the fair value of the indefinite-lived intangible asset and compare that amount to its carrying value. In this analysis, we estimate the fair value by using the relief-from-royalty method, in which we make assumptions about future conditions impacting the fair value of our indefinite-lived intangible assets, including projected growth rates, cost of capital, effective tax rates, and royalty rates. Impairment, if any, is based on the excess of the carrying value over the fair value of these assets. Definite-lived intangible assets: Acquisition-related definite-lived intangible assets are amortized on an economic-benefit basis according to the useful lives of the assets, or on a straight-line basis if a pattern of economic benefits cannot be reliably determined. Capitalized software and capitalized software licenses are presented on the consolidated balance sheets as intangible assets. Capitalized software licenses are amortized on a straight-line basis over the lesser of the term of the license or the estimated useful life of the software. Capitalized software is amortized on a straight-line basis over its estimated useful life. Reviews are regularly performed to determine whether facts or circumstances exist that indicate that the carrying values of our definite-lived intangible assets are impaired. If we determine that such facts or circumstances exist, we estimate the recoverability of these assets by comparing the projected undiscounted net cash flows associated with these assets to their respective carrying values. If the sum of the projected undiscounted net cash flows is less than the carrying value of an asset, the impairment charge is measured as the excess of the carrying value over the fair value of that asset. We determine fair value by using the appropriate income approach valuation methodology, depending on the nature of the definite-lived intangible asset. |
Income Taxes | Income Taxes We estimate our provision for (or benefit from) income taxes in each of the jurisdictions in which we operate. The provision for (or benefit from) income taxes includes both our current and deferred tax exposure. Our deferred tax exposure is measured using the asset and liability method, under which deferred income taxes are recognized to reflect the future tax consequences of differences between the tax bases of assets and liabilities and their financial reporting amounts at each balance sheet date, based on enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to reverse or settle. The effect on deferred tax assets and liabilities of a change in statutory tax rates is recognized in the consolidated statements of operations as an adjustment to income tax expense in the period that includes the enactment date. In measuring our deferred tax assets, we consider all available evidence, both positive and negative, to determine whether, based on the weight of that evidence, a valuation allowance is needed for all or some portion of the deferred tax assets. If it is determined that it is more likely than not that future tax benefits associated with a deferred tax asset will not be realized, a valuation allowance is provided. As a result, we maintain valuation allowances against the deferred tax assets in jurisdictions that have incurred losses in recent periods and in which it is more likely than not that such deferred tax assets will not be utilized in the foreseeable future. In accordance with FASB ASC Topic 740, Income Taxes , we record uncertain tax positions on the basis of a two-step process. First, we determine whether it is more likely than not that the tax positions will be sustained based on the technical merits of the position. Second, for those tax positions that meet the more-likely-than-not recognition threshold, we recognize the largest amount of tax benefit that is greater than 50 percent likely to be realized upon ultimate settlement with the relevant tax authority. Significant judgment is required in evaluating whether our tax positions meet this two-step process. The more-likely-than-not recognition threshold must be met in each reporting period to support continued recognition of any tax benefits claimed, both in the current year, as well as any year which remains open for review by the relevant tax authority at the balance sheet date. Penalties and interest related to uncertain tax positions may be classified as either income taxes or another expense line item in the consolidated statements of operations. We classify interest and penalties related to uncertain tax positions within the provision for/(benefit from) income taxes line of the consolidated statements of operations. |
Pension and Other Post-Retirement Benefits | Pension and Other Post-Retirement Benefits We sponsor various pension and other post-retirement benefit plans covering our current and former employees in several countries. The funded status of pension and other post-retirement benefit plans, recognized on our consolidated balance sheets as an asset, current liability, or long-term liability, is measured as the difference between the fair value of plan assets and the benefit obligation at the measurement date. In general, the measurement date coincides with our fiscal year end, however, certain significant events, such as (1) plan amendments, (2) business combinations, (3) settlements or curtailments, or (4) plan mergers, may trigger the need for an interim measurement of both the plan assets and benefit obligations. Benefit obligations represent the actuarial present value of all benefits attributed by the pension formula as of the measurement date to employee service rendered before that date. The value of benefit obligations takes into consideration various financial assumptions, including assumed discount rate and the rate of increase in healthcare costs, and demographic assumptions, including compensation rate increases, retirement patterns, employee turnover rates, and mortality rates. We review these assumptions annually. Our review of demographic assumptions includes analyzing historical patterns and/or referencing industry standard tables, combined with our expectations around future compensation and staffing strategies. The difference between these assumptions and our actual experience results in the recognition of an actuarial gain or loss. Actuarial gains and losses are recorded directly to other comprehensive income or loss. If the total net actuarial gain or loss included in accumulated other comprehensive loss exceeds a threshold of 10% of the greater of the projected benefit obligation or the market related value of plan assets, it is subject to amortization and recorded as a component of net periodic benefit cost over the average remaining service lives of the employees participating in the pension or post-retirement benefit plan. The discount rate reflects the current rate at which the pension and other post-retirement liabilities could be effectively settled, considering the timing of expected payments for plan participants. It is used to discount the estimated future obligations of the plans to the present value of the liability reflected in the financial statements. In estimating this rate in countries that have a market of high-quality, fixed-income investments, we consider rates of return on these investments included in various bond indices, adjusted to eliminate the effects of call provisions and differences in the timing and amounts of cash outflows related to the bonds. In other countries where a market of high-quality, fixed-income investments does not exist, we estimate the discount rate using government bond yields or long-term inflation rates. The expected return on plan assets reflects the average rate of earnings expected on the funds invested to provide for the benefits included in the projected benefit obligation. To determine the expected return on plan assets, we use the fair value of plan assets and consider the historical returns earned by similarly invested assets, the rates of return expected on plan assets in the future, and our investment strategy and asset mix with respect to the plans’ funds. Changes to benefit obligations may also be initiated by a settlement or curtailment. A settlement of a defined benefit obligation is an irrevocable transaction that relieves us (or the plan) of primary responsibility for the defined benefit obligation and eliminates significant risks related to the obligation and the assets used to effect the settlement. The settlement of all or more than a minor portion of the pension obligation constitutes an event that requires recognition of all or part of the net actuarial gains or losses deferred in accumulated other comprehensive loss. Our policy is to apply settlement accounting to the extent our year-to date settlements for a given plan exceed the sum of our forecasted full year service cost and interest cost for that particular plan. A curtailment is an event that significantly reduces the expected years of service of active employees or eliminates for a significant number of employees the accrual of defined benefits for some or all of their future service. The curtailment accounting provisions are applied on a plan-by-plan basis. The total gain or loss resulting from a curtailment is the sum of two distinct elements: (1) prior service cost write-off and (2) curtailment gain or loss. Our policy is that a curtailment event represents one for which we expect a 10% (or greater) reduction in future years of service or an elimination of the accrual of defined benefits for some or all of the future services of 10% (or greater) of the plan's participants. Contributions made to pension and other post-retirement benefit plans are presented as cash used in operations within the consolidated statements of cash flows. We present the service cost component of net periodic benefit cost in the cost of revenue, research and development ("R&D"), and SG&A expense line items, and we present the non–service components of net periodic benefit cost in other, net. Refer to Note 13, "Pension and Other Post-Retirement Benefits," for additional information related to our pension and other post-retirement benefit plans. |
Inventories | InventoriesInventories are stated at the lower of cost or estimated net realizable value. The cost of raw materials, work-in-process, and finished goods is determined based on a first-in, first-out basis and includes material, labor, and applicable manufacturing overhead. We conduct quarterly inventory reviews for salability and obsolescence, and inventory considered unlikely to be sold is adjusted to net realizable value. |
Property, Plant and Equipment and Other Capitalized Costs | Property, Plant and Equipment and Other Capitalized Costs PP&E is stated at cost, and in the case of plant and equipment, is depreciated on a straight-line basis over its estimated economic useful life. The depreciable lives of plant and equipment are as follows: Buildings and improvements 2 – 40 years Machinery and equipment 2 – 15 years Leasehold improvements are amortized using the straight-line method over the shorter of the remaining lease term or the estimated economic useful lives of the improvements. Amortization of leasehold improvements is included in depreciation expense. Assets held under finance leases are recognized at the lower of the present value of the minimum lease payments or the fair value of the leased asset at the inception of the lease. Depreciation expense associated with finance leases is computed using the straight-line method over the shorter of the estimated useful lives of the assets or the period of the related lease, unless ownership is transferred by the end of the lease or there is a bargain purchase option, in which case the asset is depreciated, normally on a straight-line basis, over the useful life that would be assigned if the asset were owned. Expenditures for maintenance and repairs are charged to expense as incurred, whereas major improvements that increase asset values and extend useful lives are capitalized. |
Leases | Leases We enter into leases agreements for many of our facilities around the world. We occupy leased facilities with initial terms ranging up to 20 years. Our lease agreements frequently include options to renew for additional periods or to purchase the leased assets and generally require that we pay taxes, insurance, and maintenance costs. Depending on the specific terms of the leases, our obligations are in two forms: finance leases and operating leases. For both forms of leases, we recognize a related lease liability and right-of-use asset on our consolidated balance sheets. Our lease liabilities are initially measured at the present value of the lease payments not yet paid, discounted using our incremental borrowing rate for a period that is comparable to the remaining lease term. We use our incremental borrowing rate, adjusted for collateralization, because the discount rate implicit in our leases are generally not readily determinable. For finance leases, the consolidated statements of operations include separate recognition of interest on the lease liability and amortization of the right-of-use asset. For operating leases, the consolidated statements of operations include a single lease cost, calculated so that the cost of the lease is allocated over the lease term on a straight-line basis. Cash flows from operating activities include (1) interest on finance lease liabilities and (2) payments arising from operating leases. Cash flows from financing activities include repayments of the principal portion of finance lease liabilities. We also lease certain vehicles and equipment, which generally have a term of one year or less. We have elected to account for leases with a term of one year or less (short-term leases) using a method similar to the operating lease model under FASB ASC Topic 840, Leases (i.e. they are not recorded on the consolidated balance sheets) as permitted by FASB ASC Topic 842, Leases |
Foreign Currency | Foreign CurrencyWe derive a significant portion of our net revenue from markets outside of the U.S. For financial reporting purposes, the functional currency of all of our subsidiaries is the USD because of the significant influence of the USD on our operations. In certain instances, we enter into transactions that are denominated in a currency other than the USD. At the date that such transaction is recognized, each asset, liability, revenue, expense, gain, or loss arising from the transaction is measured and recorded in USD using the exchange rate in effect at that date. At each balance sheet date, recorded monetary balances denominated in a currency other than USD are adjusted to USD using the exchange rate at the balance sheet date, with gains or losses recognized in other, net in the consolidated statements of operations. |
Cash and Cash Equivalents | Cash and Cash Equivalents Cash comprises cash on hand. Cash equivalents are short-term, highly liquid investments that are readily convertible to known amounts of cash, are subject to an insignificant risk of change in value, and have original maturities of three months or less. |
Recently issued accounting standards adopted in the current period and to be adopted in a future period | Recently issued accounting standards adopted in the current period: In January 2017, the FASB issued ASU No. 2017-04, Intangibles - Goodwill and Other (Topic 350), Simplifying the Test for Goodwill Impairment in order to simplify the subsequent measurement of goodwill. This guidance changes the method by which an impairment of goodwill is calculated. Under the previous guidance, goodwill impairment was calculated in two steps. In Step 1, an entity would assess whether an impairment had occurred, either qualitatively or by comparing the estimated fair values of our reporting units to their respective carrying values, including goodwill. If the results of Step 1 indicated an impairment had occurred, Step 2 would be performed, in which the implied value of goodwill of the reporting unit would be calculated and an impairment would be recognized for the difference between the implied value of goodwill and the recorded amount of goodwill. Under FASB ASU No. 2017-04, while Step 1 of this process has not changed, Step 2 as described above has been eliminated, and impairment charges are recorded for the amount by which the carrying value of the reporting unit exceeds its estimated fair value. FASB ASU No. 2017-04 was effective for annual and interim goodwill impairment tests in fiscal years beginning after December 15, 2019. We adopted FASB ASU No. 2017-04 as of January 1, 2020. This adoption did not have an impact on our financial statements as none of our reporting units were determined to have carrying values in excess of fair values during the year ended December 31, 2020. Recently issued accounting standards to be adopted in a future period: There are no recently issued accounting standards to be adopted in future periods that are expected to have a material impact on our consolidated financial position or results of operations. |
Legal Proceedings and Claims | Legal Proceedings and Claims We are regularly involved in a number of claims and litigation matters that arise in the ordinary course of business. Although it is not feasible to predict the outcome of these matters, based upon our experience and current information known to us, we do not expect the outcome of these matters, either individually or in the aggregate, to have a material adverse effect on our results of operations, financial position, and/or cash flows. We account for litigation and claims losses in accordance with FASB ASC Topic 450, Contingencies . Under FASB ASC Topic 450, loss contingency provisions are recognized for probable and estimable losses at our best estimate of a loss or, when a best estimate cannot be made, at our estimate of the minimum loss. These estimates are often developed prior to knowing the |
Significant Accounting Polici_3
Significant Accounting Policies (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Accounting Policies [Abstract] | |
Property, Plant and Equipment | The depreciable lives of plant and equipment are as follows: Buildings and improvements 2 – 40 years Machinery and equipment 2 – 15 years PP&E, net as of December 31, 2020 and 2019 consisted of the following: As of December 31, 2020 2019 Land $ 17,880 $ 17,880 Buildings and improvements 273,899 266,864 Machinery and equipment 1,428,793 1,367,293 Total property, plant and equipment 1,720,572 1,652,037 Accumulated depreciation (916,747) (821,039) Property, plant and equipment, net $ 803,825 $ 830,998 PP&E, net as of December 31, 2020 and 2019 included the following assets under finance leases: As of December 31, 2020 2019 Assets under finance leases in property, plant and equipment $ 49,714 $ 49,714 Accumulated depreciation (26,107) (24,316) Assets under finance leases in property, plant and equipment, net $ 23,607 $ 25,398 |
Revenue Recognition (Tables)
Revenue Recognition (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Revenue from Contract with Customer [Abstract] | |
Disaggregation of Revenue | The following table presents net revenue disaggregated by segment and end market for the years ended December 31, 2020, 2019, and 2018: Performance Sensing Sensing Solutions Total For the year ended December 31, For the year ended December 31, For the year ended December 31, 2020 2019 2018 2020 2019 2018 2020 2019 2018 Net revenue: Automotive $ 1,715,749 $ 1,986,537 $ 2,076,834 $ 35,621 $ 42,446 $ 49,961 $ 1,751,370 $ 2,028,983 $ 2,126,795 HVOR (1) 508,061 559,479 550,817 — — — 508,061 559,479 550,817 Industrial — — — 336,506 351,942 336,617 336,506 351,942 336,617 Appliance and HVAC (2) — — — 189,782 201,745 208,482 189,782 201,745 208,482 Aerospace — — — 136,167 176,505 164,294 136,167 176,505 164,294 Other — — — 123,692 131,977 134,622 123,692 131,977 134,622 Net revenue $ 2,223,810 $ 2,546,016 $ 2,627,651 $ 821,768 $ 904,615 $ 893,976 $ 3,045,578 $ 3,450,631 $ 3,521,627 __________________________________________ (1) Heavy vehicle and off-road (2) Heating, ventilation and air conditioning |
Share-Based Payment Plans (Tabl
Share-Based Payment Plans (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Share-based Payment Arrangement [Abstract] | |
Schedule of Share-based Compensation, Stock Options, Activity | A summary of stock option activity for the years ended December 31, 2020, 2019, and 2018 is presented in the table below (amounts have been calculated based on unrounded shares): Number of Options (thousands) Weighted-Average Weighted-Average Aggregate Balance as of December 31, 2017 3,606 $ 37.69 6.0 $ 50,130 Granted 307 $ 51.83 Forfeited or expired (39) $ 45.59 Exercised (172) $ 35.31 $ 3,143 Balance as of December 31, 2018 3,702 $ 38.89 5.3 $ 27,846 Granted 382 $ 46.92 Forfeited or expired (83) $ 48.92 Exercised (537) $ 28.21 $ 11,690 Balance as of December 31, 2019 3,464 $ 41.19 5.0 $ 44,696 Forfeited or expired (155) $ 48.30 Exercised (452) $ 34.22 $ 5,117 Balance as of December 31, 2020 2,857 $ 41.90 4.4 $ 31,955 Options vested and exercisable as of December 31, 2020 2,445 $ 40.92 3.8 $ 29,896 Vested and expected to vest as of December 31, 2020 2,831 $ 41.85 4.3 $ 31,829 |
Schedule of Nonvested Share Activity | A summary of the status of our unvested options as of December 31, 2020, and of the changes during the year then ended, is presented in the table below (amounts have been calculated based on unrounded shares): Number of Options (thousands) Weighted-Average Grant-Date Fair Value Balance as of December 31, 2019 818 $ 14.33 Vested during the year (333) $ 13.17 Forfeited during the year (73) $ 14.58 Balance as of December 31, 2020 412 $ 15.22 |
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions | The weighted-average key assumptions used in estimating the grant-date fair value of options for the years ended December 31, 2019 and 2018 were as follows: For the year ended December 31, 2019 2018 Expected dividend yield 0.00 % 0.00 % Expected volatility 25.00 % 25.00 % Risk-free interest rate 2.35 % 2.62 % Expected term (years) 6.0 6.0 Fair value per share of underlying ordinary shares $ 46.92 $ 51.83 |
Schedule of Nonvested Restricted Stock Units Activity | A summary of restricted securities granted in the years ended December 31, 2020, 2019, and 2018 is presented below: Percentage Range of Units That May Vest (1) 0.0% to 150.0% 0.0% to 172.5% (Awards in thousands) RSU Awards Granted Weighted-Average PRSU Awards Granted Weighted-Average PRSU Awards Granted Weighted-Average 2020 806 $ 29.06 — $ — 401 $ 28.22 2019 298 $ 47.73 76 $ 46.92 138 $ 46.92 2018 218 $ 51.05 63 $ 51.83 118 $ 51.83 __________________________________________ (1) Represents the percentage range of PRSU award units granted that may vest according to the terms of the awards. The amounts presented within this table do not reflect our current assessment of the probable outcome of vesting based on the achievement or expected achievement of performance conditions. A summary of activity related to outstanding restricted securities for the years ended December 31, 2020, 2019, and 2018 is presented in the table below (amounts have been calculated based on unrounded shares): Restricted Securities (thousands) Weighted-Average Balance as of December 31, 2017 1,081 $ 44.43 Granted 399 $ 51.40 Forfeited (121) $ 48.28 Vested (240) $ 53.01 Balance as of December 31, 2018 1,119 $ 44.66 Granted (1) 555 $ 46.73 Forfeited (115) $ 47.07 Vested (454) $ 39.62 Balance as of December 31, 2019 1,105 $ 47.51 Granted 1,207 $ 28.78 Forfeited (284) $ 37.89 Vested (349) $ 43.54 Balance as of December 31, 2020 1,679 $ 36.49 __________________________________________ (1) Includes 43 thousand PRSU awards granted due to greater than 100% vesting. |
Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Units, Vested and Expected to Vest | Aggregate intrinsic value information for restricted securities as of December 31, 2020, 2019, and 2018 is presented below: As of December 31, 2020 2019 2018 Outstanding $ 88,534 $ 59,526 $ 50,161 Expected to vest $ 58,675 $ 34,717 $ 44,203 |
Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Units, Weighted Average Remaining Period | The weighted-average remaining periods over which the restrictions will lapse as of December 31, 2020, 2019, and 2018 are as follows: As of December 31, 2020 2019 2018 Outstanding 1.1 1.1 1.2 Expected to vest 1.1 1.0 1.2 |
Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan | The table below presents non-cash compensation expense related to our equity awards, which is recognized within SG&A expense in the consolidated statements of operations, during the identified periods: For the year ended December 31, 2020 2019 2018 Stock options $ 2,868 $ 6,552 $ 5,739 Restricted securities 16,257 12,205 18,086 Share-based compensation expense $ 19,125 $ 18,757 $ 23,825 |
Schedule of Unrecognized Compensation Cost, Nonvested Awards | The table below presents unrecognized compensation expense at December 31, 2020 for each class of award, and the remaining expected term for this expense to be recognized: Unrecognized Expected Options $ 5,280 1.0 Restricted securities 21,943 1.7 Total unrecognized compensation expense $ 27,223 |
Restructuring and Other Charg_2
Restructuring and Other Charges, Net (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Restructuring and Related Activities [Abstract] | |
Restructuring and Related Costs | We expect these restructuring charges to impact our business segments and corporate functions as follows: Reductions-in-Force Site Closures (Dollars in millions) Positions Minimum Maximum Minimum Maximum Performance Sensing 180 $ 10.7 $ 11.6 $ 3.0 $ 4.0 Sensing Solutions 286 8.9 9.6 5.0 6.0 Corporate and other 414 11.4 12.5 — — Total 880 $ 31.0 $ 33.7 $ 8.0 $ 10.0 Charges recognized in the year ended December 31, 2020 resulting from the Q2 2020 Global Restructure Program are presented by segment below. Approximately $0.6 million of these charges relate to site closures in Sensing Solutions. For the year ended Performance Sensing $ 9,073 Sensing Solutions 6,445 Corporate and other 8,940 Q2 2020 Global Restructure Program, net $ 24,458 Restructuring and other charges, net for the years ended December 31, 2020, 2019, and 2018 were as follows: For the year ended December 31, 2020 2019 2018 Q2 2020 Global Restructure Program, net $ 24,458 $ — $ — Other restructuring charges Severance costs, net (1) 3,042 29,240 7,566 Facility and other exit costs 1,323 808 877 Gain on sale of Valves Business (2) — — (64,423) Other (3) 4,271 23,512 8,162 Restructuring and other charges, net $ 33,094 $ 53,560 $ (47,818) __________________________________________ (1) For each of the years ended December 31, 2020, 2019, and 2018, these charges include termination benefits provided in connection with workforce reductions of manufacturing, engineering, and administrative positions, including the elimination of certain positions related to site consolidations, net of reversals. For the year ended December 31, 2020, these charges related to termination benefits arising from the shutdown and relocation of operating sites in Northern Ireland and Belgium. For the year ended December 31, 2019, these charges included approximately $12.7 million of benefits provided under a voluntary retirement incentive program offered to a limited number of eligible employees in the U.S., and $6.5 million of termination benefits provided under a one-time benefit arrangement related to the shutdown and relocation of an operating site in Germany. (2) In the year ended December 31, 2018, we completed the sale of the capital stock of Schrader Bridgeport International, Inc. and August France Holding Company SAS (collectively, the "Valves Business"). The gain on this sale was recorded in restructuring and other charges, net. (3) Represents charges that are not included in one of the other classifications. In the year ended December 31, 2020, we settled intellectual property litigation brought against Schrader by Wasica Finance GmbH ("Wasica") and released $11.7 million of the related liability. This release largely offset a charge of $12.1 million resulting from a prejudgment interest-related award granted by the court on behalf of Wasica in the three months ended June 30, 2020. Refer to Note 15, "Commitments and Contingencies," for additional information related to this matter. In the year ended December 31, 2019, we recognized a $17.8 million loss related to the termination of a supply agreement in connection with the Metal Seal Precision, Ltd. ("Metal Seal") litigation. In the year ended December 31, 2018, we incurred $5.9 million of incremental direct costs in order to transact the sale of the Valves Business. For each of the years ended December 31, 2020, 2019, and 2018, we recorded expense related to the deferred compensation arrangement that we entered into in connection with the acquisition of GIGAVAC, LLC ("GIGAVAC") in the year ended December 31, 2018. |
Schedule of Restructuring Reserve by Type of Cost | The following table presents a rollforward of the severance portion of our restructuring obligations for the years ended December 31, 2020 and 2019. Q2 Plan Other Total Balance as of December 31, 2018 $ — $ 6,591 $ 6,591 Charges, net of reversals — 29,240 29,240 Payments — (21,095) (21,095) Foreign currency remeasurement — 43 43 Balance as of December 31, 2019 — 14,779 14,779 Charges, net of reversals 23,824 3,042 26,866 Payments (13,853) (13,969) (27,822) Foreign currency remeasurement 871 185 1,056 Balance as of December 31, 2020 $ 10,842 $ 4,037 $ 14,879 |
Other, Net (Tables)
Other, Net (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Other Income and Expenses [Abstract] | |
Schedule of Other, Net | Other, net consisted of the following for the years ended December 31, 2020, 2019, and 2018: For the year ended December 31, 2020 2019 2018 Currency remeasurement gain/(loss) on net monetary assets (1) $ 10,833 $ (6,802) $ (18,905) (Loss)/gain on foreign currency forward contracts (2) (6,762) 2,225 2,070 Gain/(loss) on commodity forward contracts (2) 10,027 4,888 (8,481) Loss on debt financing (3) — (4,364) (2,350) Net periodic benefit cost, excluding service cost (4) (9,980) (3,186) (3,585) Other (4,457) (669) 886 Other, net $ (339) $ (7,908) $ (30,365) __________________________________________ (1) Relates to the remeasurement of non-USD denominated net monetary assets and liabilities into USD. Refer to the Foreign Currency section of Note 2, "Significant Accounting Policies," for additional information. (2) Relates to changes in the fair value of derivative financial instruments not designated as cash flow hedges. Refer to Note 19, "Derivative Instruments and Hedging Activities," for additional information related to gains and losses on our commodity and foreign currency exchange forward contracts. (3) Refer to Note 14, "Debt," for additional information related to our debt financing transactions. (4) Refer to Note 13, "Pension and Other Post-Retirement Benefits," for additional information on net periodic benefit cost included in other, net. |
Income Taxes (Tables)
Income Taxes (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Income Tax Disclosure [Abstract] | |
Schedule of Income before Income Tax, Domestic and Foreign | Income before taxes for the years ended December 31, 2020, 2019, and 2018 was categorized by jurisdiction as follows: U.S. Non-U.S. Total 2020 $ (80,856) $ 246,497 $ 165,641 2019 $ 13,183 $ 377,240 $ 390,423 2018 $ 68,027 $ 458,348 $ 526,375 |
Schedule of Components of Income Tax Expense (Benefit) | Provision for/(benefit from) income taxes for the years ended December 31, 2020, 2019, and 2018 was categorized by jurisdiction as follows: U.S. Federal Non-U.S. U.S. State Total 2020 Current $ (2,624) $ 48,572 $ 307 $ 46,255 Deferred (14,776) (34,252) 4,128 (44,900) Total $ (17,400) $ 14,320 $ 4,435 $ 1,355 2019 Current $ 5,643 $ 73,947 $ 496 $ 80,086 Deferred 9,687 17,339 597 27,623 Total $ 15,330 $ 91,286 $ 1,093 $ 107,709 2018 Current $ 5,700 $ 64,666 $ 1,082 $ 71,448 Deferred (109,663) (18,770) (15,635) (144,068) Total $ (103,963) $ 45,896 $ (14,553) $ (72,620) |
Schedule of Effective Income Tax Rate Reconciliation | The principal reconciling items from income tax computed at the U.S. statutory tax rate for the years ended December 31, 2020, 2019, and 2018 were as follows: For the year ended December 31, 2020 2019 2018 Tax computed at statutory rate of 21% $ 34,785 $ 81,989 $ 110,539 Intangible property transfers (54,188) — — Foreign tax rate differential (21,994) (19,107) (41,200) Valuation allowances 8,869 19,640 (123,426) Withholding taxes not creditable 12,198 9,509 8,734 Change in tax laws or rates 11,229 5,121 (22,264) Research and development incentives (7,408) (8,410) (19,475) U.S. state taxes, net of federal benefit 3,504 863 (11,499) Unrealized foreign currency exchange losses/(gains), net 2,650 (43) 11,346 Reserve for tax exposure (171) 20,079 10,775 Nontaxable items and other 11,881 (1,932) 3,850 Provision for/(benefit from) income taxes $ 1,355 $ 107,709 $ (72,620) |
Schedule of Deferred Tax Assets and Liabilities | The primary components of deferred income tax assets and liabilities as of December 31, 2020 and 2019 were as follows: As of December 31, 2020 2019 Deferred tax assets: Net operating loss, interest expense, and other carryforwards $ 342,689 $ 283,094 Prepaid and accrued expenses 67,221 67,143 Intangible assets and goodwill 110,382 20,457 Pension liability and other 14,241 7,158 Property, plant and equipment 13,789 14,749 Share-based compensation 9,609 10,288 Inventories and related reserves 9,329 16,712 Unrealized exchange loss 3,182 1,959 Total deferred tax assets 570,442 421,560 Valuation allowance (202,101) (146,775) Net deferred tax asset 368,341 274,785 Deferred tax liabilities: Intangible assets and goodwill (480,082) (440,009) Tax on undistributed earnings of subsidiaries (35,254) (31,636) Operating lease right of use assets (11,324) (12,522) Property, plant and equipment (16,110) (13,762) Unrealized exchange gain (643) (6,739) Total deferred tax liabilities (543,413) (504,668) Net deferred tax liability $ (175,072) $ (229,883) |
Summary of Income Tax Contingencies | A reconciliation of the amount of unrecognized tax benefits is as follows: For the year ended December 31, 2020 2019 2018 Balance at beginning of year $ 117,591 $ 89,609 $ 59,884 Increases related to current year tax positions 46,329 17,378 15,676 Increases related to prior year tax positions 43,082 15,356 14,609 Increases related to business combinations — 450 1,000 Decreases related to settlements with tax authorities (5,183) (3,515) — Decreases related to prior year tax positions (1,294) (1,773) (1,144) Decreases related to lapse of applicable statute of limitations (452) (87) — Changes related to foreign currency exchange rate 1,337 173 (416) Balance at end of year $ 201,410 $ 117,591 $ 89,609 |
Summary of Income Tax Examinations | The table that follows presents the expense/(income) related to such interest and penalties recognized in the consolidated statements of operations during the years ended December 31, 2020, 2019, and 2018, and the amount of interest and penalties recorded on the consolidated balance sheets as of December 31, 2020 and 2019: Statements of Operations Balance Sheets For the year ended December 31, As of December 31, (In millions) 2020 2019 2018 2020 2019 Interest $ 0.4 $ 0.9 $ (0.2) $ 1.7 $ 1.3 Penalties $ 0.2 $ (0.1) $ (0.2) $ 0.4 $ 0.3 |
Net Income Per Share (Tables)
Net Income Per Share (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Earnings Per Share [Abstract] | |
Schedule of Weighted Average Number of Shares | For the years ended December 31, 2020, 2019, and 2018, the weighted-average ordinary shares outstanding used to calculate basic and diluted net income per share were as follows: For the year ended December 31, (In thousands) 2020 2019 2018 Basic weighted-average ordinary shares outstanding 157,373 160,946 168,570 Dilutive effect of stock options 275 600 822 Dilutive effect of unvested restricted securities 486 422 467 Diluted weighted-average ordinary shares outstanding 158,134 161,968 169,859 |
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share | These potential ordinary shares are as follows: For the year ended December 31, (In thousands) 2020 2019 2018 Anti-dilutive shares excluded 1,575 1,170 930 Contingently issuable shares excluded 995 641 687 |
Inventories (Tables)
Inventories (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Inventory Disclosure [Abstract] | |
Schedule of Inventory | The components of inventories as of December 31, 2020 and 2019 were as follows: As of December 31, 2020 2019 Finished goods $ 170,488 $ 197,531 Work-in-process 87,006 104,007 Raw materials 193,511 205,140 Inventories $ 451,005 $ 506,678 |
Property, Plant and Equipment_2
Property, Plant and Equipment, Net (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Property, Plant and Equipment [Abstract] | |
Property, Plant and Equipment | The depreciable lives of plant and equipment are as follows: Buildings and improvements 2 – 40 years Machinery and equipment 2 – 15 years PP&E, net as of December 31, 2020 and 2019 consisted of the following: As of December 31, 2020 2019 Land $ 17,880 $ 17,880 Buildings and improvements 273,899 266,864 Machinery and equipment 1,428,793 1,367,293 Total property, plant and equipment 1,720,572 1,652,037 Accumulated depreciation (916,747) (821,039) Property, plant and equipment, net $ 803,825 $ 830,998 PP&E, net as of December 31, 2020 and 2019 included the following assets under finance leases: As of December 31, 2020 2019 Assets under finance leases in property, plant and equipment $ 49,714 $ 49,714 Accumulated depreciation (26,107) (24,316) Assets under finance leases in property, plant and equipment, net $ 23,607 $ 25,398 |
Goodwill and Other Intangible_2
Goodwill and Other Intangible Assets, Net (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Schedule of Goodwill | The following table outlines the changes in net goodwill by segment for the years ended December 31, 2020 and 2019. Performance Sensing Sensing Solutions Total Balance as of December 31, 2018 $ 2,155,633 $ 925,669 $ 3,081,302 GIGAVAC acquisition 16,387 (16,564) (177) Other acquisition — 12,473 12,473 Balance as of December 31, 2019 2,172,020 921,578 3,093,598 Other acquisition 17,751 — 17,751 Balance as of December 31, 2020 $ 2,189,771 $ 921,578 $ 3,111,349 |
Schedule of Finite-Lived Intangible Assets by Major Class | The following tables outline the components of definite-lived intangible assets as of December 31, 2020 and 2019: As of December 31, 2020 Weighted- Gross Accumulated Accumulated Net Completed technologies 14 $ 781,508 $ (578,178) $ (2,430) $ 200,900 Customer relationships 11 1,858,998 (1,501,960) (12,144) 344,894 Tradenames 21 66,654 (19,816) — 46,838 Capitalized software and other (1) 7 69,227 (45,680) — 23,547 Total 12 $ 2,776,387 $ (2,145,634) $ (14,574) $ 616,179 As of December 31, 2019 Weighted- Gross Accumulated Accumulated Net Completed technologies 14 $ 770,608 $ (529,926) $ (2,430) $ 238,252 Customer relationships 11 1,827,998 (1,430,515) (12,144) 385,339 Non-compete agreements 8 23,400 (23,400) — — Tradenames 21 66,654 (16,598) — 50,056 Capitalized software and other (1) 7 67,784 (38,997) — 28,787 Total 12 $ 2,756,444 $ (2,039,436) $ (14,574) $ 702,434 __________________________________________ (1) During the years ended December 31, 2020 and 2019, we wrote-off approximately $0.1 million and $0.3 million, respectively, of fully-amortized capitalized software that was not in use. |
Schedule of Amortization Expense | The following table outlines amortization of definite-lived intangible assets for the years ended December 31, 2020, 2019, and 2018: For the year ended December 31, 2020 2019 2018 Acquisition-related definite-lived intangible assets $ 122,915 $ 136,087 $ 132,235 Capitalized software 6,634 6,799 7,091 Amortization of intangible assets $ 129,549 $ 142,886 $ 139,326 |
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense | The table below presents estimated amortization of definite-lived intangible assets for each of the next five years: For the year ended December 31, 2021 $ 117,489 2022 $ 104,101 2023 $ 90,208 2024 $ 73,544 2025 $ 45,629 |
Accrued Expenses and Other Cu_2
Accrued Expenses and Other Current Liabilities (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Accrued expenses and other current liabilities [Abstract] | |
Schedule of Accrued Expenses and Other Current Liabilities | Accrued expenses and other current liabilities as of December 31, 2020 and 2019 consisted of the following: As of December 31, 2020 2019 Accrued compensation and benefits $ 85,140 $ 52,394 Accrued interest 53,630 42,803 Foreign currency and commodity forward contracts 19,627 1,925 Accrued severance 14,879 14,779 Current portion of operating lease liabilities 11,389 11,543 Current portion of pension and post-retirement benefit obligations 3,498 3,220 Other accrued expenses and current liabilities 136,667 88,962 Accrued expenses and other current liabilities $ 324,830 $ 215,626 |
Pension and Other Post-Retire_2
Pension and Other Post-Retirement Benefits (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Retirement Benefits [Abstract] | |
Schedule of Net Benefit Costs | The components of net periodic benefit cost/(credit) associated with our defined benefit and retiree healthcare plans for the years ended December 31, 2020, 2019, and 2018 were as follows: For the year ended December 31, 2020 2019 2018 U.S. Plans Non-U.S. Plans U.S. Plans Non-U.S. Plans U.S. Plans Non-U.S. Plans Defined Benefit Retiree Healthcare Defined Benefit Defined Benefit Retiree Healthcare Defined Benefit Defined Benefit Retiree Healthcare Defined Benefit Service cost $ — $ 10 $ 3,522 $ — $ 7 $ 2,836 $ — $ 50 $ 3,122 Interest cost 762 155 1,466 1,483 203 1,344 1,473 272 1,310 Expected return on plan assets (1,339) — (712) (1,694) — (702) (1,710) — (929) Amortization of net loss 1,184 16 1,204 946 — 766 1,080 5 407 Amortization of net prior service (credit)/cost — (1,029) 5 — (1,306) 9 — (1,728) 6 Loss on settlement 5,026 — 2,712 565 — 1,572 1,047 — 1,461 Loss on curtailment — 530 — — — — — — 891 Net periodic benefit cost/(credit) $ 5,633 $ (318) $ 8,197 $ 1,300 $ (1,096) $ 5,825 $ 1,890 $ (1,401) $ 6,268 |
Schedule of Changes in Fair Value of Plan Assets and Projected Benefit Obligations | The following table outlines the rollforward of the benefit obligation and plan assets for the defined benefit and retiree healthcare benefit plans for the years ended December 31, 2020 and 2019: For the year ended December 31, 2020 2019 U.S. Plans Non-U.S. Plans U.S. Plans Non-U.S. Plans Defined Benefit Retiree Healthcare Defined Benefit Defined Benefit Retiree Healthcare Defined Benefit Change in benefit obligation: Beginning balance $ 45,548 $ 5,588 $ 74,172 $ 45,169 $ 6,017 $ 65,691 Service cost — 10 3,522 — 7 2,836 Interest cost 762 155 1,466 1,483 203 1,344 Plan participants’ contributions — 696 35 — 474 31 Actuarial loss/(gain) 7,526 (1,213) 13,006 1,711 (92) 9,344 Curtailment loss — 530 — — — — Benefits paid (17,568) (719) (8,507) (2,815) (1,021) (5,235) Foreign currency remeasurement — — 4,618 — — 161 Ending balance $ 36,268 $ 5,047 $ 88,312 $ 45,548 $ 5,588 $ 74,172 Change in plan assets: Beginning balance $ 44,870 $ — $ 43,906 $ 39,875 $ — $ 39,868 Actual return on plan assets 2,333 — 2,071 4,484 — 4,125 Employer contributions 19 23 7,714 3,326 547 4,889 Plan participants’ contributions — 696 35 — 474 31 Benefits paid (17,568) (719) (8,507) (2,815) (1,021) (5,235) Foreign currency remeasurement — — 3,254 — — 228 Ending balance $ 29,654 $ — $ 48,473 $ 44,870 $ — $ 43,906 Funded status at end of year $ (6,614) $ (5,047) $ (39,839) $ (678) $ (5,588) $ (30,266) Accumulated benefit obligation at end of year $ 36,268 NA $ 77,886 $ 45,548 NA $ 65,633 |
Schedule of Amounts Recognized in Balance Sheet | The following table outlines the funded status amounts recognized in the consolidated balance sheets as of December 31, 2020 and 2019: As of December 31, 2020 2019 U.S. Plans Non-U.S. Plans U.S. Plans Non-U.S. Plans Defined Benefit Retiree Healthcare Defined Benefit Defined Benefit Retiree Healthcare Defined Benefit Noncurrent assets $ — $ — $ — $ 2,788 $ — $ — Current liabilities (1,091) (586) (1,821) (952) (717) (1,551) Noncurrent liabilities (5,523) (4,461) (38,018) (2,514) (4,871) (28,715) Funded status $ (6,614) $ (5,047) $ (39,839) $ (678) $ (5,588) $ (30,266) |
Schedule of Amounts in Accumulated Other Comprehensive Income (Loss) to be Recognized over Next Fiscal Year | Balances recognized within accumulated other comprehensive loss that have not been recognized as components of net periodic benefit cost, net of tax, as of December 31, 2020, 2019, and 2018 are as follows: As of December 31, 2020 2019 2018 U.S. Plans Non-U.S. Plans U.S. Plans Non-U.S. Plans U.S. Plans Non-U.S. Plans Defined Benefit Retiree Healthcare Defined Benefit Defined Benefit Retiree Healthcare Defined Benefit Defined Benefit Retiree Healthcare Defined Benefit Net prior service cost/(credit) $ — $ 1,094 $ (20) $ — $ 306 $ (16) $ — $ (692) $ (10) Net loss $ 19,026 $ (131) $ 22,833 $ 18,780 $ 809 $ 17,151 $ 20,759 $ 880 $ 14,425 |
Schedule of Accumulated Benefit Obligations in Excess of Fair Value of Plan Assets | Information for plans with an accumulated benefit obligation in excess of plan assets as of December 31, 2020 and 2019 is as follows: As of December 31, 2020 2019 U.S. Plans Non-U.S. Plans U.S. Plans Non-U.S. Plans Projected benefit obligation $ 36,268 $ 88,312 $ 3,465 $ 74,020 Accumulated benefit obligation $ 36,268 $ 77,886 $ 3,465 $ 65,633 Plan assets $ 29,654 $ 48,473 $ — $ 43,754 |
Schedule of Accumulated and Projected Benefit Obligations | Information for plans with a projected benefit obligation in excess of plan assets as of December 31, 2020 and 2019 is as follows: As of December 31, 2020 2019 U.S. Plans Non-U.S. Plans U.S. Plans Non-U.S. Plans Projected benefit obligation $ 41,315 $ 88,312 $ 9,053 $ 74,020 Plan assets $ 29,654 $ 48,473 $ — $ 43,754 |
Schedule of Amounts Recognized in Other Comprehensive Income (Loss) | Other changes in plan assets and benefit obligations, net of tax, recognized in other comprehensive income/(loss) for the years ended December 31, 2020, 2019, and 2018 are as follows: For the year ended December 31, 2020 2019 2018 U.S. Plans Non-U.S. Plans U.S. Plans Non-U.S. Plans U.S. Plans Non-U.S. Plans Defined Benefit Retiree Healthcare Defined Benefit Defined Benefit Retiree Healthcare Defined Benefit Defined Benefit Retiree Healthcare Defined Benefit Net (gain)/loss $ 4,997 $ (928) $ 8,425 $ (824) $ (71) $ 4,365 $ 2,002 $ (124) $ 3,669 Amortization of net loss (906) (12) (839) (723) — (539) (1,080) (5) (298) Amortization of net prior service credit/(cost) — 562 (4) — 998 (6) — 1,728 (4) Divestiture — — — — — — — — (228) Plan amendment — — — — — — — (3,243) — Settlement effect (3,845) — (1,904) (432) — (1,100) (1,047) — (1,023) Curtailment effect — 226 — — — — — — 30 Total in other comprehensive (income)/loss $ 246 $ (152) $ 5,678 $ (1,979) $ 927 $ 2,720 $ (125) $ (1,644) $ 2,146 |
Schedule of Assumptions Used | Weighted-average assumptions used to calculate the projected benefit obligations of our defined benefit and retiree healthcare benefit plans as of December 31, 2020 and 2019 are as follows: As of December 31, 2020 2019 Defined Benefit Retiree Healthcare Defined Benefit Retiree Healthcare U.S. assumed discount rate 1.65 % 1.80 % 2.60 % 2.80 % Non-U.S. assumed discount rate 1.97 % NA 1.90 % NA Non-U.S. average long-term pay progression 2.93 % NA 2.87 % NA Weighted-average assumptions used to calculate the net periodic benefit cost of our defined benefit and retiree healthcare benefit plans for the years ended December 31, 2020, 2019, and 2018 are as follows: For the year ended December 31, 2020 2019 2018 Defined Benefit Retiree Healthcare Defined Benefit Retiree Healthcare Defined Benefit Retiree Healthcare U.S. assumed discount rate 2.60 % 2.80 % 3.79 % 3.90 % 3.45 % 3.10 % Non-U.S. assumed discount rate 5.53 % NA 5.76 % NA 5.87 % NA U.S. average long-term rate of return on plan assets 4.29 % NA 4.53 % NA 4.57 % NA Non-U.S. average long-term rate of return on plan assets 1.61 % NA 1.77 % NA 2.26 % NA Non-U.S. average long-term pay progression 4.83 % NA 4.43 % NA 4.82 % NA |
Schedule of Health Care Cost Trend Rates | Assumed healthcare cost trend rates for the U.S. retiree healthcare benefit plan as of December 31, 2020, 2019, and 2018 are as follows: As of December 31, 2020 2019 2018 Assumed healthcare trend rate for next year: Attributed to less than age 65 6.00 % 6.30 % 6.60 % Attributed to age 65 or greater 6.30 % 6.70 % 7.10 % Ultimate trend rate 4.50 % 4.50 % 4.50 % Year in which ultimate trend rate is reached: Attributed to less than age 65 2038 2038 2038 Attributed to age 65 or greater 2038 2038 2038 |
Schedule of Expected Benefit Payments | The table below outlines the benefits expected to be paid to participants in each of the following years, taking into consideration expected future service, as appropriate. The majority of the payments will be paid from plan assets and not company assets. Expected Benefit Payments For the year ended December 31, U.S. Defined Benefit U.S. Retiree Healthcare Non-U.S. Defined Benefit 2021 $ 12,177 $ 586 $ 3,546 2022 $ 3,378 $ 561 $ 3,809 2023 $ 4,221 $ 487 $ 3,777 2024 $ 2,548 $ 460 $ 3,766 2025 $ 2,506 $ 415 $ 4,639 2026 - 2030 $ 7,928 $ 1,463 $ 24,768 |
Schedule of Allocation of Plan Assets | The following table presents information about the plan’s target and actual asset allocation, as of December 31, 2020: Target Allocation Actual Allocation as of December 31, 2020 U.S. large cap equity 7% 9% U.S. small / mid cap equity 2% 2% Globally managed volatility fund 3% 3% International (non-U.S.) equity 4% 5% Fixed income (U.S. investment grade) 68% 70% High-yield fixed income 2% 2% International (non-U.S.) fixed income 1% 1% Money market funds 13% 9% __________________________________________ The following table presents information about the plan’s target asset allocation, as well as the actual allocation, as of December 31, 2020: Target Allocation Actual Allocation as of December 31, 2020 Fixed income securities, cash, and cash equivalents 10%-90% 72% Equity securities 10%-90% 28% |
Schedule of Defined Benefit Plans Disclosures | The following table presents information about the plan assets measured at fair value as of December 31, 2020 and 2019: As of December 31, 2020 2019 U.S. large cap equity $ 2,548 $ 2,221 U.S. small / mid cap equity 706 637 Global managed volatility fund 826 849 International (non-U.S.) equity 1,362 1,195 Total equity mutual funds 5,442 4,902 Fixed income (U.S. investment grade) 20,801 18,830 High-yield fixed income 594 561 International (non-U.S.) fixed income 277 264 Total fixed income mutual funds 21,672 19,655 Money market funds 2,540 20,313 Total plan assets $ 29,654 $ 44,870 The following table presents information about the plan assets measured at fair value as of December 31, 2020 and 2019: As of December 31, 2020 2019 U.S. equity $ 2,736 $ 2,413 International (non-U.S.) equity 6,724 6,343 Total equity securities 9,460 8,756 U.S. fixed income 3,091 3,835 International (non-U.S.) fixed income 11,142 9,716 Total fixed income securities 14,233 13,551 Cash and cash equivalents 9,793 9,726 Total plan assets $ 33,486 $ 32,033 The following table presents information about the plan assets measured at fair value as of December 31, 2020 and 2019: As of December 31, 2020 2019 Insurance policies $ 12,905 $ 10,472 |
Schedule of Effect of Significant Unobservable Inputs, Changes in Plan Assets | The following table presents a rollforward of these assets for the years ended December 31, 2020 and 2019: Insurance Policies Balance as of December 31, 2018 $ 8,897 Actual return on plan assets still held at reporting date 1,821 Purchases, sales, settlements, and exchange rate changes (246) Balance as of December 31, 2019 10,472 Actual return on plan assets still held at reporting date 1,373 Purchases, sales, settlements, and exchange rate changes 1,060 Balance as of December 31, 2020 $ 12,905 |
Debt (Tables)
Debt (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Debt Disclosure [Abstract] | |
Schedule of Long-term Debt Instruments | Our long-term debt and finance lease and other financing obligations as of December 31, 2020 and 2019 consisted of the following: As of December 31, Maturity Date 2020 2019 Term Loan September 20, 2026 $ 456,096 $ 460,725 4.875% Senior Notes October 15, 2023 500,000 500,000 5.625% Senior Notes November 1, 2024 400,000 400,000 5.0% Senior Notes October 1, 2025 700,000 700,000 6.25% Senior Notes (1) February 15, 2026 750,000 750,000 4.375% Senior Notes February 15, 2030 450,000 450,000 3.75% Senior Notes February 15, 2031 750,000 — Less: debt discount (9,605) (11,758) Less: deferred financing costs (28,114) (24,452) Less: current portion (754,630) (4,630) Long-term debt, net $ 3,213,747 $ 3,219,885 Finance lease and other financing obligations $ 30,506 $ 31,098 Less: current portion (2,575) (2,288) Finance lease and other financing obligations, less current portion $ 27,931 $ 28,810 ___________________________ (1) On February 3, 2021, we announced that we intended to redeem in full the $750.0 million aggregate principal amount outstanding on our 6.25% Senior Notes due 2026 in March 2021. As a result, these notes have been classified as current on our consolidated balance sheet as of December 31, 2020. |
Schedule of Debt | Each of the Senior Notes were issued at par, with interest payable semi-annually on the dates shown in the table below. 4.875% Senior Notes 5.625% Senior Notes 5.000% Senior Notes 6.250% Senior Notes (1) 4.375% Senior Notes (2) 3.750% Senior Notes Aggregate principal amount $ 500,000 $ 400,000 $ 700,000 $ 750,000 $ 450,000 $ 750,000 Interest rate 4.875 % 5.625 % 5.000 % 6.250 % 4.375 % 3.750 % Issuer STBV STBV STBV STUK STI STI Issue date April 2013 October 2014 March 2015 November 2015 September 2019 August 2020 Interest due April 15 May 1 April 1 February 15 February 15 February 15 Interest due October 15 November 1 October 1 August 15 August 15 August 15 Maturity Date October 2023 November 2024 October 2025 February 2026 February 2030 February 2031 __________________________________________ (1) The 6.25% Senior Notes were issued by our indirect, wholly-owned subsidiary, Sensata Technologies UK Financing Co. plc ("STUK") under an indenture dated as of November 27, 2015 (the "6.25% Senior Notes Indenture"). On February 3, 2021, we announced that we intended to redeem in full the $750.0 million aggregate principal amount outstanding on our 6.25% Senior Notes due 2026 in March 2021. |
Debt Instrument Redemption | The "make-whole" premium will not be payable with respect to any such redemption of the 4.375% Senior Notes on or after November 15, 2029. The "make-whole" premium will not be payable with respect to any such redemption of the 3.75% Senior Notes on or after February 15, 2026; on or after such date, we may optionally redeem the 3.75% Senior Notes, in whole or in part, at the following prices (expressed as a percentage of principal amount), plus accrued and unpaid interest, if any, up to but excluding the redemption date: Period beginning February 15, Price 2026 101.875 % 2027 100.938 % 2028 and thereafter 100.000 % |
Schedule of Maturities of Long-term Debt | The following table presents the remaining mandatory principal repayments of long-term debt, excluding finance lease payments, other financing obligations, and discretionary repurchases of debt, in each of the years ended December 31, 2021 through 2025 and thereafter. On February 3, 2021, we announced that we intended to redeem in full the $750.0 million aggregate principal amount outstanding on our 6.25% Senior Notes due 2026 in March 2021. This redemption is reflected in fiscal year 2021 in the following table. In accordance with the terms of the 6.25% Senior Notes, redemption will be at 103.125% of aggregate principal amount outstanding, and will represent an additional cash outflow of approximately $23.4 million in fiscal year 2021, which is not presented below. For the year ended December 31, Aggregate Maturities 2021 $ 754,630 2022 4,630 2023 504,630 2024 404,630 2025 704,630 Thereafter 1,632,946 Total long-term debt principal payments $ 4,006,096 |
Commitments and Contingencies (
Commitments and Contingencies (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Commitments and Contingencies Disclosure [Abstract] | |
Long-term Purchase Commitment | As of December 31, 2020, we had the following purchase commitments: For the year ending December 31, 2021 $ 41,355 2022 14,517 2023 6,889 2024 149 2025 132 Thereafter 196 Total purchase commitments $ 63,238 |
Shareholders' Equity (Tables)
Shareholders' Equity (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Stockholders' Equity Note [Abstract] | |
Schedule of Accumulated Other Comprehensive Income (Loss) | The components of accumulated other comprehensive loss were as follows: Cash Flow Hedges Defined Benefit and Retiree Healthcare Plans Accumulated Other Comprehensive Loss Balance as of December 31, 2017 $ (28,179) $ (34,985) $ (63,164) Pre-tax current period change 49,817 (1,183) 48,634 Tax effect (12,454) 806 (11,648) Balance as of December 31, 2018 9,184 (35,362) (26,178) Pre-tax current period change 9,816 (2,198) 7,618 Tax effect (2,454) 530 (1,924) Balance as of December 31, 2019 16,546 (37,030) (20,484) Pre-tax current period change (31,114) (7,848) (38,962) Tax effect 7,835 2,076 9,911 Balance as of December 31, 2020 $ (6,733) $ (42,802) $ (49,535) |
Comprehensive Income (Loss) | The details of the components of other comprehensive (loss)/income, net of tax, for the years ended December 31, 2020, 2019, and 2018 are as follows: For the year ended December 31, 2020 2019 2018 Cash Flow Hedges Defined Benefit and Retiree Healthcare Plans Total Cash Flow Hedges Defined Benefit and Retiree Healthcare Plans Total Cash Flow Hedges Defined Benefit and Retiree Healthcare Plans Total Other comprehensive (loss)/income before reclassifications $ (17,738) $ (12,494) $ (30,232) $ 28,795 $ (3,470) $ 25,325 $ 26,859 $ (2,120) $ 24,739 Amounts reclassified from accumulated other comprehensive loss (5,541) 6,722 1,181 (21,433) 1,802 (19,631) 10,504 1,743 12,247 Other comprehensive (loss)/income $ (23,279) $ (5,772) $ (29,051) $ 7,362 $ (1,668) $ 5,694 $ 37,363 $ (377) $ 36,986 |
Reclassification out of Accumulated Other Comprehensive Income | The details of the (gain)/loss reclassified from accumulated other comprehensive loss for the years ended December 31, 2020, 2019, and 2018 are as follows: Amount of (Gain)/Loss Reclassified from Accumulated Other Comprehensive Loss For the year ended December 31, Affected Line in Consolidated Statements of Operations 2020 2019 2018 Derivative instruments designated and qualifying as cash flow hedges: Foreign currency forward contracts $ (10,785) $ (26,180) $ 18,072 Net revenue (1) Foreign currency forward contracts 3,397 (2,397) (5,442) Cost of revenue (1) Foreign currency forward contracts — — 1,376 Other, net (1) Total, before taxes (7,388) (28,577) 14,006 Income before taxes Income tax effect 1,847 7,144 (3,502) Provision for/(benefit from) income taxes Total, net of taxes $ (5,541) $ (21,433) $ 10,504 Net income Defined benefit and retiree healthcare plans $ 9,118 $ 2,552 $ 1,993 Other, net (2) Defined benefit and retiree healthcare plans — — 228 Restructuring and other charges, net (3) Total, before taxes 9,118 2,552 2,221 Income before taxes Income tax effect (2,396) (750) (478) Provision for/(benefit from) income taxes Total, net of taxes $ 6,722 $ 1,802 $ 1,743 Net income __________________________________________ (1) Refer to Note 19, "Derivative Instruments and Hedging Activities," for additional information related to amounts to be reclassified from accumulated other comprehensive loss in future periods. (2) Refer to Note 13, "Pension and Other Post-Retirement Benefits," for additional information related to net periodic benefit cost. |
Leases (Tables)
Leases (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Leases [Abstract] | |
Schedule of Amounts Recognized in Consolidated Balance Sheet | The table below shows right-of-use asset and lease liability amounts and the financial statement line item in which those amounts are presented: December 31, 2020 December 31, 2019 Operating lease right-of-use assets: Other assets $ 49,980 $ 55,333 Total operating lease right-of-use assets $ 49,980 $ 55,333 Operating lease liabilities: Accrued expenses and other current liabilities $ 11,389 $ 11,543 Other long-term liabilities 43,307 45,457 Total operating lease liabilities $ 54,696 $ 57,000 Finance lease right-of-use assets: Property, plant and equipment, at cost $ 49,714 $ 49,714 Accumulated depreciation (26,107) (24,316) Property, plant and equipment, net $ 23,607 $ 25,398 Finance lease liabilities: Current portion of long-term debt, finance lease and other financing obligations $ 2,403 $ 1,974 Finance lease and other financing obligations, less current portion 27,931 28,669 Total finance lease liabilities $ 30,334 $ 30,643 |
Lease Cost | The table below presents the lease liabilities arising from obtaining right-of-use assets in the years ended December 31, 2020 and 2019: For the year ended December 31, 2020 2019 Operating leases $ 3,232 $ 5,423 Finance leases $ — $ — The table below presents our total lease cost for the years ended December 31, 2020 and 2019 (short-term lease cost was not material for the years ended December 31, 2020 and 2019): For the year ended December 31, 2020 2019 Operating lease cost $ 16,658 $ 16,124 Finance lease cost: Amortization of right-of-use assets $ 1,794 $ 1,808 Interest on lease liabilities 2,565 2,695 Total finance lease cost $ 4,359 $ 4,503 The table below presents the cash paid related to our operating and finance leases for the years ended December 31, 2020 and 2019: For the year ended December 31, 2020 2019 Operating cash flows from operating leases $ 16,489 $ 15,911 Operating cash flows from finance leases $ 2,262 $ 2,731 Financing cash flows from finance leases $ 944 $ 1,933 The table below presents the weighted-average remaining lease term of our operating and finance leases (in years): 2020 Operating leases 7.6 Finance leases 11.8 The table below presents our weighted-average discount rate as of December 31, 2020: 2020 Operating leases 5.7 % Finance leases 8.5 % |
Maturity of Obligations related to Financing Leases | The table below presents a maturity analysis of the obligations related to our operating lease liabilities and finance lease liabilities in effect as of December 31, 2020: Operating Leases Finance Leases Year ending December 31, 2021 $ 14,608 $ 4,572 2022 12,176 3,848 2023 8,829 3,813 2024 7,561 3,873 2025 5,048 3,934 Thereafter 21,808 29,486 Total undiscounted cash flows related to lease liabilities 70,030 49,526 Less imputed interest (15,334) (19,192) Total lease liabilities $ 54,696 $ 30,334 |
Maturity of Obligations related to Operating Leases | The table below presents a maturity analysis of the obligations related to our operating lease liabilities and finance lease liabilities in effect as of December 31, 2020: Operating Leases Finance Leases Year ending December 31, 2021 $ 14,608 $ 4,572 2022 12,176 3,848 2023 8,829 3,813 2024 7,561 3,873 2025 5,048 3,934 Thereafter 21,808 29,486 Total undiscounted cash flows related to lease liabilities 70,030 49,526 Less imputed interest (15,334) (19,192) Total lease liabilities $ 54,696 $ 30,334 |
Fair Value Measures (Tables)
Fair Value Measures (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Fair Value Disclosures [Abstract] | |
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis | The fair values of our assets and liabilities measured at fair value on a recurring basis as of as of December 31, 2020 and 2019 are as shown in the below table. All fair value measures presented are categorized in Level 2 of the fair value hierarchy. As of December 31, 2020 2019 Assets measured at fair value: Foreign currency forward contracts 16,163 23,561 Commodity forward contracts 8,902 3,623 Total assets measured at fair value 25,065 27,184 Liabilities measured at fair value: Foreign currency forward contracts 24,660 1,959 Commodity forward contracts 310 462 Total liabilities measured at fair value 24,970 2,421 |
Fair Value, by Balance Sheet Grouping | The following table presents the carrying values and fair values of financial instruments not recorded at fair value in the consolidated balance sheets as of December 31, 2020 and 2019. All fair value measures presented are categorized within Level 2 of the fair value hierarchy. As of December 31, 2020 2019 Carrying Value (1) Fair Value Carrying Value (1) Fair Value Term Loan $ 456,096 $ 454,955 $ 460,725 $ 464,181 4.875% Senior Notes $ 500,000 $ 538,750 $ 500,000 $ 532,500 5.625% Senior Notes $ 400,000 $ 448,000 $ 400,000 $ 444,000 5.0% Senior Notes $ 700,000 $ 777,000 $ 700,000 $ 759,500 6.25% Senior Notes $ 750,000 $ 778,125 $ 750,000 $ 808,125 4.375% Senior Notes $ 450,000 $ 487,125 $ 450,000 $ 457,875 3.75% Senior Notes $ 750,000 $ 776,250 $ — $ — __________________________________________ (1) Excluding any related debt discounts and deferred financing costs. |
Equity Securities without Readily Determinable Fair Value | Refer to the table below for the carrying values of equity investments using the measurement alternative, which are presented as a component of other assets in the consolidated balance sheets. As of December 31, 2020 2019 Quanergy Systems, Inc $ 50,000 $ 50,000 Other 15,000 3,700 Total $ 65,000 $ 53,700 |
Derivative Instruments and He_2
Derivative Instruments and Hedging Activities (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Schedule of Derivative Instruments | As of December 31, 2020, we had the following outstanding foreign currency forward contracts: Notional Effective Date(s) Maturity Date(s) Index (Exchange Rates) Weighted- Average Strike Rate Hedge Designation (1) 22.0 EUR December 29, 2020 January 29, 2021 Euro ("EUR") to USD 1.23 USD Not designated 317.3 EUR Various from February 2019 to December 2020 Various from January 2021 to December 2022 EUR to USD 1.17 USD Cash flow hedge 584.0 CNY December 28, 2020 January 29, 2021 USD to Chinese Renminbi ("CNY") 6.57 CNY Not designated 500.0 CNY November 5, 2020 Various from January to December 2021 USD to CNY 6.74 CNY Cash flow hedge 897.0 JPY December 28, 2020 January 29, 2021 USD to Japanese Yen ("JPY") 103.53 JPY Not designated 17,321.7 KRW Various from March 2019 to December 2020 Various from January 2021 to December 2022 USD to Korean Won ("KRW") 1,167.03 KRW Cash flow hedge 22.0 MYR December 30, 2020 January 29, 2021 USD to Malaysian Ringgit ("MYR") 4.06 MYR Not designated 284.0 MXN December 29, 2020 January 29, 2021 USD to Mexican Peso ("MXN") 19.95 MXN Not designated 2,963.5 MXN Various from February 2019 to December 2020 Various from January 2021 to December 2022 USD to MXN 22.56 MXN Cash flow hedge 6.0 GBP December 29, 2020 January 29, 2021 British Pound Sterling ("GBP") to USD 1.35 USD Not designated 48.9 GBP Various from February 2019 to December 2020 Various from January 2021 to December 2022 GBP to USD 1.29 USD Cash flow hedge ______________________________________ (1) Derivative financial instruments not designated as hedges are used to manage our exposure to currency exchange rate risk. They are intended to preserve the economic value, and they are not used for trading or speculative purposes. As of December 31, 2020, we had the following outstanding commodity forward contracts: Commodity Notional Remaining Contracted Periods Weighted-Average Silver 742,939 troy oz. January 2021- December 2022 $ 20.54 Gold 7,326 troy oz. January 2021-December 2022 $ 1,733.35 Nickel 165,037 pounds January 2021-December 2022 $ 6.62 Aluminum 2,224,837 pounds January 2021-December 2022 $ 0.86 Copper 1,803,323 pounds January 2021-December 2022 $ 2.83 Platinum 7,440 troy oz. January 2021-December 2022 $ 911.09 Palladium 831 troy oz. January 2021-December 2022 $ 1,988.33 |
Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location | The following table presents the fair values of our derivative financial instruments and their classification in the consolidated balance sheets as of December 31, 2020 and 2019: Asset Derivatives Liability Derivatives Balance Sheet As of December 31, Balance Sheet As of December 31, 2020 2019 2020 2019 Derivatives designated as hedging instruments: Foreign currency forward contracts Prepaid expenses and other current assets $ 11,281 $ 20,957 Accrued expenses and other current liabilities $ 18,834 $ 1,055 Foreign currency forward contracts Other assets 4,728 2,530 Other long-term liabilities 5,182 428 Total $ 16,009 $ 23,487 $ 24,016 $ 1,483 Derivatives not designated as hedging instruments: Commodity forward contracts Prepaid expenses and other current assets $ 7,598 $ 3,069 Accrued expenses and other current liabilities $ 149 $ 394 Commodity forward contracts Other assets 1,304 554 Other long-term liabilities 161 68 Foreign currency forward contracts Prepaid expenses and other current assets 154 74 Accrued expenses and other current liabilities 644 476 Total $ 9,056 $ 3,697 $ 954 $ 938 |
Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance | The following tables present the effect of our derivative financial instruments on the consolidated statements of operations and the consolidated statements of comprehensive income for the years ended December 31, 2020 and 2019: Derivatives designated as hedging instruments Amount of Deferred (Loss)/Gain Recognized in Other Comprehensive (Loss)/Income Location of Net Gain/(Loss) Reclassified from Accumulated Other Comprehensive Loss into Net Income Amount of Net Gain/(Loss) Reclassified from Accumulated Other Comprehensive Loss into Net Income For the year ended December 31, For the year ended December 31, 2020 2019 2020 2019 Foreign currency forward contracts $ (25,866) $ 23,881 Net revenue $ 10,785 $ 26,180 Foreign currency forward contracts $ 2,140 $ 14,512 Cost of revenue $ (3,397) $ 2,397 Derivatives not designated as hedging instruments Amount of Gain/(Loss) Recognized in Net Income Location of Gain/(Loss) Recognized in Net Income For the year ended December 31, 2020 2019 Commodity forward contracts $ 10,027 $ 4,888 Other, net Foreign currency forward contracts $ (6,762) $ 2,225 Other, net |
Segment Reporting (Tables)
Segment Reporting (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Segment Reporting [Abstract] | |
Schedule of Segment Reporting Information, by Segment | The following table presents net revenue and segment operating income for the reported segments and other operating results not allocated to the reported segments for the years ended December 31, 2020, 2019, and 2018 (prior periods have been recast as discussed above): For the year ended December 31, 2020 2019 2018 Net revenue: Performance Sensing $ 2,223,810 $ 2,546,016 $ 2,627,651 Sensing Solutions 821,768 904,615 893,976 Total net revenue $ 3,045,578 $ 3,450,631 $ 3,521,627 Segment operating income (as defined above): Performance Sensing $ 532,529 $ 670,470 $ 728,251 Sensing Solutions 241,218 293,967 294,996 Total segment operating income 773,747 964,437 1,023,247 Corporate and other (273,367) (211,106) (221,320) Amortization of intangible assets (129,549) (142,886) (139,326) Restructuring and other charges, net (33,094) (53,560) 47,818 Operating income 337,737 556,885 710,419 Interest expense, net (171,757) (158,554) (153,679) Other, net (339) (7,908) (30,365) Income before taxes $ 165,641 $ 390,423 $ 526,375 |
Revenue from External Customers by Products and Services | The following table presents net revenue by product category for the years ended December 31, 2020, 2019, and 2018: Performance Sensing Sensing Solutions For the year ended December 31, 2020 2019 2018 Net revenue: Sensors X X $ 2,380,608 $ 2,712,926 $ 2,755,280 Electrical Protection (1) X X 504,001 573,631 522,172 Other (1) X X 160,969 164,074 244,175 Net revenue $ 3,045,578 $ 3,450,631 $ 3,521,627 (1) Beginning in the year ended December 31, 2020, we adjusted our product categories to better reflect how we view our products. The product category we previously referred to as "controls" was renamed to "electrical protection," and our GIGAVAC products, which were previously grouped in "other," have been recast into "electrical protection." The amount of revenue recast from "other" to "electrical protection" in the years ended December 31, 2019 and 2018 was $91.9 million and $13.4 million, respectively. The "sensors" product category was unchanged. |
Schedule of Depreciation and Amortization, by Segment | The following table presents depreciation and amortization expense for our reportable segments for the years ended December 31, 2020, 2019, and 2018: For the year ended December 31, 2020 2019 2018 Depreciation and amortization: Performance Sensing $ 91,522 $ 85,511 $ 72,067 Sensing Solutions 16,564 16,678 16,798 Corporate and other (1) 147,143 156,559 156,475 Total depreciation and amortization $ 255,229 $ 258,748 $ 245,340 __________________________________________ (1) Included within corporate and other is depreciation and amortization expense associated with the fair value step-up recognized in prior acquisitions and accelerated depreciation recognized in connection with restructuring actions. We do not allocate the additional depreciation and amortization expense associated with the step-up in the fair value of the PP&E and intangible assets associated with these acquisitions or accelerated depreciation related to restructuring actions |
Reconciliation of Assets from Segment to Consolidated | The following table presents total assets for our reportable segments as of December 31, 2020 and 2019: As of December 31, 2020 2019 Assets: Performance Sensing $ 1,447,885 $ 1,515,396 Sensing Solutions 459,544 479,455 Corporate and other (1) 5,936,773 4,839,668 Total assets $ 7,844,202 $ 6,834,519 __________________________________________ (1) The following is included within corporate and other as of December 31, 2020 and 2019: goodwill of $3,111.3 million and $3,093.6 million, respectively; other intangible assets, net of $691.5 million and $770.9 million, respectively; cash and cash equivalents of $1,862.0 million and $774.1 million, respectively; and PP&E, net of $41.7 million and $41.2 million, respectively. This treatment is consistent with the financial information reviewed by our chief operating decision maker. |
Schedule of Capital Expenditures by Segment | The following table presents additions to PP&E and capitalized software for our reportable segments for the years ended December 31, 2020, 2019, and 2018: For the year ended December 31, 2020 2019 2018 Additions to property, plant and equipment and capitalized software: Performance Sensing $ 79,252 $ 125,412 $ 130,234 Sensing Solutions 16,885 19,520 12,492 Corporate and other 10,582 16,327 17,061 Total additions to property, plant and equipment and capitalized software $ 106,719 $ 161,259 $ 159,787 |
Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area | The following tables present net revenue by geographic area and by significant country for the years ended December 31, 2020, 2019, and 2018. In these tables, net revenue is aggregated according to the location of our subsidiaries. For the year ended December 31, 2020 2019 2018 Net revenue: Americas $ 1,197,846 $ 1,460,101 $ 1,480,567 Europe 816,287 969,470 1,028,534 Asia and rest of world 1,031,445 1,021,060 1,012,526 Net revenue $ 3,045,578 $ 3,450,631 $ 3,521,627 For the year ended December 31, 2020 2019 2018 Net revenue: United States $ 1,082,671 $ 1,333,532 $ 1,360,590 Netherlands 482,020 576,804 585,036 China 641,516 575,211 560,938 Korea 172,229 188,226 188,114 United Kingdom 122,403 151,674 163,963 All other 544,739 625,184 662,986 Net revenue $ 3,045,578 $ 3,450,631 $ 3,521,627 |
Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country | The following tables present PP&E, net, by geographic area and by significant country as of December 31, 2020 and 2019. In these tables, PP&E, net is aggregated based on the location of our subsidiaries. As of December 31, 2020 2019 Property, plant and equipment, net: Americas $ 266,378 $ 289,300 Europe 196,132 192,772 Asia and rest of world 341,315 348,926 Property, plant and equipment, net $ 803,825 $ 830,998 As of December 31, 2020 2019 Property, plant and equipment, net: United States $ 108,615 $ 97,226 China 257,935 266,161 Mexico 157,576 191,861 Bulgaria 147,103 138,644 United Kingdom 34,453 40,003 Malaysia 78,752 78,310 All other 19,391 18,793 Property, plant and equipment, net $ 803,825 $ 830,998 |
Unaudited Quarterly Data (Table
Unaudited Quarterly Data (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Quarterly Financial Information Disclosure [Abstract] | |
Schedules of Unaudited Quarterly Data | A summary of the unaudited quarterly results of operations for the years ended December 31, 2020 and 2019 is as follows: For the three months ended December 31, 2020 September 30, 2020 June 30, 2020 March 31, 2020 Net revenue $ 906,491 $ 788,313 $ 576,505 $ 774,269 Gross profit $ 296,551 $ 258,058 $ 164,062 $ 207,863 Net income $ 121,667 $ 76,729 $ (42,541) $ 8,431 Basic net income per share $ 0.77 $ 0.49 $ (0.27) $ 0.05 Diluted net income per share $ 0.77 $ 0.49 $ (0.27) $ 0.05 For the three months ended December 31, 2019 September 30, 2019 June 30, 2019 March 31, 2019 Net revenue $ 846,691 $ 849,715 $ 883,726 $ 870,499 Gross profit $ 290,209 $ 294,805 $ 308,491 $ 289,693 Net income $ 53,538 $ 70,675 $ 73,436 $ 85,065 Basic net income per share (1) $ 0.34 $ 0.44 $ 0.45 $ 0.52 Diluted net income per share $ 0.34 $ 0.44 $ 0.45 $ 0.52 __________________________________________ (1) The sum of net income per share for the four quarters does not equal the full year net income per share due to rounding. The below table presents amounts recognized in restructuring and other charges, net in the periods presented: For the three months ended December 31, September 30, June 30, March 31, 2020 $ 897 $ (10,519) $ 38,218 $ 4,498 2019 $ 25,520 $ 6,421 $ 16,310 $ 5,309 |
Business Description and Basi_2
Business Description and Basis of Presentation (Details) | 12 Months Ended |
Dec. 31, 2020segment | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Number of segments | 2 |
Significant Accounting Polici_4
Significant Accounting Policies - Revenue Recognition (Details) | 12 Months Ended |
Dec. 31, 2020 | |
Minimum | |
Disaggregation of Revenue [Line Items] | |
Warranty Term | 12 months |
Maximum | |
Disaggregation of Revenue [Line Items] | |
Warranty Term | 18 months |
Significant Accounting Polici_5
Significant Accounting Policies - Share-Based Compensation (Details) | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Stock options | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Expected dividend yield | 0.00% | 0.00% | 0.00% |
Significant Accounting Polici_6
Significant Accounting Policies - Financial Instruments (Details) | 12 Months Ended |
Dec. 31, 2020 | |
Largest Customer | Customer Concentration Risk | Net revenue | |
Concentration Risk [Line Items] | |
Percent of net revenue | 7.00% |
Significant Accounting Polici_7
Significant Accounting Policies - Property, Plant and Equipment and Other Capitalized Costs (Details) | 12 Months Ended |
Dec. 31, 2020 | |
Buildings and improvements | Minimum | |
Property, Plant and Equipment [Line Items] | |
Useful life (in years) | 2 years |
Buildings and improvements | Maximum | |
Property, Plant and Equipment [Line Items] | |
Useful life (in years) | 40 years |
Machinery and equipment | Minimum | |
Property, Plant and Equipment [Line Items] | |
Useful life (in years) | 2 years |
Machinery and equipment | Maximum | |
Property, Plant and Equipment [Line Items] | |
Useful life (in years) | 15 years |
Significant Accounting Polici_8
Significant Accounting Policies - Leases (Details) | 12 Months Ended |
Dec. 31, 2020 | |
Vehicles and Equipment | |
Lessee, Lease, Description [Line Items] | |
Leased vehicles and equipment, term of contract | 1 year |
Maximum | |
Lessee, Lease, Description [Line Items] | |
Leased facilities, initial term | 20 years |
Revenue Recognition (Details)
Revenue Recognition (Details) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended | |||||||||
Dec. 31, 2020 | Sep. 30, 2020 | Jun. 30, 2020 | Mar. 31, 2020 | Dec. 31, 2019 | Sep. 30, 2019 | Jun. 30, 2019 | Mar. 31, 2019 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Disaggregation of Revenue [Line Items] | |||||||||||
Net revenue | $ 906,491 | $ 788,313 | $ 576,505 | $ 774,269 | $ 846,691 | $ 849,715 | $ 883,726 | $ 870,499 | $ 3,045,578 | $ 3,450,631 | $ 3,521,627 |
Performance Sensing | |||||||||||
Disaggregation of Revenue [Line Items] | |||||||||||
Net revenue | 2,223,810 | 2,546,016 | 2,627,651 | ||||||||
Sensing Solutions | |||||||||||
Disaggregation of Revenue [Line Items] | |||||||||||
Net revenue | 821,768 | 904,615 | 893,976 | ||||||||
Automotive | |||||||||||
Disaggregation of Revenue [Line Items] | |||||||||||
Net revenue | 1,751,370 | 2,028,983 | 2,126,795 | ||||||||
Automotive | Performance Sensing | |||||||||||
Disaggregation of Revenue [Line Items] | |||||||||||
Net revenue | 1,715,749 | 1,986,537 | 2,076,834 | ||||||||
Automotive | Sensing Solutions | |||||||||||
Disaggregation of Revenue [Line Items] | |||||||||||
Net revenue | 35,621 | 42,446 | 49,961 | ||||||||
HVOR | |||||||||||
Disaggregation of Revenue [Line Items] | |||||||||||
Net revenue | 508,061 | 559,479 | 550,817 | ||||||||
HVOR | Performance Sensing | |||||||||||
Disaggregation of Revenue [Line Items] | |||||||||||
Net revenue | 508,061 | 559,479 | 550,817 | ||||||||
HVOR | Sensing Solutions | |||||||||||
Disaggregation of Revenue [Line Items] | |||||||||||
Net revenue | 0 | 0 | 0 | ||||||||
Industrial | |||||||||||
Disaggregation of Revenue [Line Items] | |||||||||||
Net revenue | 336,506 | 351,942 | 336,617 | ||||||||
Industrial | Performance Sensing | |||||||||||
Disaggregation of Revenue [Line Items] | |||||||||||
Net revenue | 0 | 0 | 0 | ||||||||
Industrial | Sensing Solutions | |||||||||||
Disaggregation of Revenue [Line Items] | |||||||||||
Net revenue | 336,506 | 351,942 | 336,617 | ||||||||
Appliance and HVAC | |||||||||||
Disaggregation of Revenue [Line Items] | |||||||||||
Net revenue | 189,782 | 201,745 | 208,482 | ||||||||
Appliance and HVAC | Performance Sensing | |||||||||||
Disaggregation of Revenue [Line Items] | |||||||||||
Net revenue | 0 | 0 | 0 | ||||||||
Appliance and HVAC | Sensing Solutions | |||||||||||
Disaggregation of Revenue [Line Items] | |||||||||||
Net revenue | 189,782 | 201,745 | 208,482 | ||||||||
Aerospace | |||||||||||
Disaggregation of Revenue [Line Items] | |||||||||||
Net revenue | 136,167 | 176,505 | 164,294 | ||||||||
Aerospace | Performance Sensing | |||||||||||
Disaggregation of Revenue [Line Items] | |||||||||||
Net revenue | 0 | 0 | 0 | ||||||||
Aerospace | Sensing Solutions | |||||||||||
Disaggregation of Revenue [Line Items] | |||||||||||
Net revenue | 136,167 | 176,505 | 164,294 | ||||||||
Other | |||||||||||
Disaggregation of Revenue [Line Items] | |||||||||||
Net revenue | 123,692 | 131,977 | 134,622 | ||||||||
Other | Performance Sensing | |||||||||||
Disaggregation of Revenue [Line Items] | |||||||||||
Net revenue | 0 | 0 | 0 | ||||||||
Other | Sensing Solutions | |||||||||||
Disaggregation of Revenue [Line Items] | |||||||||||
Net revenue | $ 123,692 | $ 131,977 | $ 134,622 |
Share-Based Payment Plans - Nar
Share-Based Payment Plans - Narrative (Details) - USD ($) $ / shares in Units, $ in Millions | 1 Months Ended | 12 Months Ended | |||
Apr. 30, 2020 | Apr. 30, 2019 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Granted (in shares) | 0 | 382,000 | 307,000 | ||
Tax benefit associated with share-based compensation expense | $ 2.5 | $ 3.2 | $ 3 | ||
Stock options | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Fair value of options vested | $ 4.4 | $ 7.8 | $ 5.5 | ||
Award vesting period | 4 years | ||||
Expiration period | 10 years | ||||
Granted during the year (in dollars per share) | $ 13.90 | $ 15.70 | |||
Stock options | Vesting in year one | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Vesting percent | 25.00% | ||||
Stock options | Vesting in year two | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Vesting percent | 25.00% | ||||
Stock options | Vesting in year three | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Vesting percent | 25.00% | ||||
Stock options | Vesting in year four | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Vesting percent | 25.00% | ||||
Stock options | Termination of Employment | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Expiration period | 60 days | 90 days | |||
Stock options | Death or Disability | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Expiration period | 6 months | 1 year | |||
Restricted securities | Minimum | Performance Cliff Vesting | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Award vesting period | 1 year | ||||
Restricted securities | Maximum | Performance Cliff Vesting | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Award vesting period | 3 years | 3 years | |||
Restricted Securities With Performance Criteria | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Award vesting period | 3 years | ||||
2010 Equity Incentive Plan | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Authorized shares (in shares) | 10,000,000 | ||||
Shares available (in shares) | 1,800,000 |
Share-Based Payment Plans - Sum
Share-Based Payment Plans - Summary of Stock Option Activity (Details) - USD ($) $ / shares in Units, $ in Thousands | 12 Months Ended | |||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | Dec. 31, 2017 | |
Number of Options (thousands) | ||||
Beginning balance (in shares) | 3,464,000 | 3,702,000 | 3,606,000 | |
Granted (in shares) | 0 | 382,000 | 307,000 | |
Forfeited and expired (in shares) | (155,000) | (83,000) | (39,000) | |
Exercised (in shares) | (452,000) | (537,000) | (172,000) | |
Ending balance (in shares) | 2,857,000 | 3,464,000 | 3,702,000 | 3,606,000 |
Options vested and exercisable (in shares) | 2,445,000 | |||
Options vested and expected to vest (in shares) | 2,831,000 | |||
Weighted-Average Exercise Price Per Option | ||||
Beginning balance (in dollars per share) | $ 41.19 | $ 38.89 | $ 37.69 | |
Granted (in dollars per share) | 46.92 | 51.83 | ||
Forfeited and expired (in dollars per share) | 48.30 | 48.92 | 45.59 | |
Exercised (in dollars per share) | 34.22 | 28.21 | 35.31 | |
Ending balance (in dollars per share) | 41.90 | $ 41.19 | $ 38.89 | $ 37.69 |
Options vested and exercisable, weighted-average exercise price (in dollars per share) | 40.92 | |||
Options vested and expected to vest, weighted-average exercise price (in dollars per share) | $ 41.85 | |||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] | ||||
Weighted average remaining contractual term (in years) | 4 years 4 months 24 days | 5 years | 5 years 3 months 18 days | 6 years |
Options vested and exercisable, weighted-average remaining contractual term (in years) | 3 years 9 months 18 days | |||
Options vested and expected to vest, weighted-average remaining contractual term (in years) | 4 years 3 months 18 days | |||
Beginning balance, aggregate intrinsic value | $ 44,696 | $ 27,846 | $ 50,130 | |
Exercised, aggregate intrinsic value | 5,117 | 11,690 | 3,143 | |
Ending balance, aggregate intrinsic value | 31,955 | $ 44,696 | $ 27,846 | $ 50,130 |
Options vested and exercisable, aggregate intrinsic value | 29,896 | |||
Options vested and expected to vest, aggregate intrinsic value | $ 31,829 | |||
Number of Options (thousands) | ||||
Forfeited and expired (in shares) | (155,000) | (83,000) | (39,000) | |
Nonvested Options | ||||
Number of Options (thousands) | ||||
Forfeited and expired (in shares) | (73,000) | |||
Number of Options (thousands) | ||||
Beginning balance (in shares) | 818,000 | |||
Vested (in shares) | (333,000) | |||
Forfeited and expired (in shares) | (73,000) | |||
Ending balance (in shares) | 412,000 | 818,000 | ||
Weighted-Average Grant-Date Fair Value | ||||
Beginning balance (in dollars per share) | $ 14.33 | |||
Vested during the year (in dollars per share) | 13.17 | |||
Forfeited during the year (in dollars per share) | 14.58 | |||
Ending balance (in dollars per share) | $ 15.22 | $ 14.33 |
Share-Based Payment Plans - Wei
Share-Based Payment Plans - Weighted Average Key Assumptions in Estimating Grant Date Fair Value of Options (Details) - $ / shares | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Fair value per share of underlying ordinary shares (in dollars per share) | $ 46.92 | $ 51.83 | |
Stock options | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Expected dividend yield | 0.00% | 0.00% | 0.00% |
Expected volatility | 25.00% | 25.00% | |
Risk-free interest rate | 2.35% | 2.62% | |
Expected term (years) | 6 years | 6 years |
Share-Based Payment Plans - Res
Share-Based Payment Plans - Restricted Securities Granted (Details) - $ / shares shares in Thousands | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Restricted Stock Without Performance Criteria | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Granted (in shares) | 806 | 298 | 218 |
Granted (in dollars per share) | $ 29.06 | $ 47.73 | $ 51.05 |
Restricted Securities With Performance Criteria | 0.0% to 150.0% | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Granted (in shares) | 0 | 76 | 63 |
Granted (in dollars per share) | $ 0 | $ 46.92 | $ 51.83 |
Threshold range, lower limit | 0.00% | ||
Threshold range, upper limit | 150.00% | ||
Restricted Securities With Performance Criteria | 0.0% to 172.5% | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Granted (in shares) | 401 | 138 | 118 |
Granted (in dollars per share) | $ 28.22 | $ 46.92 | $ 51.83 |
Threshold range, lower limit | 0.00% | ||
Threshold range, upper limit | 172.50% |
Share-Based Payment Plans - Out
Share-Based Payment Plans - Outstanding Restricted Securities (Details) - $ / shares shares in Thousands | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Restricted securities | |||
Restricted Securities | |||
Beginning balance (in shares) | 1,105 | 1,119 | 1,081 |
Granted (in shares) | 1,207 | 555 | 399 |
Forfeited (in shares) | (284) | (115) | (121) |
Vested (in shares) | (349) | (454) | (240) |
Ending balance (in shares) | 1,679 | 1,105 | 1,119 |
Weighted-Average Grant-Date Fair Value | |||
Beginning balance (in dollars per share) | $ 47.51 | $ 44.66 | $ 44.43 |
Granted (in dollars per share) | 28.78 | 46.73 | 51.40 |
Forfeited (in dollars per share) | 37.89 | 47.07 | 48.28 |
Vested (in dollars per share) | 43.54 | 39.62 | 53.01 |
Ending balance (in dollars per share) | $ 36.49 | $ 47.51 | $ 44.66 |
PRSU | |||
Weighted-Average Grant-Date Fair Value | |||
Shares available (in shares) | 43 |
Share-Based Payment Plans - Agg
Share-Based Payment Plans - Aggregate Intrinsic Value and Weighted-Average Remaining Periods On Restricted Stock (Details) - Restricted securities - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Outstanding, aggregate intrinsic value | $ 88,534 | $ 59,526 | $ 50,161 |
Expected to vest, aggregate intrinsic value | $ 58,675 | $ 34,717 | $ 44,203 |
Outstanding, weighted-average remaining period | 1 year 1 month 6 days | 1 year 1 month 6 days | 1 year 2 months 12 days |
Expected to vest, weighted-average remaining period | 1 year 1 month 6 days | 1 year | 1 year 2 months 12 days |
Share-Based Payment Plans - Sha
Share-Based Payment Plans - Share Based Compensation Expense (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Share-based Compensation Expense | $ 19,125 | $ 18,757 | $ 23,825 |
Unrecognized Compensation Expense | 27,223 | ||
Stock options | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Share-based Compensation Expense | 2,868 | 6,552 | 5,739 |
Unrecognized Compensation Expense | $ 5,280 | ||
Expected Recognition (years) | 1 year | ||
Restricted securities | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Share-based Compensation Expense | $ 16,257 | $ 12,205 | $ 18,086 |
Unrecognized Compensation Expense | $ 21,943 | ||
Expected Recognition (years) | 1 year 8 months 12 days |
Restructuring and Other Charg_3
Restructuring and Other Charges, Net - Additional Information (Details) $ in Thousands | 12 Months Ended | |
Dec. 31, 2020USD ($)position | Dec. 31, 2019USD ($) | |
Restructuring Cost and Reserve [Line Items] | ||
Number of positions eliminated | position | 880 | |
Charges, net of reversals | $ 26,866 | $ 29,240 |
Reduction In Force | Minimum | ||
Restructuring Cost and Reserve [Line Items] | ||
Charges, net of reversals | 31,000 | |
Reduction In Force | Maximum | ||
Restructuring Cost and Reserve [Line Items] | ||
Charges, net of reversals | 33,700 | |
Site Closures | Minimum | ||
Restructuring Cost and Reserve [Line Items] | ||
Charges, net of reversals | 8,000 | |
Site Closures | Maximum | ||
Restructuring Cost and Reserve [Line Items] | ||
Charges, net of reversals | $ 10,000 |
Restructuring and Other Charg_4
Restructuring and Other Charges, Net - Schedule of Restructuring and Other Charges, Net (Details) $ in Thousands | Jul. 06, 2020USD ($) | Feb. 14, 2020USD ($) | Sep. 30, 2020USD ($) | Jun. 30, 2020USD ($) | Mar. 31, 2020USD ($) | Dec. 31, 2020USD ($)position | Dec. 31, 2019USD ($) | Dec. 31, 2018USD ($) |
Restructuring Cost and Reserve [Line Items] | ||||||||
Number of positions eliminated | position | 880 | |||||||
Charges, net of reversals | $ 26,866 | $ 29,240 | ||||||
Facility and other exit costs | 1,323 | 808 | $ 877 | |||||
Gain on sale of valves business | 0 | 0 | (64,423) | |||||
Other | 4,271 | 23,512 | 8,162 | |||||
Restructuring and other charges, net | $ 33,094 | 53,560 | (47,818) | |||||
Voluntary retirement incentive program benefits | 12,700 | |||||||
Termination benefits on one-time incentive program | 6,500 | |||||||
Performance Sensing | ||||||||
Restructuring Cost and Reserve [Line Items] | ||||||||
Number of positions eliminated | position | 180 | |||||||
Sensing Solutions | ||||||||
Restructuring Cost and Reserve [Line Items] | ||||||||
Number of positions eliminated | position | 286 | |||||||
Corporate and other | ||||||||
Restructuring Cost and Reserve [Line Items] | ||||||||
Number of positions eliminated | position | 414 | |||||||
Reduction In Force | Minimum | ||||||||
Restructuring Cost and Reserve [Line Items] | ||||||||
Charges, net of reversals | $ 31,000 | |||||||
Reduction In Force | Maximum | ||||||||
Restructuring Cost and Reserve [Line Items] | ||||||||
Charges, net of reversals | 33,700 | |||||||
Reduction In Force | Performance Sensing | Minimum | ||||||||
Restructuring Cost and Reserve [Line Items] | ||||||||
Charges, net of reversals | 10,700 | |||||||
Reduction In Force | Performance Sensing | Maximum | ||||||||
Restructuring Cost and Reserve [Line Items] | ||||||||
Charges, net of reversals | 11,600 | |||||||
Reduction In Force | Sensing Solutions | Minimum | ||||||||
Restructuring Cost and Reserve [Line Items] | ||||||||
Charges, net of reversals | 8,900 | |||||||
Reduction In Force | Sensing Solutions | Maximum | ||||||||
Restructuring Cost and Reserve [Line Items] | ||||||||
Charges, net of reversals | 9,600 | |||||||
Reduction In Force | Corporate and other | Minimum | ||||||||
Restructuring Cost and Reserve [Line Items] | ||||||||
Charges, net of reversals | 11,400 | |||||||
Reduction In Force | Corporate and other | Maximum | ||||||||
Restructuring Cost and Reserve [Line Items] | ||||||||
Charges, net of reversals | 12,500 | |||||||
Site Closures | Minimum | ||||||||
Restructuring Cost and Reserve [Line Items] | ||||||||
Charges, net of reversals | 8,000 | |||||||
Site Closures | Maximum | ||||||||
Restructuring Cost and Reserve [Line Items] | ||||||||
Charges, net of reversals | 10,000 | |||||||
Site Closures | Performance Sensing | Minimum | ||||||||
Restructuring Cost and Reserve [Line Items] | ||||||||
Charges, net of reversals | 3,000 | |||||||
Site Closures | Performance Sensing | Maximum | ||||||||
Restructuring Cost and Reserve [Line Items] | ||||||||
Charges, net of reversals | 4,000 | |||||||
Site Closures | Sensing Solutions | Minimum | ||||||||
Restructuring Cost and Reserve [Line Items] | ||||||||
Charges, net of reversals | 5,000 | |||||||
Site Closures | Sensing Solutions | Maximum | ||||||||
Restructuring Cost and Reserve [Line Items] | ||||||||
Charges, net of reversals | 6,000 | |||||||
Site Closures | Corporate and other | Minimum | ||||||||
Restructuring Cost and Reserve [Line Items] | ||||||||
Charges, net of reversals | 0 | |||||||
Site Closures | Corporate and other | Maximum | ||||||||
Restructuring Cost and Reserve [Line Items] | ||||||||
Charges, net of reversals | 0 | |||||||
Q2 2020 Global Restructure Program | ||||||||
Restructuring Cost and Reserve [Line Items] | ||||||||
Charges, net of reversals | 24,458 | |||||||
Severance costs, net | $ 24,100 | 24,458 | 0 | 0 | ||||
Q2 2020 Global Restructure Program | Performance Sensing | ||||||||
Restructuring Cost and Reserve [Line Items] | ||||||||
Charges, net of reversals | 9,073 | |||||||
Q2 2020 Global Restructure Program | Sensing Solutions | ||||||||
Restructuring Cost and Reserve [Line Items] | ||||||||
Charges, net of reversals | 6,445 | |||||||
Q2 2020 Global Restructure Program | Corporate and other | ||||||||
Restructuring Cost and Reserve [Line Items] | ||||||||
Charges, net of reversals | 8,940 | |||||||
Q2 2020 Global Restructure Program | Site Closures | Sensing Solutions | ||||||||
Restructuring Cost and Reserve [Line Items] | ||||||||
Charges, net of reversals | 600 | |||||||
Other Restructuring Charges | ||||||||
Restructuring Cost and Reserve [Line Items] | ||||||||
Severance costs, net | 3,042 | 29,240 | 7,566 | |||||
Disposal Group, Disposed of by Sale, Not Discontinued Operations | Valves Business | ||||||||
Restructuring Cost and Reserve [Line Items] | ||||||||
Other | $ 5,900 | |||||||
Metal Seal Precision, Ltd. | ||||||||
Restructuring Cost and Reserve [Line Items] | ||||||||
Gain (loss) related to litigation settlement | $ (17,800) | |||||||
Wasica Finance Gmbh et al v. Schrader International Inc. | ||||||||
Restructuring Cost and Reserve [Line Items] | ||||||||
Gain (loss) related to litigation settlement | $ 11,700 | (12,100) | $ (29,200) | $ 11,700 | ||||
Litigation settlement, amount awarded to other party | $ 12,100 | $ 31,200 | $ 12,100 |
Restructuring and Other Charg_5
Restructuring and Other Charges, Net - Schedule of Restructuring Liabilities (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
Restructuring Reserve [Roll Forward] | ||
Restructuring reserve, beginning balance | $ 14,779 | $ 6,591 |
Charges, net of reversals | 26,866 | 29,240 |
Payments | (27,822) | (21,095) |
Foreign currency remeasurement | 1,056 | 43 |
Restructuring reserve, ending balance | 14,879 | 14,779 |
Q2 2020 Global Restructure Program | ||
Restructuring Reserve [Roll Forward] | ||
Charges, net of reversals | 24,458 | |
Employee Severance | Q2 2020 Global Restructure Program | ||
Restructuring Reserve [Roll Forward] | ||
Restructuring reserve, beginning balance | 0 | 0 |
Charges, net of reversals | 23,824 | 0 |
Payments | (13,853) | 0 |
Foreign currency remeasurement | 871 | 0 |
Restructuring reserve, ending balance | 10,842 | 0 |
Employee Severance | Other | ||
Restructuring Reserve [Roll Forward] | ||
Restructuring reserve, beginning balance | 14,779 | 6,591 |
Charges, net of reversals | 3,042 | 29,240 |
Payments | (13,969) | (21,095) |
Foreign currency remeasurement | 185 | 43 |
Restructuring reserve, ending balance | $ 4,037 | $ 14,779 |
Other, Net (Details)
Other, Net (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Other Income and Expenses [Abstract] | |||
Currency remeasurement (loss)/gain on net monetary assets | $ 10,833 | $ (6,802) | $ (18,905) |
(Loss)/gain on foreign currency forward contracts | (6,762) | 2,225 | |
(Loss)/gain on foreign currency forward contracts | 2,070 | ||
(Loss)/gain on commodity forward contracts | 10,027 | 4,888 | (8,481) |
Loss on debt financing | 0 | (4,364) | (2,350) |
Net periodic benefit cost, excluding service cost | (9,980) | (3,186) | (3,585) |
Other | (4,457) | (669) | 886 |
Other, net | $ (339) | $ (7,908) | $ (30,365) |
Income Taxes - Narrative (Detai
Income Taxes - Narrative (Details) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Income Tax Contingency [Line Items] | ||||
Intangible property transfers | $ 54,200 | $ 54,188 | $ 0 | $ 0 |
Research credit, tax benefit, prior period | $ 10,000 | |||
Valuation allowance | 202,101 | 202,101 | 146,775 | |
Decrease of unrecognized tax benefits | 56,800 | 56,800 | ||
Unrecognized tax benefits | 109,200 | 109,200 | ||
Intangible Property Transfer | ||||
Income Tax Contingency [Line Items] | ||||
Valuation allowance | 43,200 | $ 43,200 | ||
Minimum | ||||
Income Tax Contingency [Line Items] | ||||
Amortization period (in years) | 6 years | |||
Maximum | ||||
Income Tax Contingency [Line Items] | ||||
Amortization period (in years) | 20 years | |||
US Federal | ||||
Income Tax Contingency [Line Items] | ||||
Increase (decrease) in valuation allowance | $ 55,300 | $ (10,300) | ||
Operating loss carryforwards | 801,100 | 801,100 | ||
US Federal | 2028 to 2037 | ||||
Income Tax Contingency [Line Items] | ||||
Operating loss carryforwards | 446,600 | 446,600 | ||
US Federal | Unlimited | ||||
Income Tax Contingency [Line Items] | ||||
Operating loss carryforwards | 354,500 | 354,500 | ||
Interest expense carryforward | 339,100 | 339,100 | ||
Foreign Tax Authority | ||||
Income Tax Contingency [Line Items] | ||||
Operating loss carryforwards | $ 239,700 | $ 239,700 | ||
Changzhou, China Subsidiary | ||||
Income Tax Contingency [Line Items] | ||||
Reduced tax rate | 15.00% |
Income Taxes - Income Before Ta
Income Taxes - Income Before Taxes (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Income Tax Disclosure [Abstract] | |||
U.S. | $ (80,856) | $ 13,183 | $ 68,027 |
Non-U.S. | 246,497 | 377,240 | 458,348 |
Income before taxes | $ 165,641 | $ 390,423 | $ 526,375 |
Income Taxes - (Benefit from)_P
Income Taxes - (Benefit from)/Provision for Income Taxes (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
U.S. Federal | |||
U.S. Federal, Current | $ (2,624) | $ 5,643 | $ 5,700 |
U.S. Federal, Deferred | (14,776) | 9,687 | (109,663) |
U.S. Federal, Total | (17,400) | 15,330 | (103,963) |
Non-U.S. | |||
Non-U.S., Current | 48,572 | 73,947 | 64,666 |
Non-U.S., Deferred | (34,252) | 17,339 | (18,770) |
Non-U.S., Total | 14,320 | 91,286 | 45,896 |
U.S. State | |||
U.S. State, Current | 307 | 496 | 1,082 |
U.S. State, Deferred | 4,128 | 597 | (15,635) |
U.S. State, Total | 4,435 | 1,093 | (14,553) |
Total, Current | 46,255 | 80,086 | 71,448 |
Total, Deferred | (44,900) | 27,623 | (144,068) |
Provision for/(benefit from) income taxes | $ 1,355 | $ 107,709 | $ (72,620) |
Income Taxes - Effective Tax Ra
Income Taxes - Effective Tax Rate Reconciliation (Details) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Income Tax Disclosure [Abstract] | ||||
Tax computed at statutory rate of 21% | $ 34,785 | $ 81,989 | $ 110,539 | |
Intangible property transfers | $ (54,200) | (54,188) | 0 | 0 |
Reserve for tax exposure | (171) | 20,079 | 10,775 | |
Valuation allowances | 8,869 | 19,640 | (123,426) | |
Foreign tax rate differential | (21,994) | (19,107) | (41,200) | |
Withholding taxes not creditable | 12,198 | 9,509 | 8,734 | |
Change in tax laws or rates | 11,229 | 5,121 | (22,264) | |
Research and development incentives | (7,408) | (8,410) | (19,475) | |
U.S. state taxes, net of federal benefit | 3,504 | 863 | (11,499) | |
Unrealized foreign currency exchange losses/(gains), net | 2,650 | (43) | 11,346 | |
Nontaxable items and other | 11,881 | (1,932) | 3,850 | |
Provision for/(benefit from) income taxes | $ 1,355 | $ 107,709 | $ (72,620) |
Income Taxes - Deferred Income
Income Taxes - Deferred Income Tax Assets and Liabilities (Details) - USD ($) $ in Thousands | Dec. 31, 2020 | Dec. 31, 2019 |
Deferred tax assets: | ||
Net operating loss, interest expense, and other carryforwards | $ 342,689 | $ 283,094 |
Prepaid and accrued expenses | 67,221 | 67,143 |
Intangible assets and goodwill | 110,382 | 20,457 |
Pension liability and other | 14,241 | 7,158 |
Property, plant and equipment | 13,789 | 14,749 |
Share-based compensation | 9,609 | 10,288 |
Inventories and related reserves | 9,329 | 16,712 |
Unrealized exchange loss | 3,182 | 1,959 |
Total deferred tax assets | 570,442 | 421,560 |
Valuation allowance | (202,101) | (146,775) |
Net deferred tax asset | 368,341 | 274,785 |
Deferred tax liabilities: | ||
Intangible assets and goodwill | (480,082) | (440,009) |
Tax on undistributed earnings of subsidiaries | (35,254) | (31,636) |
Operating lease right of use assets | (11,324) | (12,522) |
Property, plant and equipment | (16,110) | (13,762) |
Unrealized exchange gain | (643) | (6,739) |
Total deferred tax liabilities | (543,413) | (504,668) |
Net deferred tax liability | $ (175,072) | $ (229,883) |
Income Taxes - Unrecognized Tax
Income Taxes - Unrecognized Tax Benefits (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] | |||
Unrecognized tax benefits, beginning of period | $ 117,591 | $ 89,609 | $ 59,884 |
Increases related to prior year tax positions | 43,082 | 15,356 | 14,609 |
Increases related to current year tax positions | 46,329 | 17,378 | 15,676 |
Increases related to business combinations | 0 | 450 | 1,000 |
Decreases related to prior year tax positions | (1,294) | (1,773) | (1,144) |
Changes related to foreign currency exchange rate | 1,337 | 173 | |
Changes related to foreign currency exchange rate | (416) | ||
Decreases related to lapse of applicable statute of limitations | (452) | (87) | 0 |
Decreases related to settlements with tax authorities | (5,183) | (3,515) | 0 |
Unrecognized tax benefits, end of period | $ 201,410 | $ 117,591 | $ 89,609 |
Income Taxes - Interest and Pen
Income Taxes - Interest and Penalties (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Statements of Operations | |||
Interest | $ 0.4 | $ 0.9 | $ (0.2) |
Penalties | 0.2 | (0.1) | $ (0.2) |
Balance Sheets | |||
Interest | 1.7 | 1.3 | |
Penalties | $ 0.4 | $ 0.3 |
Net Income Per Share - Weighted
Net Income Per Share - Weighted-average Ordinary Shares Outstanding for Basic and Diluted Net Income Per Share (Details) - shares shares in Thousands | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Weighted Average Number of Shares Outstanding, Diluted [Abstract] | |||
Basic weighted-average ordinary shares outstanding (in shares) | 157,373 | 160,946 | 168,570 |
Dilutive effect of stock options (in shares) | 275 | 600 | 822 |
Dilutive effect of unvested restricted securities (in shares) | 486 | 422 | 467 |
Diluted weighted-average ordinary shares outstanding (in shares) | 158,134 | 161,968 | 169,859 |
Net Income Per Share - Anti-dil
Net Income Per Share - Anti-dilutive Shares (Details) - shares shares in Thousands | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Anti-dilutive shares excluded | |||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |||
Shares excluded (in shares) | 1,575 | 1,170 | 930 |
Contingently issuable shares excluded | |||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |||
Shares excluded (in shares) | 995 | 641 | 687 |
Inventories (Details)
Inventories (Details) - USD ($) $ in Thousands | Dec. 31, 2020 | Dec. 31, 2019 |
Inventory, Net [Abstract] | ||
Finished goods | $ 170,488 | $ 197,531 |
Work-in-process | 87,006 | 104,007 |
Raw materials | 193,511 | 205,140 |
Inventories | $ 451,005 | $ 506,678 |
Property, Plant and Equipment_3
Property, Plant and Equipment, Net (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Property, Plant and Equipment, Net, by Type [Abstract] | |||
Total property, plant and equipment | $ 1,720,572 | $ 1,652,037 | |
Accumulated depreciation | (916,747) | (821,039) | |
Property, plant and equipment, net | 803,825 | 830,998 | |
Depreciation | 125,680 | 115,862 | $ 106,014 |
Land | |||
Property, Plant and Equipment, Net, by Type [Abstract] | |||
Total property, plant and equipment | 17,880 | 17,880 | |
Buildings and improvements | |||
Property, Plant and Equipment, Net, by Type [Abstract] | |||
Total property, plant and equipment | 273,899 | 266,864 | |
Machinery and equipment | |||
Property, Plant and Equipment, Net, by Type [Abstract] | |||
Total property, plant and equipment | $ 1,428,793 | $ 1,367,293 |
Property, Plant and Equipment_4
Property, Plant and Equipment, Net - Assets Under Finance Leases (Details) - USD ($) $ in Thousands | Dec. 31, 2020 | Dec. 31, 2019 |
Property, Plant and Equipment [Abstract] | ||
Assets under finance leases in property, plant and equipment | $ 49,714 | $ 49,714 |
Accumulated depreciation | 26,107 | 24,316 |
Assets under finance leases in property, plant and equipment, net | $ 23,607 | $ 25,398 |
Goodwill and Other Intangible_3
Goodwill and Other Intangible Assets, Net - Schedule of Changes in Goodwill (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Goodwill [Roll Forward] | |||
Net Goodwill, Beginning Balance | $ 3,093,598 | $ 3,081,302 | |
Net Goodwill, Ending Balance | 3,111,349 | 3,093,598 | |
In Process Research and Development | |||
Goodwill [Roll Forward] | |||
Indefinite-lived intangible assets acquired | 6,900 | ||
Performance Sensing | |||
Goodwill [Roll Forward] | |||
Net Goodwill, Beginning Balance | 2,172,020 | 2,155,633 | |
Net Goodwill, Ending Balance | 2,189,771 | 2,172,020 | |
Accumulated goodwill impairment | 0 | 0 | $ 0 |
Sensing Solutions | |||
Goodwill [Roll Forward] | |||
Net Goodwill, Beginning Balance | 921,578 | 925,669 | |
Net Goodwill, Ending Balance | 921,578 | 921,578 | |
Accumulated goodwill impairment | 18,500 | 18,500 | $ 18,500 |
GIGAVAC | |||
Goodwill [Roll Forward] | |||
Goodwill, acquired during the period | (177) | ||
GIGAVAC | Performance Sensing | |||
Goodwill [Roll Forward] | |||
Goodwill, acquired during the period | 16,387 | ||
GIGAVAC | Sensing Solutions | |||
Goodwill [Roll Forward] | |||
Goodwill, acquired during the period | (16,564) | ||
Other | |||
Goodwill [Roll Forward] | |||
Goodwill, acquired during the period | 17,751 | 12,473 | |
Other | Performance Sensing | |||
Goodwill [Roll Forward] | |||
Goodwill, acquired during the period | 17,751 | 0 | |
Other | Sensing Solutions | |||
Goodwill [Roll Forward] | |||
Goodwill, acquired during the period | $ 0 | $ 12,473 | |
Klixon and Airpax | |||
Goodwill [Roll Forward] | |||
Length of time in existence (in years) | 65 years | ||
Klixon | |||
Goodwill [Roll Forward] | |||
Tradenames | $ 59,100 | ||
Airpax | |||
Goodwill [Roll Forward] | |||
Tradenames | $ 9,400 |
Goodwill and Other Intangible_4
Goodwill and Other Intangible Assets, Net - Acquired Finite-Lived Intangible Assets (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Acquired Finite-Lived Intangible Assets [Line Items] | |||
Weighted- Average Life (years) | 12 years | 12 years | |
Gross Carrying Amount | $ 2,776,387 | $ 2,756,444 | |
Accumulated Amortization | (2,145,634) | (2,039,436) | |
Accumulated Impairment | (14,574) | (14,574) | |
Net Carrying Value | 616,179 | 702,434 | |
Amortization of intangible assets | 129,549 | $ 142,886 | $ 139,326 |
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract] | |||
2021 | 117,489 | ||
2022 | 104,101 | ||
2023 | 90,208 | ||
2024 | 73,544 | ||
2025 | $ 45,629 | ||
Completed technologies | |||
Acquired Finite-Lived Intangible Assets [Line Items] | |||
Weighted- Average Life (years) | 14 years | 14 years | |
Gross Carrying Amount | $ 781,508 | $ 770,608 | |
Accumulated Amortization | (578,178) | (529,926) | |
Accumulated Impairment | (2,430) | (2,430) | |
Net Carrying Value | $ 200,900 | $ 238,252 | |
Customer relationships | |||
Acquired Finite-Lived Intangible Assets [Line Items] | |||
Weighted- Average Life (years) | 11 years | 11 years | |
Gross Carrying Amount | $ 1,858,998 | $ 1,827,998 | |
Accumulated Amortization | (1,501,960) | (1,430,515) | |
Accumulated Impairment | (12,144) | (12,144) | |
Net Carrying Value | $ 344,894 | $ 385,339 | |
Non-compete agreements | |||
Acquired Finite-Lived Intangible Assets [Line Items] | |||
Weighted- Average Life (years) | 8 years | ||
Gross Carrying Amount | $ 23,400 | ||
Accumulated Amortization | (23,400) | ||
Accumulated Impairment | 0 | ||
Net Carrying Value | $ 0 | ||
Tradenames | |||
Acquired Finite-Lived Intangible Assets [Line Items] | |||
Weighted- Average Life (years) | 21 years | 21 years | |
Gross Carrying Amount | $ 66,654 | $ 66,654 | |
Accumulated Amortization | (19,816) | (16,598) | |
Accumulated Impairment | 0 | 0 | |
Net Carrying Value | $ 46,838 | $ 50,056 | |
Capitalized software and other | |||
Acquired Finite-Lived Intangible Assets [Line Items] | |||
Weighted- Average Life (years) | 7 years | 7 years | |
Gross Carrying Amount | $ 69,227 | $ 67,784 | |
Accumulated Amortization | (45,680) | (38,997) | |
Accumulated Impairment | 0 | 0 | |
Net Carrying Value | 23,547 | 28,787 | |
Capitalized software | 100 | 300 | |
Amortization of intangible assets | 6,634 | 6,799 | 7,091 |
Acquisition-related definite-lived intangible assets | |||
Acquired Finite-Lived Intangible Assets [Line Items] | |||
Amortization of intangible assets | $ 122,915 | $ 136,087 | $ 132,235 |
Accrued Expenses and Other Cu_3
Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands | Dec. 31, 2020 | Dec. 31, 2019 |
Accrued expenses and other current liabilities [Abstract] | ||
Accrued compensation and benefits | $ 85,140 | $ 52,394 |
Accrued interest | 53,630 | 42,803 |
Foreign currency and commodity forward contracts | 19,627 | 1,925 |
Accrued severance | 14,879 | 14,779 |
Current portion of operating lease liabilities | 11,389 | 11,543 |
Current portion of pension and post-retirement benefit obligations | 3,498 | 3,220 |
Other accrued expenses and current liabilities | 136,667 | 88,962 |
Accrued expenses and other current liabilities | $ 324,830 | $ 215,626 |
Pension and Other Post-Retire_3
Pension and Other Post-Retirement Benefits - Defined Benefit Pension Plans (Details) | 12 Months Ended |
Dec. 31, 2020 | |
Defined Benefit Pension Plans | |
Defined Benefit Plan Disclosure [Line Items] | |
Defined Benefit Plan, Determination of Benefits Calculation, Highest Consecutive Years of Compensation Used for Formula | 5 years |
Pension and Other Post-Retire_4
Pension and Other Post-Retirement Benefits - Defined Contribution Plans (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Defined Contribution Plan Disclosure [Line Items] | |||
Aggregate expense | $ 4.3 | $ 5.5 | $ 5.7 |
Pension Plan | United States | |||
Defined Contribution Plan Disclosure [Line Items] | |||
Percent of annual eligible earnings | 4.00% |
Pension and Other Post-Retire_5
Pension and Other Post-Retirement Benefits - Components of Net Periodic Benefit Costs (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Pension Plan | United States | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Service cost | $ 0 | $ 0 | $ 0 |
Interest cost | 762 | 1,483 | 1,473 |
Expected return on plan assets | (1,339) | (1,694) | (1,710) |
Amortization of net loss | 1,184 | 946 | 1,080 |
Amortization of net prior service (credit)/cost | 0 | 0 | 0 |
Loss on settlement | 5,026 | 565 | 1,047 |
Loss on curtailment | 0 | 0 | 0 |
Net periodic benefit cost/(credit) | 5,633 | 1,300 | 1,890 |
Pension Plan | Foreign Plan | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Service cost | 3,522 | 2,836 | 3,122 |
Interest cost | 1,466 | 1,344 | 1,310 |
Expected return on plan assets | (712) | (702) | (929) |
Amortization of net loss | 1,204 | 766 | 407 |
Amortization of net prior service (credit)/cost | 5 | 9 | 6 |
Loss on settlement | 2,712 | 1,572 | 1,461 |
Loss on curtailment | 0 | 0 | 891 |
Net periodic benefit cost/(credit) | 8,197 | 5,825 | 6,268 |
Postemployment Retirement Benefits | United States | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Service cost | 10 | 7 | 50 |
Interest cost | 155 | 203 | 272 |
Expected return on plan assets | 0 | 0 | 0 |
Amortization of net loss | 16 | 0 | 5 |
Amortization of net prior service (credit)/cost | (1,029) | (1,306) | (1,728) |
Loss on settlement | 0 | 0 | 0 |
Loss on curtailment | 530 | 0 | 0 |
Net periodic benefit cost/(credit) | $ (318) | $ (1,096) | $ (1,401) |
Pension and Other Post-Retire_6
Pension and Other Post-Retirement Benefits - Change in Benefit Obligation and Plan Assets (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Pension Plan | United States | |||
Change in benefit obligation: | |||
Beginning balance | $ 45,548 | $ 45,169 | |
Service cost | 0 | 0 | $ 0 |
Interest cost | 762 | 1,483 | 1,473 |
Plan participants’ contributions | 0 | 0 | |
Actuarial loss/(gain) | 7,526 | 1,711 | |
Curtailment loss | 0 | 0 | |
Benefits paid | (17,568) | (2,815) | |
Foreign currency remeasurement | 0 | 0 | |
Ending balance | 36,268 | 45,548 | 45,169 |
Change in plan assets: | |||
Beginning balance | 44,870 | 39,875 | |
Actual return on plan assets | 2,333 | 4,484 | |
Employer contributions | 19 | 3,326 | |
Plan participants’ contributions | 0 | 0 | |
Benefits paid | (17,568) | (2,815) | |
Foreign currency remeasurement | 0 | 0 | |
Ending balance | 29,654 | 44,870 | 39,875 |
Funded status at end of year | (6,614) | (678) | |
Accumulated benefit obligation at end of year | 36,268 | 45,548 | |
Pension Plan | Foreign Plan | |||
Change in benefit obligation: | |||
Beginning balance | 74,172 | 65,691 | |
Service cost | 3,522 | 2,836 | 3,122 |
Interest cost | 1,466 | 1,344 | 1,310 |
Plan participants’ contributions | 35 | 31 | |
Actuarial loss/(gain) | 13,006 | 9,344 | |
Curtailment loss | 0 | 0 | |
Benefits paid | (8,507) | (5,235) | |
Foreign currency remeasurement | 4,618 | 161 | |
Ending balance | 88,312 | 74,172 | 65,691 |
Change in plan assets: | |||
Beginning balance | 43,906 | 39,868 | |
Actual return on plan assets | 2,071 | 4,125 | |
Employer contributions | 7,714 | 4,889 | |
Plan participants’ contributions | 35 | 31 | |
Benefits paid | (8,507) | (5,235) | |
Foreign currency remeasurement | 3,254 | 228 | |
Ending balance | 48,473 | 43,906 | 39,868 |
Funded status at end of year | (39,839) | (30,266) | |
Accumulated benefit obligation at end of year | 77,886 | 65,633 | |
Postemployment Retirement Benefits | United States | |||
Change in benefit obligation: | |||
Beginning balance | 5,588 | 6,017 | |
Service cost | 10 | 7 | |
Interest cost | 155 | 203 | |
Plan participants’ contributions | 696 | 474 | |
Actuarial loss/(gain) | (1,213) | (92) | |
Curtailment loss | 530 | 0 | |
Benefits paid | (719) | (1,021) | |
Foreign currency remeasurement | 0 | 0 | |
Ending balance | 5,047 | 5,588 | 6,017 |
Change in plan assets: | |||
Beginning balance | 0 | 0 | |
Actual return on plan assets | 0 | 0 | |
Employer contributions | 23 | 547 | |
Plan participants’ contributions | 696 | 474 | |
Benefits paid | (719) | (1,021) | |
Foreign currency remeasurement | 0 | 0 | |
Ending balance | 0 | 0 | $ 0 |
Funded status at end of year | $ (5,047) | $ (5,588) |
Pension and Other Post-Retire_7
Pension and Other Post-Retirement Benefits - Funded Status Amounts Recognized on Balance Sheets (Details) - USD ($) $ in Thousands | Dec. 31, 2020 | Dec. 31, 2019 |
Defined Benefit Plan Disclosure [Line Items] | ||
Current liabilities | $ (3,498) | $ (3,220) |
Noncurrent liabilities | (48,002) | (36,100) |
Pension Plan | United States | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Noncurrent assets | 0 | 2,788 |
Current liabilities | (1,091) | (952) |
Noncurrent liabilities | (5,523) | (2,514) |
Funded status | (6,614) | (678) |
Pension Plan | Foreign Plan | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Noncurrent assets | 0 | 0 |
Current liabilities | (1,821) | (1,551) |
Noncurrent liabilities | (38,018) | (28,715) |
Funded status | (39,839) | (30,266) |
Postemployment Retirement Benefits | United States | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Noncurrent assets | 0 | 0 |
Current liabilities | (586) | (717) |
Noncurrent liabilities | (4,461) | (4,871) |
Funded status | $ (5,047) | $ (5,588) |
Pension and Other Post-Retire_8
Pension and Other Post-Retirement Benefits - Balances Included within Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Thousands | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 |
Pension Plan | United States | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Net prior service cost/(credit) | $ 0 | $ 0 | $ 0 |
Net loss | 19,026 | 18,780 | 20,759 |
Pension Plan | Foreign Plan | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Net prior service cost/(credit) | (20) | (16) | (10) |
Net loss | 22,833 | 17,151 | 14,425 |
Postemployment Retirement Benefits | United States | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Net prior service cost/(credit) | 1,094 | 306 | (692) |
Net loss | $ (131) | $ 809 | $ 880 |
Pension and Other Post-Retire_9
Pension and Other Post-Retirement Benefits - Accumulated and Projected Benefit Obligation (Details) - Pension Plan - USD ($) $ in Thousands | Dec. 31, 2020 | Dec. 31, 2019 |
United States | ||
Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets [Abstract] | ||
Projected benefit obligation | $ 36,268 | $ 3,465 |
Accumulated benefit obligation | 36,268 | 3,465 |
Plan assets | 29,654 | 0 |
Defined Benefit Plan, Pension Plan with Project Benefit Obligation in Excess of Plan Assets [Abstract] | ||
Projected benefit obligation | 41,315 | 9,053 |
Plan assets | 29,654 | 0 |
Foreign Plan | ||
Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets [Abstract] | ||
Projected benefit obligation | 88,312 | 74,020 |
Accumulated benefit obligation | 77,886 | 65,633 |
Plan assets | 48,473 | 43,754 |
Defined Benefit Plan, Pension Plan with Project Benefit Obligation in Excess of Plan Assets [Abstract] | ||
Projected benefit obligation | 88,312 | 74,020 |
Plan assets | $ 48,473 | $ 43,754 |
Pension and Other Post-Retir_10
Pension and Other Post-Retirement Benefits - Other Changes in Plan Assets and Benefit Obligations (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total in other comprehensive (income)/loss | $ 5,772 | $ 1,668 | $ 377 |
Pension Plan | United States | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Net (gain)/loss | 4,997 | (824) | 2,002 |
Amortization of net loss | (906) | (723) | (1,080) |
Amortization of net prior service credit/(cost) | 0 | 0 | 0 |
Divestiture | 0 | 0 | 0 |
Plan amendment | 0 | 0 | 0 |
Settlement effect | (3,845) | (432) | (1,047) |
Curtailment effect | 0 | 0 | 0 |
Total in other comprehensive (income)/loss | 246 | (1,979) | (125) |
Pension Plan | Foreign Plan | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Net (gain)/loss | 8,425 | 4,365 | 3,669 |
Amortization of net loss | (839) | (539) | (298) |
Amortization of net prior service credit/(cost) | (4) | (6) | (4) |
Divestiture | 0 | 0 | (228) |
Plan amendment | 0 | 0 | 0 |
Settlement effect | (1,904) | (1,100) | (1,023) |
Curtailment effect | 0 | 0 | 30 |
Total in other comprehensive (income)/loss | 5,678 | 2,720 | 2,146 |
Postemployment Retirement Benefits | United States | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Net (gain)/loss | (928) | (71) | (124) |
Amortization of net loss | (12) | 0 | (5) |
Amortization of net prior service credit/(cost) | 562 | 998 | 1,728 |
Divestiture | 0 | 0 | 0 |
Plan amendment | 0 | 0 | (3,243) |
Settlement effect | 0 | 0 | 0 |
Curtailment effect | 226 | 0 | 0 |
Total in other comprehensive (income)/loss | $ (152) | $ 927 | $ (1,644) |
Pension and Other Post-Retir_11
Pension and Other Post-Retirement Benefits - Assumptions and Investment Policies and Plan Assets (Details) - USD ($) $ in Thousands | 12 Months Ended | |||||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Defined Benefit Plan, Information about Plan Assets [Abstract] | ||||||
Target allocation | 40.00% | |||||
Defined Benefit | Fair Value, Inputs, Level 2 | ||||||
Defined Benefit Plan, Information about Plan Assets [Abstract] | ||||||
Plan assets | $ 300 | $ 300 | $ 300 | $ 300 | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||||
Beginning balance | 300 | |||||
Ending balance | $ 300 | $ 300 | ||||
Defined Benefit | United States | ||||||
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract] | ||||||
Discount rate | 1.65% | 2.60% | ||||
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract] | ||||||
Discount rate | 2.60% | 3.79% | 3.45% | |||
Long-term rate of return on plan assets | 4.29% | 4.53% | 4.57% | |||
Defined Benefit Plan, Expected Future Benefit Payment [Abstract] | ||||||
2021 | $ 12,177 | |||||
2022 | 3,378 | |||||
2023 | 4,221 | |||||
2024 | 2,548 | |||||
2025 | 2,506 | |||||
2026 - 2030 | 7,928 | |||||
Defined Benefit Plan, Information about Plan Assets [Abstract] | ||||||
Plan assets | $ 29,654 | $ 39,875 | $ 39,875 | 29,654 | $ 44,870 | $ 39,875 |
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||||
Beginning balance | 44,870 | 39,875 | ||||
Ending balance | 29,654 | 44,870 | $ 39,875 | |||
Defined Benefit | United States | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||||||
Defined Benefit Plan, Information about Plan Assets [Abstract] | ||||||
Plan assets | 44,870 | 44,870 | $ 29,654 | 44,870 | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||||
Beginning balance | 44,870 | |||||
Ending balance | 29,654 | 44,870 | ||||
Defined Benefit | United States | U.S. large cap equity | ||||||
Defined Benefit Plan, Information about Plan Assets [Abstract] | ||||||
Target allocation | 7.00% | |||||
Actual allocation | 9.00% | |||||
Defined Benefit | United States | U.S. large cap equity | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||||||
Defined Benefit Plan, Information about Plan Assets [Abstract] | ||||||
Plan assets | 2,221 | 2,221 | $ 2,548 | 2,221 | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||||
Beginning balance | 2,221 | |||||
Ending balance | 2,548 | 2,221 | ||||
Defined Benefit | United States | U.S. small / mid cap equity | ||||||
Defined Benefit Plan, Information about Plan Assets [Abstract] | ||||||
Target allocation | 2.00% | |||||
Actual allocation | 2.00% | |||||
Defined Benefit | United States | U.S. small / mid cap equity | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||||||
Defined Benefit Plan, Information about Plan Assets [Abstract] | ||||||
Plan assets | 637 | 637 | $ 706 | 637 | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||||
Beginning balance | 637 | |||||
Ending balance | 706 | 637 | ||||
Defined Benefit | United States | Globally managed volatility fund | ||||||
Defined Benefit Plan, Information about Plan Assets [Abstract] | ||||||
Target allocation | 3.00% | |||||
Actual allocation | 3.00% | |||||
Defined Benefit | United States | Globally managed volatility fund | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||||||
Defined Benefit Plan, Information about Plan Assets [Abstract] | ||||||
Plan assets | 849 | 849 | $ 826 | 849 | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||||
Beginning balance | 849 | |||||
Ending balance | 826 | 849 | ||||
Defined Benefit | United States | International (non-U.S.) equity | ||||||
Defined Benefit Plan, Information about Plan Assets [Abstract] | ||||||
Target allocation | 4.00% | |||||
Actual allocation | 5.00% | |||||
Defined Benefit | United States | International (non-U.S.) equity | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||||||
Defined Benefit Plan, Information about Plan Assets [Abstract] | ||||||
Plan assets | 1,195 | 1,195 | $ 1,362 | 1,195 | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||||
Beginning balance | 1,195 | |||||
Ending balance | 1,362 | 1,195 | ||||
Defined Benefit | United States | Equity securities | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||||||
Defined Benefit Plan, Information about Plan Assets [Abstract] | ||||||
Plan assets | 4,902 | 4,902 | $ 5,442 | 4,902 | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||||
Beginning balance | 4,902 | |||||
Ending balance | 5,442 | 4,902 | ||||
Defined Benefit | United States | Fixed income (U.S. investment grade) | ||||||
Defined Benefit Plan, Information about Plan Assets [Abstract] | ||||||
Target allocation | 68.00% | |||||
Actual allocation | 70.00% | |||||
Defined Benefit | United States | Fixed income (U.S. investment grade) | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||||||
Defined Benefit Plan, Information about Plan Assets [Abstract] | ||||||
Plan assets | 18,830 | 18,830 | $ 20,801 | 18,830 | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||||
Beginning balance | 18,830 | |||||
Ending balance | 20,801 | 18,830 | ||||
Defined Benefit | United States | High-yield fixed income | ||||||
Defined Benefit Plan, Information about Plan Assets [Abstract] | ||||||
Target allocation | 2.00% | |||||
Actual allocation | 2.00% | |||||
Defined Benefit | United States | High-yield fixed income | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||||||
Defined Benefit Plan, Information about Plan Assets [Abstract] | ||||||
Plan assets | 561 | 561 | $ 594 | 561 | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||||
Beginning balance | 561 | |||||
Ending balance | 594 | 561 | ||||
Defined Benefit | United States | International (non-U.S.) fixed income | ||||||
Defined Benefit Plan, Information about Plan Assets [Abstract] | ||||||
Target allocation | 1.00% | |||||
Actual allocation | 1.00% | |||||
Defined Benefit | United States | International (non-U.S.) fixed income | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||||||
Defined Benefit Plan, Information about Plan Assets [Abstract] | ||||||
Plan assets | 264 | 264 | $ 277 | 264 | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||||
Beginning balance | 264 | |||||
Ending balance | 277 | 264 | ||||
Defined Benefit | United States | Fixed income funds | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||||||
Defined Benefit Plan, Information about Plan Assets [Abstract] | ||||||
Plan assets | 19,655 | 19,655 | $ 21,672 | 19,655 | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||||
Beginning balance | 19,655 | |||||
Ending balance | 21,672 | 19,655 | ||||
Defined Benefit | United States | Money market funds | ||||||
Defined Benefit Plan, Information about Plan Assets [Abstract] | ||||||
Target allocation | 13.00% | |||||
Actual allocation | 9.00% | |||||
Defined Benefit | United States | Money market funds | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||||||
Defined Benefit Plan, Information about Plan Assets [Abstract] | ||||||
Plan assets | 20,313 | 20,313 | $ 2,540 | $ 20,313 | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||||
Beginning balance | 20,313 | |||||
Ending balance | $ 2,540 | $ 20,313 | ||||
Defined Benefit | Foreign Plan | ||||||
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract] | ||||||
Discount rate | 1.97% | 1.90% | ||||
Non-U.S. average long-term pay progression | 2.93% | 2.87% | ||||
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract] | ||||||
Discount rate | 5.53% | 5.76% | 5.87% | |||
Long-term rate of return on plan assets | 1.61% | 1.77% | 2.26% | |||
Non-U.S. average long-term pay progression | 4.83% | 4.43% | 4.82% | |||
Defined Benefit Plan, Expected Future Benefit Payment [Abstract] | ||||||
2021 | $ 3,546 | |||||
2022 | 3,809 | |||||
2023 | 3,777 | |||||
2024 | 3,766 | |||||
2025 | 4,639 | |||||
2026 - 2030 | 24,768 | |||||
Defined Benefit Plan, Information about Plan Assets [Abstract] | ||||||
Plan assets | $ 48,473 | $ 39,868 | $ 39,868 | 48,473 | $ 43,906 | 39,868 |
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||||
Beginning balance | 43,906 | 39,868 | ||||
Ending balance | 48,473 | 43,906 | 39,868 | |||
Defined Benefit | Japan | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||||||
Defined Benefit Plan, Information about Plan Assets [Abstract] | ||||||
Plan assets | 32,033 | 32,033 | $ 33,486 | 32,033 | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||||
Beginning balance | 32,033 | |||||
Ending balance | 33,486 | 32,033 | ||||
Defined Benefit | Japan | Equity securities | ||||||
Defined Benefit Plan, Information about Plan Assets [Abstract] | ||||||
Actual allocation | 28.00% | |||||
Defined Benefit | Japan | Equity securities | Minimum | ||||||
Defined Benefit Plan, Information about Plan Assets [Abstract] | ||||||
Target allocation | 10.00% | |||||
Defined Benefit | Japan | Equity securities | Maximum | ||||||
Defined Benefit Plan, Information about Plan Assets [Abstract] | ||||||
Target allocation | 90.00% | |||||
Defined Benefit | Japan | Equity securities | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||||||
Defined Benefit Plan, Information about Plan Assets [Abstract] | ||||||
Plan assets | 8,756 | 8,756 | $ 9,460 | 8,756 | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||||
Beginning balance | 8,756 | |||||
Ending balance | 9,460 | 8,756 | ||||
Defined Benefit | Japan | Fixed income (U.S. investment grade) | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||||||
Defined Benefit Plan, Information about Plan Assets [Abstract] | ||||||
Plan assets | 3,835 | 3,835 | 3,091 | 3,835 | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||||
Beginning balance | 3,835 | |||||
Ending balance | 3,091 | 3,835 | ||||
Defined Benefit | Japan | International (non-U.S.) fixed income | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||||||
Defined Benefit Plan, Information about Plan Assets [Abstract] | ||||||
Plan assets | 9,716 | 9,716 | $ 11,142 | 9,716 | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||||
Beginning balance | 9,716 | |||||
Ending balance | 11,142 | 9,716 | ||||
Defined Benefit | Japan | Fixed income funds | ||||||
Defined Benefit Plan, Information about Plan Assets [Abstract] | ||||||
Actual allocation | 72.00% | |||||
Defined Benefit | Japan | Fixed income funds | Minimum | ||||||
Defined Benefit Plan, Information about Plan Assets [Abstract] | ||||||
Target allocation | 10.00% | |||||
Defined Benefit | Japan | Fixed income funds | Maximum | ||||||
Defined Benefit Plan, Information about Plan Assets [Abstract] | ||||||
Target allocation | 90.00% | |||||
Defined Benefit | Japan | Fixed income funds | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||||||
Defined Benefit Plan, Information about Plan Assets [Abstract] | ||||||
Plan assets | 13,551 | 13,551 | $ 14,233 | 13,551 | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||||
Beginning balance | 13,551 | |||||
Ending balance | 14,233 | 13,551 | ||||
Defined Benefit | Japan | Cash and cash equivalents | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||||||
Defined Benefit Plan, Information about Plan Assets [Abstract] | ||||||
Plan assets | 9,726 | 9,726 | 9,793 | 9,726 | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||||
Beginning balance | 9,726 | |||||
Ending balance | 9,793 | 9,726 | ||||
Defined Benefit | Japan | U.S. equity | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||||||
Defined Benefit Plan, Information about Plan Assets [Abstract] | ||||||
Plan assets | 2,413 | 2,413 | 2,736 | 2,413 | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||||
Beginning balance | 2,413 | |||||
Ending balance | 2,736 | 2,413 | ||||
Defined Benefit | Japan | International (non-U.S.) equity | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||||||
Defined Benefit Plan, Information about Plan Assets [Abstract] | ||||||
Plan assets | 6,343 | 6,343 | 6,724 | 6,343 | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||||
Beginning balance | 6,343 | |||||
Ending balance | 6,724 | 6,343 | ||||
Defined Benefit | Netherlands | Significant Unobservable Inputs (Level 3) | ||||||
Defined Benefit Plan, Information about Plan Assets [Abstract] | ||||||
Plan assets | 12,905 | 10,472 | 8,897 | 12,905 | 10,472 | $ 8,897 |
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||||
Beginning balance | 10,472 | 8,897 | ||||
Actual return on plan assets still held at reporting date | 1,373 | 1,821 | ||||
Purchases, sales, settlements, and exchange rate changes | 1,060 | (246) | ||||
Ending balance | 12,905 | 10,472 | $ 8,897 | |||
Defined Benefit | Netherlands | Insurance policies | Significant Unobservable Inputs (Level 3) | ||||||
Defined Benefit Plan, Information about Plan Assets [Abstract] | ||||||
Plan assets | 10,472 | 10,472 | 12,905 | 10,472 | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||||
Beginning balance | 10,472 | |||||
Ending balance | 12,905 | 10,472 | ||||
Defined Benefit | Belgium | Significant Unobservable Inputs (Level 3) | ||||||
Defined Benefit Plan, Information about Plan Assets [Abstract] | ||||||
Plan assets | 1,300 | 1,300 | $ 1,500 | $ 1,300 | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||||
Beginning balance | 1,300 | |||||
Ending balance | $ 1,500 | $ 1,300 | ||||
Retiree Healthcare | ||||||
Defined Benefit Plan, Assumed Health Care Cost Trend Rates [Abstract] | ||||||
Ultimate trend rate | 4.50% | 4.50% | 4.50% | |||
Retiree Healthcare | Attributed to less than age 65 | ||||||
Defined Benefit Plan, Assumed Health Care Cost Trend Rates [Abstract] | ||||||
Assumed healthcare trend rate for next year: | 6.00% | 6.30% | 6.60% | |||
Year in which ultimate trend rate is reached: | 2038 | 2038 | 2038 | |||
Retiree Healthcare | Attributed to age 65 or greater | ||||||
Defined Benefit Plan, Assumed Health Care Cost Trend Rates [Abstract] | ||||||
Assumed healthcare trend rate for next year: | 6.30% | 6.70% | 7.10% | |||
Year in which ultimate trend rate is reached: | 2038 | 2038 | 2038 | |||
Retiree Healthcare | United States | ||||||
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract] | ||||||
Discount rate | 1.80% | 2.80% | ||||
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract] | ||||||
Discount rate | 2.80% | 3.90% | 3.10% | |||
Defined Benefit Plan, Expected Future Benefit Payment [Abstract] | ||||||
2021 | $ 586 | |||||
2022 | 561 | |||||
2023 | 487 | |||||
2024 | 460 | |||||
2025 | 415 | |||||
2026 - 2030 | 1,463 | |||||
Defined Benefit Plan, Information about Plan Assets [Abstract] | ||||||
Plan assets | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 |
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||||
Beginning balance | 0 | 0 | ||||
Ending balance | $ 0 | $ 0 | $ 0 | |||
Fixed Income Securities | ||||||
Defined Benefit Plan, Information about Plan Assets [Abstract] | ||||||
Target allocation | 50.00% | |||||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||||
Defined benefit plan asset allocation percentage | 83.00% | |||||
Equity Securities | ||||||
Defined Benefit Plan, Information about Plan Assets [Abstract] | ||||||
Target allocation | 50.00% | |||||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||||
Defined benefit plan asset allocation percentage | 17.00% |
Debt - Schedule of Long-Term De
Debt - Schedule of Long-Term Debt (Details) - USD ($) $ in Thousands | Dec. 31, 2020 | Dec. 31, 2019 | Sep. 20, 2019 | Sep. 19, 2019 |
Debt Instrument [Line Items] | ||||
Long-term debt | $ 4,006,096 | |||
Less: debt discount | (9,605) | $ (11,758) | ||
Less: deferred financing costs | (28,114) | (24,452) | ||
Less: current portion | (754,630) | (4,630) | ||
Long-term debt, net | 3,213,747 | 3,219,885 | ||
Finance lease and other financing obligations | 30,506 | 31,098 | ||
Less: current portion | (2,575) | (2,288) | ||
Finance lease and other financing obligations, less current portion | 27,931 | 28,810 | ||
Original Term Loans | ||||
Debt Instrument [Line Items] | ||||
Long-term debt | $ 456,096 | 460,725 | ||
Senior Notes | 4.875% Senior Notes | ||||
Debt Instrument [Line Items] | ||||
Debt instrument, interest rate, stated percentage | 4.875% | 4.875% | ||
Long-term debt | $ 500,000 | 500,000 | $ 500,000 | |
Senior Notes | 5.625% Senior Notes | ||||
Debt Instrument [Line Items] | ||||
Debt instrument, interest rate, stated percentage | 5.625% | 5.625% | ||
Long-term debt | $ 400,000 | 400,000 | 400,000 | |
Senior Notes | 5.000% Senior Notes | ||||
Debt Instrument [Line Items] | ||||
Debt instrument, interest rate, stated percentage | 5.00% | 5.00% | ||
Long-term debt | $ 700,000 | 700,000 | 700,000 | |
Senior Notes | 6.25% Senior Notes | ||||
Debt Instrument [Line Items] | ||||
Debt instrument, interest rate, stated percentage | 6.25% | 6.25% | ||
Long-term debt | $ 750,000 | 750,000 | $ 750,000 | |
Senior Notes | 4.375% Senior Notes | ||||
Debt Instrument [Line Items] | ||||
Debt instrument, interest rate, stated percentage | 4.375% | |||
Long-term debt | $ 450,000 | 450,000 | ||
Senior Notes | 3.75% Senior Notes | ||||
Debt Instrument [Line Items] | ||||
Debt instrument, interest rate, stated percentage | 3.75% | |||
Long-term debt | $ 750,000 | $ 0 |
Debt - Credit Facilities (Detai
Debt - Credit Facilities (Details) | Mar. 05, 2021 | Apr. 01, 2020USD ($) | Sep. 20, 2019USD ($) | Dec. 31, 2020USD ($) | Aug. 17, 2020USD ($) | Dec. 31, 2019USD ($) | Sep. 19, 2019USD ($) | Mar. 27, 2019 | Mar. 26, 2019 |
Debt Instrument [Line Items] | |||||||||
Outstanding borrowings | $ 4,006,096,000 | ||||||||
Original Term Loans | |||||||||
Debt Instrument [Line Items] | |||||||||
Outstanding borrowings | $ 456,096,000 | $ 460,725,000 | |||||||
Amortization percent of principal | 1.00% | ||||||||
Base Rate Loans | |||||||||
Debt Instrument [Line Items] | |||||||||
Basis spread | 0.75% | ||||||||
Base interest rate | 1.00% | ||||||||
Eurodollar Rate Loans | |||||||||
Debt Instrument [Line Items] | |||||||||
Basis spread | 1.75% | ||||||||
Base interest rate | 0.00% | ||||||||
Term loan rate, accrued interest | 1.90% | ||||||||
3.750% Senior Notes | |||||||||
Debt Instrument [Line Items] | |||||||||
Interest rate | 3.75% | ||||||||
Face amount | $ 750,000,000 | ||||||||
Leverage Ratio Achievement Scenario Two | Maximum | |||||||||
Debt Instrument [Line Items] | |||||||||
Commitment fee percent | 1.375% | ||||||||
Revolving Credit Facility | Base Rate Loans | Minimum | |||||||||
Debt Instrument [Line Items] | |||||||||
Basis spread | 0.00% | ||||||||
Revolving Credit Facility | Base Rate Loans | Maximum | |||||||||
Debt Instrument [Line Items] | |||||||||
Basis spread | 0.50% | ||||||||
Revolving Credit Facility | Eurodollar Rate Loans | Minimum | |||||||||
Debt Instrument [Line Items] | |||||||||
Basis spread | 1.00% | ||||||||
Revolving Credit Facility | Eurodollar Rate Loans | Maximum | |||||||||
Debt Instrument [Line Items] | |||||||||
Basis spread | 1.50% | ||||||||
Letter of Credit | Leverage Ratio Achievement Scenario One | Minimum | |||||||||
Debt Instrument [Line Items] | |||||||||
Commitment fee percent | 0.875% | ||||||||
Line of Credit | Revolving Credit Facility | |||||||||
Debt Instrument [Line Items] | |||||||||
Financial covenant | 0.20 | 0.10 | |||||||
Line of Credit | Amendment to Credit Agreement | |||||||||
Debt Instrument [Line Items] | |||||||||
Line of credit facility, periodic payment | $ 50,000,000 | ||||||||
Line of Credit | Revolving Credit Facility | |||||||||
Debt Instrument [Line Items] | |||||||||
Outstanding borrowings | $ 0 | 0 | |||||||
Maximum borrowing capacity | $ 420,000,000 | ||||||||
Remaining borrowing capacity | 416,100,000 | ||||||||
Letters of credit outstanding | $ 3,900,000 | ||||||||
Proceeds from Lines of Credit | $ 400,000,000 | ||||||||
Line of Credit | Revolving Credit Facility | Minimum | |||||||||
Debt Instrument [Line Items] | |||||||||
Commitment fee on unused portion | 0.125% | ||||||||
Line of Credit | Revolving Credit Facility | Maximum | |||||||||
Debt Instrument [Line Items] | |||||||||
Commitment fee on unused portion | 0.25% | ||||||||
Line of Credit | Letter of Credit | |||||||||
Debt Instrument [Line Items] | |||||||||
Letters of credit outstanding | $ 0 | ||||||||
Senior Notes | 6.25% Senior Notes | |||||||||
Debt Instrument [Line Items] | |||||||||
Outstanding borrowings | $ 750,000,000 | $ 750,000,000 | $ 750,000,000 | ||||||
Interest rate | 6.25% | 6.25% | |||||||
Senior Notes | 6.25% Senior Notes | Forecast | |||||||||
Debt Instrument [Line Items] | |||||||||
Redemption price percent | 103.125% |
Debt - Senior Notes (Details)
Debt - Senior Notes (Details) - USD ($) $ in Thousands | Sep. 20, 2019 | Dec. 31, 2020 | Aug. 17, 2020 | Dec. 31, 2019 | Sep. 19, 2019 |
Debt Instrument [Line Items] | |||||
Long-term debt, gross | $ 4,006,096 | ||||
3.750% Senior Notes | |||||
Debt Instrument [Line Items] | |||||
Interest rate | 3.75% | ||||
Senior Notes | |||||
Debt Instrument [Line Items] | |||||
Debt instrument, redemption price, percentage offered on change of control | 101.00% | ||||
Percent of holders | 25.00% | ||||
Senior Notes | 4.875% Senior Notes | |||||
Debt Instrument [Line Items] | |||||
Long-term debt, gross | $ 500,000 | $ 500,000 | $ 500,000 | ||
Interest rate | 4.875% | 4.875% | |||
Senior Notes | 5.625% Senior Notes | |||||
Debt Instrument [Line Items] | |||||
Long-term debt, gross | $ 400,000 | 400,000 | 400,000 | ||
Interest rate | 5.625% | 5.625% | |||
Senior Notes | 5.000% Senior Notes | |||||
Debt Instrument [Line Items] | |||||
Long-term debt, gross | $ 700,000 | 700,000 | 700,000 | ||
Interest rate | 5.00% | 5.00% | |||
Senior Notes | 6.25% Senior Notes | |||||
Debt Instrument [Line Items] | |||||
Long-term debt, gross | $ 750,000 | $ 750,000 | $ 750,000 | ||
Interest rate | 6.25% | 6.25% | |||
Senior Notes | 4.375% Senior Notes | |||||
Debt Instrument [Line Items] | |||||
Long-term debt, gross | $ 450,000 | ||||
Interest rate | 4.375% | ||||
Debt instrument, redemption price, percentage offered on change of control | 100.00% | 100.00% |
Debt - Debt Instrument Redempti
Debt - Debt Instrument Redemption (Details) - 3.75% Senior Notes | 12 Months Ended |
Dec. 31, 2020 | |
2026 | |
Debt Instrument, Redemption [Line Items] | |
Redemption price percent | 101.875% |
2027 | |
Debt Instrument, Redemption [Line Items] | |
Redemption price percent | 100.938% |
2028 and thereafter | |
Debt Instrument, Redemption [Line Items] | |
Redemption price percent | 100.00% |
Debt - Restrictions and Covenan
Debt - Restrictions and Covenants (Details) | Dec. 31, 2020USD ($) | Dec. 31, 2019USD ($) |
Revolving Credit Facility | ||
Debt Instrument [Line Items] | ||
Maximum allowable leverage ratio | 5 | |
Maximum percent of commitment | 20.00% | |
Parent Company | ||
Debt Instrument [Line Items] | ||
Investment in subsidiaries | $ 2,726,216,000 | $ 2,554,954,000 |
STBV | Senior Secured Credit Facilities and Senior Notes | ||
Debt Instrument [Line Items] | ||
Maximum allowable leverage ratio | 2 | |
Maximum allowable leverage ratio, no default or event of default exists | 2.5 | |
Maximum costs | $ 20,000,000 | |
Maximum amount for distributions | 200,000,000 | |
Maximum amount for dividends and distributions | 50,000,000 | |
Maximum amount for aggregate dividends and other distributions | $ 150,000,000 |
Debt - Accounting for Debt Tran
Debt - Accounting for Debt Transactions (Details) - USD ($) $ in Millions | 12 Months Ended | |||
Dec. 31, 2019 | Dec. 31, 2018 | Dec. 31, 2020 | Sep. 20, 2019 | |
Extinguishment of Debt [Line Items] | ||||
Payments for merger related costs | $ 5.8 | |||
Other, net | ||||
Extinguishment of Debt [Line Items] | ||||
Loss on debt financing | 2.4 | |||
Long-term Debt | ||||
Extinguishment of Debt [Line Items] | ||||
Payments for merger related costs | $ 3.5 | |||
3.75% Senior Notes | Senior Notes | ||||
Extinguishment of Debt [Line Items] | ||||
Debt financing costs, net | $ 8.4 | |||
Debt instrument, interest rate, stated percentage | 3.75% | |||
Amendment To Credit Agreement | Line of Credit | ||||
Extinguishment of Debt [Line Items] | ||||
Debt instrument, fee amount | $ 2.4 | |||
Senior Notes 4.375% Due 2030 | Senior Notes | ||||
Extinguishment of Debt [Line Items] | ||||
Debt financing costs, net | 5 | |||
Debt instrument, interest rate, stated percentage | 4.375% | |||
Loss on extinguishment of debt | $ 4.4 |
Debt - Maturities (Details)
Debt - Maturities (Details) - USD ($) $ in Thousands | Mar. 05, 2021 | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | Sep. 20, 2019 | Sep. 19, 2019 |
Long-term Debt, Fiscal Year Maturity [Abstract] | ||||||
2021 | $ 754,630 | |||||
2022 | 4,630 | |||||
2023 | 504,630 | |||||
2024 | 404,630 | |||||
2025 | 704,630 | |||||
Thereafter | 1,632,946 | |||||
Total long-term debt principal payments | 4,006,096 | |||||
Debt Instrument [Line Items] | ||||||
Long-term debt, gross | 4,006,096 | |||||
6.25% Senior Notes | Senior Notes | ||||||
Long-term Debt, Fiscal Year Maturity [Abstract] | ||||||
Total long-term debt principal payments | 750,000 | $ 750,000 | $ 750,000 | |||
Debt Instrument [Line Items] | ||||||
Long-term debt, gross | $ 750,000 | $ 750,000 | $ 750,000 | |||
Interest rate | 6.25% | 6.25% | ||||
6.25% Senior Notes | Senior Notes | Forecast | ||||||
Debt Instrument [Line Items] | ||||||
Redemption price percent | 103.125% | |||||
Repayments of Debt | $ 23,400 |
Commitments and Contingencies -
Commitments and Contingencies - Purchase Commitments (Details) $ in Thousands | 12 Months Ended |
Dec. 31, 2020USD ($) | |
Commitments and Contingencies Disclosure [Abstract] | |
2021 | $ 41,355 |
2022 | 14,517 |
2023 | 6,889 |
2024 | 149 |
2025 | 132 |
Thereafter | 196 |
Total purchase commitments | $ 63,238 |
Commitments and Contingencies_2
Commitments and Contingencies - Litigation (Details) - Wasica Finance Gmbh et al v. Schrader International Inc. - USD ($) $ in Millions | Sep. 18, 2020 | Jul. 06, 2020 | Feb. 14, 2020 | Sep. 30, 2020 | Jun. 30, 2020 | Mar. 31, 2020 | Dec. 31, 2020 |
Loss Contingencies [Line Items] | |||||||
Litigation settlement, amount awarded to other party | $ 12.1 | $ 31.2 | $ 12.1 | ||||
Gain (loss) related to litigation settlement | $ 11.7 | $ (12.1) | $ (29.2) | $ 11.7 | |||
Payments for litigation settlement | $ 31.6 |
Shareholders' Equity - Narrativ
Shareholders' Equity - Narrative (Details) - USD ($) | 12 Months Ended | |
Dec. 31, 2020 | Jul. 31, 2019 | |
Stockholders' Equity Note [Abstract] | ||
Reduction in retained earnings due to cancellation of treasury shares | $ 286,100,000 | |
Authorized share repurchase amount | $ 500,000,000 | |
Remaining amount under share repurchase program | $ 302,300,000 |
Shareholders' Equity - Accumula
Shareholders' Equity - Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Accumulated Other Comprehensive Income (Loss) [Roll Forward] | |||
Stockholders equity, beginning of period | $ 2,573,755 | $ 2,608,434 | $ 2,345,626 |
Stockholders equity, end of period | 2,705,486 | 2,573,755 | 2,608,434 |
Cash Flow Hedges | |||
Accumulated Other Comprehensive Income (Loss) [Roll Forward] | |||
Stockholders equity, beginning of period | 16,546 | 9,184 | (28,179) |
Pre-tax current period change | (31,114) | 9,816 | 49,817 |
Tax effect | 7,835 | (2,454) | (12,454) |
Stockholders equity, end of period | (6,733) | 16,546 | 9,184 |
Defined Benefit and Retiree Healthcare Plans | |||
Accumulated Other Comprehensive Income (Loss) [Roll Forward] | |||
Stockholders equity, beginning of period | (37,030) | (35,362) | (34,985) |
Pre-tax current period change | (7,848) | (2,198) | (1,183) |
Tax effect | 2,076 | 530 | 806 |
Stockholders equity, end of period | (42,802) | (37,030) | (35,362) |
Accumulated Other Comprehensive Loss | |||
Accumulated Other Comprehensive Income (Loss) [Roll Forward] | |||
Stockholders equity, beginning of period | (20,484) | (26,178) | (63,164) |
Pre-tax current period change | (38,962) | 7,618 | 48,634 |
Tax effect | 9,911 | (1,924) | (11,648) |
Stockholders equity, end of period | $ (49,535) | $ (20,484) | $ (26,178) |
Shareholders' Equity - Componen
Shareholders' Equity - Components of Other Comprehensive Loss (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Other comprehensive (loss)/income before reclassifications | $ (30,232) | $ 25,325 | $ 24,739 |
Amounts reclassified from accumulated other comprehensive loss | 1,181 | (19,631) | 12,247 |
Other comprehensive (loss)/income | (29,051) | 5,694 | 36,986 |
Cash Flow Hedges | |||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Other comprehensive (loss)/income before reclassifications | (17,738) | 28,795 | 26,859 |
Amounts reclassified from accumulated other comprehensive loss | (5,541) | (21,433) | 10,504 |
Other comprehensive (loss)/income | (23,279) | 7,362 | 37,363 |
Defined Benefit and Retiree Healthcare Plans | |||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Other comprehensive (loss)/income before reclassifications | (12,494) | (3,470) | (2,120) |
Amounts reclassified from accumulated other comprehensive loss | 6,722 | 1,802 | 1,743 |
Other comprehensive (loss)/income | $ (5,772) | $ (1,668) | $ (377) |
Shareholders' Equity - Reclassi
Shareholders' Equity - Reclassification out of Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended | |||||||||
Dec. 31, 2020 | Sep. 30, 2020 | Jun. 30, 2020 | Mar. 31, 2020 | Dec. 31, 2019 | Sep. 30, 2019 | Jun. 30, 2019 | Mar. 31, 2019 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||
Net revenue | $ 906,491 | $ 788,313 | $ 576,505 | $ 774,269 | $ 846,691 | $ 849,715 | $ 883,726 | $ 870,499 | $ 3,045,578 | $ 3,450,631 | $ 3,521,627 |
Cost of revenue | 2,119,044 | 2,267,433 | 2,266,863 | ||||||||
Other, net | (339) | (7,908) | (30,365) | ||||||||
Restructuring and other charges, net | (897) | 10,519 | (38,218) | (4,498) | (25,520) | (6,421) | (16,310) | (5,309) | |||
Income before taxes | 165,641 | 390,423 | 526,375 | ||||||||
Provision for/(benefit from) income taxes | (1,355) | (107,709) | 72,620 | ||||||||
Net income | $ 121,667 | $ 76,729 | $ (42,541) | $ 8,431 | $ 53,538 | $ 70,675 | $ 73,436 | $ 85,065 | 164,286 | 282,714 | 598,995 |
Derivative instruments designated and qualifying as cash flow hedges: | Reclassification out of Accumulated Other Comprehensive Income | |||||||||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||
Income before taxes | (7,388) | (28,577) | 14,006 | ||||||||
Provision for/(benefit from) income taxes | 1,847 | 7,144 | (3,502) | ||||||||
Net income | (5,541) | (21,433) | 10,504 | ||||||||
Defined Benefit and Retiree Healthcare Plans | Reclassification out of Accumulated Other Comprehensive Income | |||||||||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||
Other, net | 9,118 | 2,552 | 1,993 | ||||||||
Restructuring and other charges, net | 0 | 0 | 228 | ||||||||
Income before taxes | 9,118 | 2,552 | 2,221 | ||||||||
Provision for/(benefit from) income taxes | (2,396) | (750) | (478) | ||||||||
Net income | 6,722 | 1,802 | 1,743 | ||||||||
Foreign currency forward contracts | Derivative instruments designated and qualifying as cash flow hedges: | Reclassification out of Accumulated Other Comprehensive Income | |||||||||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||
Net revenue | (10,785) | (26,180) | 18,072 | ||||||||
Cost of revenue | 3,397 | (2,397) | (5,442) | ||||||||
Other, net | $ 0 | $ 0 | $ 1,376 |
Leases - Narrative (Details)
Leases - Narrative (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2018 | Dec. 31, 2020 | Dec. 31, 2019 | |
Lessee, Lease, Description [Line Items] | |||
Finance lease obligation | $ 30,334 | $ 30,643 | |
Rent expense | $ 21,000 | ||
Facilities in Baoying, China and Attleboro, Massachusetts | |||
Lessee, Lease, Description [Line Items] | |||
Finance lease obligation | $ 29,400 | $ 29,400 |
Leases - Supplemental Balance S
Leases - Supplemental Balance Sheet Information (Details) - USD ($) $ in Thousands | Dec. 31, 2020 | Dec. 31, 2019 |
Leases [Abstract] | ||
Total operating lease right-of-use assets | $ 49,980 | $ 55,333 |
Accrued expenses and other current liabilities | 11,389 | 11,543 |
Other long-term liabilities | 43,307 | 45,457 |
Total operating lease liabilities | 54,696 | 57,000 |
Property, plant and equipment, at cost | 49,714 | 49,714 |
Accumulated depreciation | (26,107) | (24,316) |
Assets under finance leases in property, plant and equipment, net | 23,607 | 25,398 |
Current portion of long-term debt, finance lease and other financing obligations | 2,403 | 1,974 |
Finance lease and other financing obligations, less current portion | 27,931 | 28,669 |
Total finance lease liabilities | $ 30,334 | $ 30,643 |
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List] | us-gaap:AccruedLiabilitiesCurrent | us-gaap:AccruedLiabilitiesCurrent |
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List] | us-gaap:OtherAssetsNoncurrent | us-gaap:OtherAssetsNoncurrent |
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List] | us-gaap:OtherLiabilitiesNoncurrent | us-gaap:OtherLiabilitiesNoncurrent |
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List] | us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization | us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization |
Finance Lease, Liability, Current, Statement of Financial Position [Extensible List] | st:Long-termDebtCapitalLeaseandOtherFinancingObligationsCurrent | st:Long-termDebtCapitalLeaseandOtherFinancingObligationsCurrent |
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List] | st:FinanceLeaseandOtherFinancingObligationsNoncurrent | st:FinanceLeaseandOtherFinancingObligationsNoncurrent |
Leases - Lease Liabilities (Det
Leases - Lease Liabilities (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
Leases [Abstract] | ||
Operating leases | $ 3,232 | $ 5,423 |
Finance leases | $ 0 | $ 0 |
Leases - Lease Cost (Details)
Leases - Lease Cost (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
Leases [Abstract] | ||
Operating lease cost | $ 16,658 | $ 16,124 |
Amortization of right-of-use assets | 1,794 | 1,808 |
Interest on lease liabilities | 2,565 | 2,695 |
Total finance lease cost | $ 4,359 | $ 4,503 |
Leases - Supplemental Cash Flow
Leases - Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
Leases [Abstract] | ||
Operating cash flows from operating leases | $ 16,489 | $ 15,911 |
Operating cash flows from finance leases | 2,262 | 2,731 |
Financing cash flows from finance leases | $ 944 | $ 1,933 |
Leases - Weighted Average Remai
Leases - Weighted Average Remaining Lease Term and Discount Rate (Details) | Dec. 31, 2020 |
Leases [Abstract] | |
Weighted average remaining lease term - operating leases | 7 years 7 months 6 days |
Weighted average remaining lease term - finance leases | 11 years 9 months 18 days |
Weighted average discount rate - operating lease | 5.70% |
Weighted average discount rate - finance lease | 8.50% |
Leases - Maturity of Obligation
Leases - Maturity of Obligations related to Operating and Finance Leases (Details) - USD ($) $ in Thousands | Dec. 31, 2020 | Dec. 31, 2019 |
Operating Leases | ||
2021 | $ 14,608 | |
2022 | 12,176 | |
2023 | 8,829 | |
2024 | 7,561 | |
2025 | 5,048 | |
Thereafter | 21,808 | |
Total undiscounted cash flows related to lease liabilities | 70,030 | |
Less imputed interest | (15,334) | |
Total lease liabilities | 54,696 | $ 57,000 |
Finance Leases | ||
2021 | 4,572 | |
2022 | 3,848 | |
2023 | 3,813 | |
2024 | 3,873 | |
2025 | 3,934 | |
Thereafter | 29,486 | |
Total undiscounted cash flows related to lease liabilities | 49,526 | |
Less imputed interest | (19,192) | |
Total lease liabilities | $ 30,334 | $ 30,643 |
Fair Value Measures - Schedule
Fair Value Measures - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) - Fair Value, Measurements, Recurring - Significant Other Observable Inputs (Level 2) - USD ($) $ in Thousands | Dec. 31, 2020 | Dec. 31, 2019 |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | $ 25,065 | $ 27,184 |
Liabilities | 24,970 | 2,421 |
Foreign currency forward contracts | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 16,163 | 23,561 |
Liabilities | 24,660 | 1,959 |
Commodity forward contracts | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 8,902 | 3,623 |
Liabilities | $ 310 | $ 462 |
Fair Value Measures - Balance S
Fair Value Measures - Balance Sheet Grouping (Details) - USD ($) $ in Thousands | Dec. 31, 2020 | Dec. 31, 2019 | Sep. 20, 2019 |
Term Loan | Carrying Value | |||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | |||
Liabilities | $ 456,096 | $ 460,725 | |
4.875% Senior Notes | Senior Notes | |||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | |||
Interest rate | 4.875% | 4.875% | |
4.875% Senior Notes | Carrying Value | |||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | |||
Liabilities | $ 500,000 | 500,000 | |
5.625% Senior Notes | Senior Notes | |||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | |||
Interest rate | 5.625% | 5.625% | |
5.625% Senior Notes | Carrying Value | |||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | |||
Liabilities | $ 400,000 | 400,000 | |
5.000% Senior Notes | Senior Notes | |||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | |||
Interest rate | 5.00% | 5.00% | |
5.000% Senior Notes | Carrying Value | |||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | |||
Liabilities | $ 700,000 | 700,000 | |
6.25% Senior Notes | Senior Notes | |||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | |||
Interest rate | 6.25% | 6.25% | |
6.25% Senior Notes | Carrying Value | |||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | |||
Liabilities | $ 750,000 | 750,000 | |
4.375% Senior Notes | Senior Notes | |||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | |||
Interest rate | 4.375% | ||
4.375% Senior Notes | Carrying Value | |||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | |||
Liabilities | $ 450,000 | 450,000 | |
3.75% Senior Notes | Senior Notes | |||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | |||
Interest rate | 3.75% | ||
3.75% Senior Notes | Carrying Value | |||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | |||
Liabilities | $ 750,000 | 0 | |
Level 2 | Term Loan | |||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | |||
Liabilities | 454,955 | 464,181 | |
Level 2 | 4.875% Senior Notes | |||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | |||
Liabilities | 538,750 | 532,500 | |
Level 2 | 5.625% Senior Notes | |||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | |||
Liabilities | 448,000 | 444,000 | |
Level 2 | 5.000% Senior Notes | |||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | |||
Liabilities | 777,000 | 759,500 | |
Level 2 | 6.25% Senior Notes | |||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | |||
Liabilities | 778,125 | 808,125 | |
Level 2 | 4.375% Senior Notes | |||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | |||
Liabilities | 487,125 | 457,875 | |
Level 2 | 3.75% Senior Notes | |||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | |||
Liabilities | $ 776,250 | $ 0 |
Fair Value Measures - Carrying
Fair Value Measures - Carrying Values of these Investments (Details) - USD ($) $ in Thousands | Dec. 31, 2020 | Dec. 31, 2019 |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Equity investment | $ 65,000 | $ 53,700 |
Quanergy Systems, Inc | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Equity investment | 50,000 | 50,000 |
Other | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Equity investment | $ 15,000 | $ 3,700 |
Derivative Instruments and He_3
Derivative Instruments and Hedging Activities - Schedule of Derivative Instruments (Details) - Dec. 31, 2020 € in Millions, ₩ in Millions, ¥ in Millions, ¥ in Millions, £ in Millions, RM in Millions, $ in Millions, $ in Millions | USD ($)oztlb | EUR (€)oztlb | CNY (¥)oztlb | JPY (¥)oztlb | KRW (₩)oztlb | MYR (RM)oztlb | MXN ($)oztlb | GBP (£)oztlb |
Derivative [Line Items] | ||||||||
Foreign currency cash flow hedge gain (loss) to be reclassified during the next 12 months | $ | $ 9.7 | |||||||
Derivatives not designated as hedging instruments under ASC 815 | Silver | ||||||||
Interest Rate Derivatives [Abstract] | ||||||||
Weighted- Average Strike Rate | 20.54 | 20.54 | 20.54 | 20.54 | 20.54 | 20.54 | 20.54 | 20.54 |
Price Risk Derivatives [Abstract] | ||||||||
Notional | 742,939 | 742,939 | 742,939 | 742,939 | 742,939 | 742,939 | 742,939 | 742,939 |
Derivatives not designated as hedging instruments under ASC 815 | Gold | ||||||||
Interest Rate Derivatives [Abstract] | ||||||||
Weighted- Average Strike Rate | 1,733.35 | 1,733.35 | 1,733.35 | 1,733.35 | 1,733.35 | 1,733.35 | 1,733.35 | 1,733.35 |
Price Risk Derivatives [Abstract] | ||||||||
Notional | 7,326 | 7,326 | 7,326 | 7,326 | 7,326 | 7,326 | 7,326 | 7,326 |
Derivatives not designated as hedging instruments under ASC 815 | Nickel | ||||||||
Interest Rate Derivatives [Abstract] | ||||||||
Weighted- Average Strike Rate | 6.62 | 6.62 | 6.62 | 6.62 | 6.62 | 6.62 | 6.62 | 6.62 |
Price Risk Derivatives [Abstract] | ||||||||
Notional | lb | 165,037 | 165,037 | 165,037 | 165,037 | 165,037 | 165,037 | 165,037 | 165,037 |
Derivatives not designated as hedging instruments under ASC 815 | Aluminum | ||||||||
Interest Rate Derivatives [Abstract] | ||||||||
Weighted- Average Strike Rate | 0.86 | 0.86 | 0.86 | 0.86 | 0.86 | 0.86 | 0.86 | 0.86 |
Price Risk Derivatives [Abstract] | ||||||||
Notional | lb | 2,224,837 | 2,224,837 | 2,224,837 | 2,224,837 | 2,224,837 | 2,224,837 | 2,224,837 | 2,224,837 |
Derivatives not designated as hedging instruments under ASC 815 | Copper | ||||||||
Interest Rate Derivatives [Abstract] | ||||||||
Weighted- Average Strike Rate | 2.83 | 2.83 | 2.83 | 2.83 | 2.83 | 2.83 | 2.83 | 2.83 |
Price Risk Derivatives [Abstract] | ||||||||
Notional | lb | 1,803,323 | 1,803,323 | 1,803,323 | 1,803,323 | 1,803,323 | 1,803,323 | 1,803,323 | 1,803,323 |
Derivatives not designated as hedging instruments under ASC 815 | Platinum | ||||||||
Interest Rate Derivatives [Abstract] | ||||||||
Weighted- Average Strike Rate | 911.09 | 911.09 | 911.09 | 911.09 | 911.09 | 911.09 | 911.09 | 911.09 |
Price Risk Derivatives [Abstract] | ||||||||
Notional | 7,440 | 7,440 | 7,440 | 7,440 | 7,440 | 7,440 | 7,440 | 7,440 |
Derivatives not designated as hedging instruments under ASC 815 | Palladium | ||||||||
Interest Rate Derivatives [Abstract] | ||||||||
Weighted- Average Strike Rate | 1,988.33 | 1,988.33 | 1,988.33 | 1,988.33 | 1,988.33 | 1,988.33 | 1,988.33 | 1,988.33 |
Price Risk Derivatives [Abstract] | ||||||||
Notional | 831 | 831 | 831 | 831 | 831 | 831 | 831 | 831 |
Euro (EUR) to USD | Derivatives designated as hedging instruments under ASC 815 | Foreign currency forward contracts | ||||||||
Interest Rate Derivatives [Abstract] | ||||||||
Notional (in millions) | € | € 317.3 | |||||||
Weighted- Average Strike Rate | 1.17 | 1.17 | 1.17 | 1.17 | 1.17 | 1.17 | 1.17 | 1.17 |
Euro (EUR) to USD | Derivatives not designated as hedging instruments under ASC 815 | Foreign currency forward contracts | ||||||||
Interest Rate Derivatives [Abstract] | ||||||||
Notional (in millions) | € | € 22 | |||||||
Weighted- Average Strike Rate | 1.23 | 1.23 | 1.23 | 1.23 | 1.23 | 1.23 | 1.23 | 1.23 |
USD to Chinese Renminbi (CNY) | Derivatives designated as hedging instruments under ASC 815 | Foreign currency forward contracts | ||||||||
Interest Rate Derivatives [Abstract] | ||||||||
Notional (in millions) | ¥ | ¥ 500 | |||||||
Weighted- Average Strike Rate | 6.74 | 6.74 | 6.74 | 6.74 | 6.74 | 6.74 | 6.74 | 6.74 |
USD to Chinese Renminbi (CNY) | Derivatives not designated as hedging instruments under ASC 815 | Foreign currency forward contracts | ||||||||
Interest Rate Derivatives [Abstract] | ||||||||
Notional (in millions) | ¥ | ¥ 584 | |||||||
Weighted- Average Strike Rate | 6.57 | 6.57 | 6.57 | 6.57 | 6.57 | 6.57 | 6.57 | 6.57 |
USD to Japanese Yen (JPY) | Derivatives not designated as hedging instruments under ASC 815 | Foreign currency forward contracts | ||||||||
Interest Rate Derivatives [Abstract] | ||||||||
Notional (in millions) | ¥ | ¥ 897 | |||||||
Weighted- Average Strike Rate | 103.53 | 103.53 | 103.53 | 103.53 | 103.53 | 103.53 | 103.53 | 103.53 |
USD to Korean Won (KRW) | Derivatives designated as hedging instruments under ASC 815 | Foreign currency forward contracts | ||||||||
Interest Rate Derivatives [Abstract] | ||||||||
Notional (in millions) | ₩ | ₩ 17,321.7 | |||||||
Weighted- Average Strike Rate | 1,167.03 | 1,167.03 | 1,167.03 | 1,167.03 | 1,167.03 | 1,167.03 | 1,167.03 | 1,167.03 |
USD to Malaysian Ringgit Exchange Rate | Derivatives not designated as hedging instruments under ASC 815 | Foreign currency forward contracts | ||||||||
Interest Rate Derivatives [Abstract] | ||||||||
Notional (in millions) | RM | RM 22 | |||||||
Weighted- Average Strike Rate | 4.06 | 4.06 | 4.06 | 4.06 | 4.06 | 4.06 | 4.06 | 4.06 |
USD to Mexican Peso (MXN) | Derivatives designated as hedging instruments under ASC 815 | Foreign currency forward contracts | ||||||||
Interest Rate Derivatives [Abstract] | ||||||||
Notional (in millions) | $ | $ 2,963.5 | |||||||
Weighted- Average Strike Rate | 22.56 | 22.56 | 22.56 | 22.56 | 22.56 | 22.56 | 22.56 | 22.56 |
USD to Mexican Peso (MXN) | Derivatives not designated as hedging instruments under ASC 815 | Foreign currency forward contracts | ||||||||
Interest Rate Derivatives [Abstract] | ||||||||
Notional (in millions) | $ | $ 284 | |||||||
Weighted- Average Strike Rate | 19.95 | 19.95 | 19.95 | 19.95 | 19.95 | 19.95 | 19.95 | 19.95 |
British Pound Sterling to USD Exchange Rate | Derivatives designated as hedging instruments under ASC 815 | Foreign currency forward contracts | ||||||||
Interest Rate Derivatives [Abstract] | ||||||||
Notional (in millions) | £ | £ 48.9 | |||||||
Weighted- Average Strike Rate | 1.29 | 1.29 | 1.29 | 1.29 | 1.29 | 1.29 | 1.29 | 1.29 |
British Pound Sterling to USD Exchange Rate | Derivatives not designated as hedging instruments under ASC 815 | Foreign currency forward contracts | ||||||||
Interest Rate Derivatives [Abstract] | ||||||||
Notional (in millions) | £ | £ 6 | |||||||
Weighted- Average Strike Rate | 1.35 | 1.35 | 1.35 | 1.35 | 1.35 | 1.35 | 1.35 | 1.35 |
Derivative Instruments and He_4
Derivative Instruments and Hedging Activities - Fair Value (Details) - USD ($) $ in Thousands | Dec. 31, 2020 | Dec. 31, 2019 |
Derivatives designated as hedging instruments under ASC 815 | ||
Derivatives, Fair Value [Line Items] | ||
Asset Derivatives, Fair Value | $ 16,009 | $ 23,487 |
Liability Derivatives, Fair Value | 24,016 | 1,483 |
Derivatives not designated as hedging instruments under ASC 815 | ||
Derivatives, Fair Value [Line Items] | ||
Asset Derivatives, Fair Value | 9,056 | 3,697 |
Liability Derivatives, Fair Value | 954 | 938 |
Foreign currency forward contracts | Derivatives designated as hedging instruments under ASC 815 | Prepaid expenses and other current assets | ||
Derivatives, Fair Value [Line Items] | ||
Asset Derivatives, Fair Value | 11,281 | 20,957 |
Foreign currency forward contracts | Derivatives designated as hedging instruments under ASC 815 | Other assets | ||
Derivatives, Fair Value [Line Items] | ||
Asset Derivatives, Fair Value | 4,728 | 2,530 |
Foreign currency forward contracts | Derivatives designated as hedging instruments under ASC 815 | Accrued expenses and other current liabilities | ||
Derivatives, Fair Value [Line Items] | ||
Liability Derivatives, Fair Value | 18,834 | 1,055 |
Foreign currency forward contracts | Derivatives designated as hedging instruments under ASC 815 | Other long-term liabilities | ||
Derivatives, Fair Value [Line Items] | ||
Liability Derivatives, Fair Value | 5,182 | 428 |
Foreign currency forward contracts | Derivatives not designated as hedging instruments under ASC 815 | Prepaid expenses and other current assets | ||
Derivatives, Fair Value [Line Items] | ||
Asset Derivatives, Fair Value | 154 | 74 |
Foreign currency forward contracts | Derivatives not designated as hedging instruments under ASC 815 | Accrued expenses and other current liabilities | ||
Derivatives, Fair Value [Line Items] | ||
Liability Derivatives, Fair Value | 644 | 476 |
Commodity forward contracts | Derivatives not designated as hedging instruments under ASC 815 | Prepaid expenses and other current assets | ||
Derivatives, Fair Value [Line Items] | ||
Asset Derivatives, Fair Value | 7,598 | 3,069 |
Commodity forward contracts | Derivatives not designated as hedging instruments under ASC 815 | Other assets | ||
Derivatives, Fair Value [Line Items] | ||
Asset Derivatives, Fair Value | 1,304 | 554 |
Commodity forward contracts | Derivatives not designated as hedging instruments under ASC 815 | Accrued expenses and other current liabilities | ||
Derivatives, Fair Value [Line Items] | ||
Liability Derivatives, Fair Value | 149 | 394 |
Commodity forward contracts | Derivatives not designated as hedging instruments under ASC 815 | Other long-term liabilities | ||
Derivatives, Fair Value [Line Items] | ||
Liability Derivatives, Fair Value | $ 161 | $ 68 |
Derivative Instruments and He_5
Derivative Instruments and Hedging Activities - Income Statement Disclosures (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
Foreign currency forward contracts | Derivatives designated as hedging instruments under ASC 815 | Net revenue | ||
Derivative Instruments, Gain (Loss) [Line Items] | ||
Amount of Deferred (Loss)/Gain Recognized in Other Comprehensive (Loss)/Income | $ (25,866) | $ 23,881 |
Amount of Net Gain/(Loss) Reclassified from Accumulated Other Comprehensive Loss into Net Income | 10,785 | 26,180 |
Foreign currency forward contracts | Derivatives designated as hedging instruments under ASC 815 | Cost of revenue | ||
Derivative Instruments, Gain (Loss) [Line Items] | ||
Amount of Deferred (Loss)/Gain Recognized in Other Comprehensive (Loss)/Income | 2,140 | 14,512 |
Amount of Net Gain/(Loss) Reclassified from Accumulated Other Comprehensive Loss into Net Income | (3,397) | 2,397 |
Foreign currency forward contracts | Derivatives not designated as hedging instruments under ASC 815 | Other, net | ||
Derivative Instruments, Gain (Loss) [Line Items] | ||
Amount of Gain/(Loss) Recognized in Net Income | (6,762) | 2,225 |
Commodity forward contracts | Derivatives not designated as hedging instruments under ASC 815 | Other, net | ||
Derivative Instruments, Gain (Loss) [Line Items] | ||
Amount of Gain/(Loss) Recognized in Net Income | $ 10,027 | $ 4,888 |
Derivative Instruments and He_6
Derivative Instruments and Hedging Activities - Credit Risk Related Contingent Features (Details) $ in Millions | Dec. 31, 2020USD ($) |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Termination value | $ 25.1 |
Cash collateral posted | $ 0 |
Segment Reporting - Schedules o
Segment Reporting - Schedules of Segment Reporting (Details) $ in Thousands | 3 Months Ended | 12 Months Ended | |||||||||
Dec. 31, 2020USD ($) | Sep. 30, 2020USD ($) | Jun. 30, 2020USD ($) | Mar. 31, 2020USD ($) | Dec. 31, 2019USD ($) | Sep. 30, 2019USD ($) | Jun. 30, 2019USD ($) | Mar. 31, 2019USD ($) | Dec. 31, 2020USD ($)segment | Dec. 31, 2019USD ($) | Dec. 31, 2018USD ($) | |
Segment Reporting Information [Line Items] | |||||||||||
Number of segments | segment | 2 | ||||||||||
Segment Reconciliation [Abstract] | |||||||||||
Net revenue | $ 906,491 | $ 788,313 | $ 576,505 | $ 774,269 | $ 846,691 | $ 849,715 | $ 883,726 | $ 870,499 | $ 3,045,578 | $ 3,450,631 | $ 3,521,627 |
Operating income | 337,737 | 556,885 | 710,419 | ||||||||
Amortization of intangible assets | (129,549) | (142,886) | (139,326) | ||||||||
Restructuring and other charges, net | (897) | $ 10,519 | $ (38,218) | $ (4,498) | (25,520) | $ (6,421) | $ (16,310) | $ (5,309) | |||
Interest expense, net | (171,757) | (158,554) | (153,679) | ||||||||
Other, net | (339) | (7,908) | (30,365) | ||||||||
Income before taxes | 165,641 | 390,423 | 526,375 | ||||||||
Depreciation and amortization: | 255,229 | 258,748 | 245,340 | ||||||||
Assets: | 7,844,202 | 6,834,519 | 7,844,202 | 6,834,519 | |||||||
Goodwill | 3,111,349 | 3,093,598 | 3,111,349 | 3,093,598 | 3,081,302 | ||||||
Other intangible assets, net | 691,549 | 770,904 | 691,549 | 770,904 | |||||||
Cash and cash equivalents | 1,861,980 | 774,119 | 1,861,980 | 774,119 | |||||||
Additions to property, plant and equipment and capitalized software | 106,719 | 161,259 | 159,787 | ||||||||
Performance Sensing | |||||||||||
Segment Reconciliation [Abstract] | |||||||||||
Net revenue | 2,223,810 | 2,546,016 | 2,627,651 | ||||||||
Goodwill | 2,189,771 | 2,172,020 | 2,189,771 | 2,172,020 | 2,155,633 | ||||||
Sensing Solutions | |||||||||||
Segment Reconciliation [Abstract] | |||||||||||
Net revenue | 821,768 | 904,615 | 893,976 | ||||||||
Goodwill | 921,578 | 921,578 | 921,578 | 921,578 | 925,669 | ||||||
Sensors | |||||||||||
Segment Reconciliation [Abstract] | |||||||||||
Net revenue | 2,380,608 | 2,712,926 | 2,755,280 | ||||||||
Electrical Protection | |||||||||||
Segment Reconciliation [Abstract] | |||||||||||
Net revenue | 504,001 | 573,631 | 522,172 | ||||||||
Electrical Protection | Restatement Adjustment | |||||||||||
Segment Reconciliation [Abstract] | |||||||||||
Net revenue | 91,900 | 13,400 | |||||||||
Other | |||||||||||
Segment Reconciliation [Abstract] | |||||||||||
Net revenue | 160,969 | 164,074 | 244,175 | ||||||||
Other | Restatement Adjustment | |||||||||||
Segment Reconciliation [Abstract] | |||||||||||
Net revenue | (91,900) | (13,400) | |||||||||
Operating Segments | |||||||||||
Segment Reconciliation [Abstract] | |||||||||||
Net revenue | 3,045,578 | 3,450,631 | 3,521,627 | ||||||||
Operating income | 773,747 | 964,437 | 1,023,247 | ||||||||
Operating Segments | Performance Sensing | |||||||||||
Segment Reconciliation [Abstract] | |||||||||||
Net revenue | 2,223,810 | 2,546,016 | 2,627,651 | ||||||||
Operating income | 532,529 | 670,470 | 728,251 | ||||||||
Depreciation and amortization: | 91,522 | 85,511 | 72,067 | ||||||||
Assets: | 1,447,885 | 1,515,396 | 1,447,885 | 1,515,396 | |||||||
Additions to property, plant and equipment and capitalized software | 79,252 | 125,412 | 130,234 | ||||||||
Operating Segments | Sensing Solutions | |||||||||||
Segment Reconciliation [Abstract] | |||||||||||
Net revenue | 821,768 | 904,615 | 893,976 | ||||||||
Operating income | 241,218 | 293,967 | 294,996 | ||||||||
Depreciation and amortization: | 16,564 | 16,678 | 16,798 | ||||||||
Assets: | 459,544 | 479,455 | 459,544 | 479,455 | |||||||
Additions to property, plant and equipment and capitalized software | 16,885 | 19,520 | 12,492 | ||||||||
Corporate and other | |||||||||||
Segment Reconciliation [Abstract] | |||||||||||
Operating income | (273,367) | (211,106) | (221,320) | ||||||||
Depreciation and amortization: | 147,143 | 156,559 | 156,475 | ||||||||
Assets: | 5,936,773 | 4,839,668 | 5,936,773 | 4,839,668 | |||||||
Goodwill | 3,111,300 | 3,093,600 | 3,111,300 | 3,093,600 | |||||||
Other intangible assets, net | 691,500 | 770,900 | 691,500 | 770,900 | |||||||
Cash and cash equivalents | 1,862,000 | 774,100 | 1,862,000 | 774,100 | |||||||
Property, plant and equipment, net | $ 41,700 | $ 41,200 | 41,700 | 41,200 | |||||||
Additions to property, plant and equipment and capitalized software | 10,582 | 16,327 | 17,061 | ||||||||
Segment Reconciling Items | |||||||||||
Segment Reconciliation [Abstract] | |||||||||||
Amortization of intangible assets | (129,549) | (142,886) | (139,326) | ||||||||
Restructuring and other charges, net | $ (33,094) | $ (53,560) | $ 47,818 |
Segment Reporting - Geographic
Segment Reporting - Geographic Information (Details) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended | |||||||||
Dec. 31, 2020 | Sep. 30, 2020 | Jun. 30, 2020 | Mar. 31, 2020 | Dec. 31, 2019 | Sep. 30, 2019 | Jun. 30, 2019 | Mar. 31, 2019 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Revenues from External Customers and Long-Lived Assets [Line Items] | |||||||||||
Net revenue | $ 906,491 | $ 788,313 | $ 576,505 | $ 774,269 | $ 846,691 | $ 849,715 | $ 883,726 | $ 870,499 | $ 3,045,578 | $ 3,450,631 | $ 3,521,627 |
Long-lived assets | 803,825 | 830,998 | 803,825 | 830,998 | |||||||
Americas | |||||||||||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||||||||||
Net revenue | 1,197,846 | 1,460,101 | 1,480,567 | ||||||||
Long-lived assets | 266,378 | 289,300 | 266,378 | 289,300 | |||||||
Europe | |||||||||||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||||||||||
Net revenue | 816,287 | 969,470 | 1,028,534 | ||||||||
Long-lived assets | 196,132 | 192,772 | 196,132 | 192,772 | |||||||
Asia and rest of world | |||||||||||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||||||||||
Net revenue | 1,031,445 | 1,021,060 | 1,012,526 | ||||||||
Long-lived assets | 341,315 | 348,926 | 341,315 | 348,926 | |||||||
United States | |||||||||||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||||||||||
Net revenue | 1,082,671 | 1,333,532 | 1,360,590 | ||||||||
Long-lived assets | 108,615 | 97,226 | 108,615 | 97,226 | |||||||
Netherlands | |||||||||||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||||||||||
Net revenue | 482,020 | 576,804 | 585,036 | ||||||||
China | |||||||||||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||||||||||
Net revenue | 641,516 | 575,211 | 560,938 | ||||||||
Long-lived assets | 257,935 | 266,161 | 257,935 | 266,161 | |||||||
Korea | |||||||||||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||||||||||
Net revenue | 172,229 | 188,226 | 188,114 | ||||||||
United Kingdom | |||||||||||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||||||||||
Net revenue | 122,403 | 151,674 | 163,963 | ||||||||
Long-lived assets | 34,453 | 40,003 | 34,453 | 40,003 | |||||||
All other | |||||||||||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||||||||||
Net revenue | 544,739 | 625,184 | $ 662,986 | ||||||||
Long-lived assets | 19,391 | 18,793 | 19,391 | 18,793 | |||||||
Mexico | |||||||||||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||||||||||
Long-lived assets | 157,576 | 191,861 | 157,576 | 191,861 | |||||||
Bulgaria | |||||||||||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||||||||||
Long-lived assets | 147,103 | 138,644 | 147,103 | 138,644 | |||||||
Malaysia | |||||||||||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||||||||||
Long-lived assets | $ 78,752 | $ 78,310 | $ 78,752 | $ 78,310 |
Unaudited Quarterly Data (Detai
Unaudited Quarterly Data (Details) - USD ($) $ / shares in Units, $ in Thousands | Jul. 06, 2020 | Feb. 14, 2020 | Dec. 31, 2020 | Sep. 30, 2020 | Jun. 30, 2020 | Mar. 31, 2020 | Dec. 31, 2019 | Sep. 30, 2019 | Jun. 30, 2019 | Mar. 31, 2019 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 |
Quarterly Financial Information [Line Items] | |||||||||||||
Net revenue | $ 906,491 | $ 788,313 | $ 576,505 | $ 774,269 | $ 846,691 | $ 849,715 | $ 883,726 | $ 870,499 | $ 3,045,578 | $ 3,450,631 | $ 3,521,627 | ||
Gross profit | 296,551 | 258,058 | 164,062 | 207,863 | 290,209 | 294,805 | 308,491 | 289,693 | |||||
Net income | $ 121,667 | $ 76,729 | $ (42,541) | $ 8,431 | $ 53,538 | $ 70,675 | $ 73,436 | $ 85,065 | $ 164,286 | $ 282,714 | $ 598,995 | ||
Basic net income per share (in dollars per share) | $ 0.77 | $ 0.49 | $ (0.27) | $ 0.05 | $ 0.34 | $ 0.44 | $ 0.45 | $ 0.52 | $ 1.04 | $ 1.76 | $ 3.55 | ||
Diluted net income per share (in dollars per share) | $ 0.77 | $ 0.49 | $ (0.27) | $ 0.05 | $ 0.34 | $ 0.44 | $ 0.45 | $ 0.52 | $ 1.04 | $ 1.75 | $ 3.53 | ||
Restructuring and other charges, net | $ 897 | $ (10,519) | $ 38,218 | $ 4,498 | $ 25,520 | $ 6,421 | $ 16,310 | $ 5,309 | |||||
CARES Act, deferred tax benefit | 7,500 | ||||||||||||
Supply Agreement Termination | |||||||||||||
Quarterly Financial Information [Line Items] | |||||||||||||
Restructuring and other charges, net | $ (17,800) | ||||||||||||
One-time Termination Benefits | |||||||||||||
Quarterly Financial Information [Line Items] | |||||||||||||
Restructuring and other charges, net | $ 6,500 | ||||||||||||
Voluntary Incentive Retirement Program | |||||||||||||
Quarterly Financial Information [Line Items] | |||||||||||||
Restructuring and other charges, net | $ 12,700 | ||||||||||||
Q2 2020 Global Restructure Program | |||||||||||||
Quarterly Financial Information [Line Items] | |||||||||||||
Severance costs | 24,100 | $ 24,458 | $ 0 | $ 0 | |||||||||
Wasica Finance Gmbh et al v. Schrader International Inc. | |||||||||||||
Quarterly Financial Information [Line Items] | |||||||||||||
Gain (loss) related to litigation settlement | $ 11,700 | (12,100) | $ (29,200) | $ 11,700 | |||||||||
Litigation settlement, amount awarded to other party | $ 12,100 | $ 31,200 | $ 12,100 |
Subsequent Event (Details)
Subsequent Event (Details) - USD ($) $ in Thousands | Feb. 11, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | Sep. 20, 2019 | Sep. 19, 2019 |
Subsequent Event [Line Items] | |||||
Long-term debt, gross | $ 4,006,096 | ||||
Xirgo Technologies, LLC | Subsequent Event | |||||
Subsequent Event [Line Items] | |||||
Aggregate purchase price | $ 400,000 | ||||
6.25% Senior Notes | Senior Notes | |||||
Subsequent Event [Line Items] | |||||
Long-term debt, gross | $ 750,000 | $ 750,000 | $ 750,000 | ||
Interest rate | 6.25% | 6.25% |
Schedule I - Condensed Financ_2
Schedule I - Condensed Financial Information of the Registrant (Details) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended | ||||||||||
Dec. 31, 2020 | Sep. 30, 2020 | Jun. 30, 2020 | Mar. 31, 2020 | Dec. 31, 2019 | Sep. 30, 2019 | Jun. 30, 2019 | Mar. 31, 2019 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | Dec. 31, 2017 | |
Current assets: | ||||||||||||
Cash and cash equivalents | $ 1,861,980 | $ 774,119 | $ 1,861,980 | $ 774,119 | ||||||||
Prepaid expenses and other current assets | 90,340 | 126,981 | 90,340 | 126,981 | ||||||||
Total current assets | 2,979,972 | 1,965,652 | 2,979,972 | 1,965,652 | ||||||||
Deferred income tax assets | 84,785 | 21,150 | 84,785 | 21,150 | ||||||||
Other non-current assets | 172,722 | 152,217 | 172,722 | 152,217 | ||||||||
Total assets | 7,844,202 | 6,834,519 | 7,844,202 | 6,834,519 | ||||||||
Current liabilities: | ||||||||||||
Accounts payable | 393,907 | 376,968 | 393,907 | 376,968 | ||||||||
Accrued expenses and other current liabilities | 324,830 | 215,626 | 324,830 | 215,626 | ||||||||
Total current liabilities | 1,495,157 | 634,746 | 1,495,157 | 634,746 | ||||||||
Total liabilities | 5,138,716 | 4,260,764 | 5,138,716 | 4,260,764 | ||||||||
Total shareholders’ equity | 2,705,486 | 2,573,755 | 2,705,486 | 2,573,755 | $ 2,608,434 | $ 2,345,626 | ||||||
Total liabilities and shareholders’ equity | 7,844,202 | 6,834,519 | 7,844,202 | 6,834,519 | ||||||||
Income Statement [Abstract] | ||||||||||||
Net revenue | 906,491 | $ 788,313 | $ 576,505 | $ 774,269 | 846,691 | $ 849,715 | $ 883,726 | $ 870,499 | 3,045,578 | 3,450,631 | 3,521,627 | |
Operating costs and expenses: | ||||||||||||
Selling, general and administrative | 294,725 | 281,442 | 305,558 | |||||||||
Total operating costs and expenses | 2,707,841 | 2,893,746 | 2,811,208 | |||||||||
Loss from operations | 337,737 | 556,885 | 710,419 | |||||||||
Interest expense, net | (171,757) | (158,554) | (153,679) | |||||||||
Other, net | (339) | (7,908) | (30,365) | |||||||||
Income before taxes | 165,641 | 390,423 | 526,375 | |||||||||
Provision for/(benefit from) income taxes | (1,355) | (107,709) | 72,620 | |||||||||
Other comprehensive (loss)/income, net of tax: | ||||||||||||
Defined benefit plan | (5,772) | (1,668) | (377) | |||||||||
Other comprehensive (loss)/income | (29,051) | 5,694 | 36,986 | |||||||||
Statement of Cash Flows [Abstract] | ||||||||||||
Net cash used in operating activities | 559,775 | 619,562 | 620,563 | |||||||||
Net cash used in investing activities | (182,092) | (208,777) | (237,606) | |||||||||
Proceeds from exercise of stock options and issuance of ordinary shares | 15,457 | 15,150 | 6,093 | |||||||||
Payments to repurchase ordinary shares | (35,175) | (350,004) | (399,417) | |||||||||
Payments of employee restricted stock tax withholdings | (2,911) | (6,990) | (3,674) | |||||||||
Net cash provided by/(used in) financing activities | 710,178 | (366,499) | (406,213) | |||||||||
Cash and cash equivalents, beginning of year | 774,119 | 729,833 | 774,119 | 729,833 | 753,089 | |||||||
Cash and cash equivalents, end of year | 1,861,980 | 774,119 | 1,861,980 | 774,119 | 729,833 | |||||||
Parent Company | ||||||||||||
Current assets: | ||||||||||||
Cash and cash equivalents | 664 | 238 | 664 | 238 | ||||||||
Intercompany receivables | 837 | 0 | 837 | 0 | ||||||||
Intercompany notes receivable from subsidiaries | 65,972 | 43,673 | 65,972 | 43,673 | ||||||||
Prepaid expenses and other current assets | 1,821 | 1,246 | 1,821 | 1,246 | ||||||||
Total current assets | 69,294 | 45,157 | 69,294 | 45,157 | ||||||||
Deferred income tax assets | 506 | 570 | 506 | 570 | ||||||||
Other non-current assets | 51 | 0 | 51 | 0 | ||||||||
Investment in subsidiaries | 2,726,216 | 2,554,954 | 2,726,216 | 2,554,954 | ||||||||
Total assets | 2,796,067 | 2,600,681 | 2,796,067 | 2,600,681 | ||||||||
Current liabilities: | ||||||||||||
Accounts payable | 414 | 572 | 414 | 572 | ||||||||
Intercompany accounts payable to subsidiaries | 12,937 | 1,909 | 12,937 | 1,909 | ||||||||
Intercompany notes payable to subsidiaries | 76,482 | 23,216 | 76,482 | 23,216 | ||||||||
Accrued expenses and other current liabilities | 748 | 1,229 | 748 | 1,229 | ||||||||
Total current liabilities | 90,581 | 26,926 | 90,581 | 26,926 | ||||||||
Total liabilities | 90,581 | 26,926 | 90,581 | 26,926 | ||||||||
Total shareholders’ equity | 2,705,486 | 2,573,755 | 2,705,486 | 2,573,755 | ||||||||
Total liabilities and shareholders’ equity | 2,796,067 | 2,600,681 | 2,796,067 | 2,600,681 | ||||||||
Income Statement [Abstract] | ||||||||||||
Net revenue | 0 | 0 | 0 | |||||||||
Operating costs and expenses: | ||||||||||||
Selling, general and administrative | 12,477 | 8,860 | 10,153 | |||||||||
Total operating costs and expenses | 12,477 | 8,860 | 10,153 | |||||||||
Loss from operations | (12,477) | (8,860) | (10,153) | |||||||||
Intercompany dividend income | 0 | 700,000 | 0 | |||||||||
Interest expense, net | (479) | (23,294) | (4,709) | |||||||||
Other, net | 115 | (21) | 474 | |||||||||
Income before taxes | (12,841) | 667,825 | (14,388) | |||||||||
Equity in net income/(loss) of subsidiaries | 182,733 | (401,715) | 613,383 | |||||||||
Provision for/(benefit from) income taxes | (5,606) | 16,604 | 0 | |||||||||
Net income | 164,286 | 282,714 | 598,995 | |||||||||
Statement of Comprehensive Income [Abstract] | ||||||||||||
Net income | 164,286 | 282,714 | 598,995 | |||||||||
Other comprehensive (loss)/income, net of tax: | ||||||||||||
Defined benefit plan | 0 | 0 | 535 | |||||||||
Subsidiaries' other comprehensive (loss)/income | (29,051) | 5,694 | 36,451 | |||||||||
Other comprehensive (loss)/income | (29,051) | 5,694 | 36,986 | |||||||||
Comprehensive income | 135,235 | 288,408 | 635,981 | |||||||||
Statement of Cash Flows [Abstract] | ||||||||||||
Net cash used in operating activities | (7,911) | (14,989) | (14,253) | |||||||||
Dividends received from subsidiary | 0 | 700,000 | 0 | |||||||||
Net cash used in investing activities | 0 | 700,000 | 0 | |||||||||
Proceeds from exercise of stock options and issuance of ordinary shares | 15,457 | 15,150 | 6,093 | |||||||||
Proceeds from/(payments on) intercompany borrowings | 30,966 | (344,018) | 410,190 | |||||||||
Payments to repurchase ordinary shares | (35,175) | (350,004) | (399,417) | |||||||||
Payments of employee restricted stock tax withholdings | (2,911) | (6,990) | (3,674) | |||||||||
Net cash provided by/(used in) financing activities | 8,337 | (685,862) | 13,192 | |||||||||
Net change in cash and cash equivalents | 426 | (851) | (1,061) | |||||||||
Cash and cash equivalents, beginning of year | $ 238 | $ 1,089 | 238 | 1,089 | 2,150 | |||||||
Cash and cash equivalents, end of year | $ 664 | $ 238 | $ 664 | $ 238 | $ 1,089 |
Schedule II - Valuation and Q_2
Schedule II - Valuation and Qualifying Accounts (Details) - Accounts receivable allowances - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward] | |||
Balance at the Beginning of the Period | $ 15,129 | $ 13,762 | $ 12,947 |
Addition Charged, Net of Reversal to Expenses/Against Revenue | 5,654 | 3,005 | 2,194 |
Deductions | (1,750) | (1,638) | (1,379) |
Balance at the End of the Period | $ 19,033 | $ 15,129 | $ 13,762 |